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Abstract
The increasing burden of chronic conditions creates a need to develop more effective 
approaches to improve management and health outcomes of chronic conditions. 
Information- and communication technologies provide tools to promote the management 
of chronic conditions. 
This thesis presents three randomized controlled trials that assessed the effect of 
telemonitoring interventions on health outcomes in individuals with type 2 diabetes (T2D), 
heart failure (HF) and coronary artery diseases (CAD). In all studies, telemonitoring 
involved self-monitoring of chronic condition related health parameters on a weekly basis, 
and sharing these data with healthcare professionals using a mobile phone. In addition, 
each study had a specific patient decision support component linked to the telemonitoring 
data. Study I, the Mobile Sipoo study, was conducted at the healthcare center of Sipoo, and 
included 51 patients with T2D who were followed for 10 months. The participants in the 
intervention arm recorded their weight, blood pressure, steps and/or blood glucose. These 
data were further linked with an automatic feedback system that provided patients with 
real-time, behavioral theory-based feedback messages that summarized the telemonitoring 
data, and motivated patients and provided them with behavioral skills to strengthen their 
self-management practices. The primary aim of Study I was to improve glycemic control, 
measured as HbA1c, and decrease blood pressure. Study II, the Heart at Home study, was 
conducted at the Cardiology Outpatient Clinic of Helsinki University Central Hospital 
and included 94 patients with systolic heart failure. The intervention participants were 
instructed to monitor their weight, blood pressure, heart rate and symptoms, and the data 
were linked with real-time, short feedback messages that summarized the data in relation 
to pre-specified individual target values. The primary aim of Study II was to reduce HF-
related hospitalizations during the 6-month follow-up. Study III, the Renewing Health 
study, was conducted at healthcare centers in South Karelia and included 519 patients with 
T2D (n=250), CAD (n=227) or HF (n=42). Participants monitored their weight, blood 
pressure, steps and/or blood glucose. In addition, each participant received individual 
iv
health coaching calls every 4 to 6 weeks to empower the patients and to teach them 
appropriate self-management skills tailored for each condition. The primary aim of Study 
III was to improve the health-related quality of life in all patients, and to reduce HbA1c in 
patients with T2D. In all studies the control group consisted of patients receiving standard 
care. As adherence is a prerequisite for achieving the intervention effects, adherence to the 
telemonitoring interventions was investigated in detail using the log files, and was defined 
as a percentage of weeks including at least one health parameter recorded. Analyses were 
performed according to the intention-to-treat principle.
In all studies, adherence to the weekly telemonitoring was moderate (Study III) to high 
(Study I and II) with the median percentage of adherent weeks being 93%, 90% and 66% 
in Study I, II and III, respectively, without major attrition in time. The telemonitoring 
intervention in Study I demonstrated a statistically significant improvement in glycemic 
control by reducing HbA1c by 0.44 percentage points. However, the blood pressure levels 
did not differ between the treatment arms. In study II, the telemonitoring intervention 
did not significantly reduce HF-related hospital admissions but, in fact, the utilization of 
the healthcare resources increased with the number of appointments and calls to the HF-
nurse being 2–5 times higher in the telemonitoring arm, and more unplanned visits to the 
cardiology clinic. A combination of telemonitoring and health coaching in Study III did 
not improve the health-related quality of life in patients with T2D, HF or CAD. Neither 
did it reduce HbA1c in patients with T2D. 
Sustained, fairly high adherence seen in all studies suggests that weekly telemonitoring 
of health-related parameters is feasible. Nevertheless, high adherence does not guarantee 
positive health effects. Two of the studies showed no improvement in health outcomes 
although participants were actively involved with telemonitoring. This indicates that 
telemonitoring as such might not be effective in improving chronic disease outcomes. 
Positive health effects were seen only in study I, where the individuals received real-time, 
behavioral-theory based feedback messages that summarized the TM data, and motivated 
and guided patients to take actions to promote self-management. Putting the results 
together, the findings of this work support earlier research findings on the importance 
of grounding interventions on behavioral theory and providing timely feedback with 
enriched content to promote self-management and further improve the health outcomes 
of individuals with chronic conditions. However, telemonitoring interventions might 
increase the use of healthcare resources, especially personnel resources by requiring more 
time of the responsible nurse. Thus, sufficient resources should be ensured and the benefits 
gained evaluated in the light of other findings. Telemonitoring interventions should be 
carefully designed to target patients who are likely to adhere to them and likely to benefit 
from such interventions.
vTiivistelmä
Kroonisten sairauksien hoitoon vaaditaan tehokkaampia ratkaisuja. Informaatio- ja kom-
munikaatioteknologiat tarjoavat mahdollisuuksia pitkäaikaissairaiden potilaiden hoidon 
kehittämiseksi ja paremman hoitotasapainon saavuttamiseksi.
Tässä väitöskirjassa esitellään kolme satunnaistettua kontrolloitua tutkimusta, joissa 
arvioitiin etämittausinterventioiden vaikuttavuutta terveyteen liittyviin muuttujiin tyy-
pin 2 diabeetikoilla, sydämen vajaatoimintapotilailla sekä sepelvaltimotautipotilailla. Kai-
kissa tutkimuksissa etämittausinterventio käsitti pitkäaikaissairauteen liittyvien terveys-
parametrien viikoittaista seurantaa sekä mittausarvojen välittämisen terveydenhuollon 
ammattilaisten käyttöön matkapuhelimen avulla. Etämittausten tueksi jokaisessa tutki-
muksessa interventioon sisältyi erilainen potilaan päätöksentukikomponentti. Tutkimus 
I, Mobile Sipoo -tutkimus, toteutettiin Sipoon terveyskeskuksessa. Tutkimuksessa oli mu-
kana 51 tyypin 2 diabeetikkoa, joita seurattiin 10 kuukauden ajan. Etämittausryhmässä 
potilaat ohjeistettiin mittaamaan painoa, verenpainetta, askelia ja/tai verensokeria. Mit-
taustuloksiin perustuen potilaat saivat reaaliaikaisia palauteviestejä omahoidon tukemi-
seksi. Käyttäytymisteoriaan pohjautuvat palauteviestit sisälsivät tiivistettyä tietoa potilaan 
pitkäaikaismittauksista, motivoivat muutokseen ja tarjosivat käytännön keinoja muutok-
sen saavuttamiseksi. Tutkimus I:n primääritavoite oli potilaiden glykohemoglobiinin ja 
verenpaineen alentaminen. Tutkimus II, Heart at Home -tutkimus, toteutettiin sydän- 
ja keuhkokeskuksen poliklinikalla Helsingin yliopistollisessa sairaalassa. Tutkimukseen 
osallistui 94 sydämen vajaatoimintapotilasta. Etämittausryhmän potilaat ohjeistettiin vii-
koittain mittaamaan painoa, verenpainetta, sykettä sekä sydämen vajaatoimintaan liittyviä 
oireita. Etämittauksiin perustuen potilaat saivat reaaliaikaisen palauteviestin, joka sisälsi 
lyhyen palautteen suhteessa asetettuihin tavoitearvoihin sekä kuvaajan mittaushistoriasta. 
Tutkimuksen II primääritavoite oli sydämen vajaatoimintaan liittyvien sairaalakäyntien 
määrän vähentäminen. Tutkimuksen kesto oli kuusi kuukautta. Tutkimus III, Renewing 
Health -tutkimus, toteutettiin Etelä-Karjalan sairaanhoitopiirin terveyskeskuksissa. Tut-
kimukseen osallistui 519 potilasta; 250 tyypin 2 diabeetikkoa, 227 sepelvaltimotautipo-
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tilasta ja 42 sydämen vajaatoimintapotilasta. Potilaat ohjeistettiin mittamaan painoa, ve-
renpainetta, askelia ja/tai verensokeria viikoittain. Etämittausten lisäksi osallistujat saivat 
henkilökohtaisen terveysvalmentajan, joka oli heihin puhelimitse yhteydessä 4–6 viikon 
välein. Terveysvalmennuksen avulla pyrittiin voimaannuttamaan potilasta sekä tarjoa-
maan keinoja pitkäaikaissairauden paremman hoitotasapainon saavuttamiseksi. Primääri-
tavoite tutkimus III:ssa oli parantaa potilaiden elämänlaatua sekä tyypin 2 diabeetikoiden 
osalta madaltaa veren glykohemoglobiinia, jota mitattiin HbA1c:n avulla. Kaikissa kol-
messa tutkimuksessa kontrolliryhmä sai tavanomaista hoitoa. Koska terveysvaikutusten 
saavuttaminen edellyttää potilaiden sitoutumista interventioon, potilaiden sitoutumista 
etämittausinterventioihin tutkittiin yksityiskohtaisesti lokitietojen avulla. Sitoutuminen 
määriteltiin niiden viikkojen prosentuaalisena osuutena, jotka sisälsivät vähintään yhden 
etämittauksen. Tilastolliset analyysit toteutettiin intention-to-treat periaatteiden mukai-
sesti. 
Sitoutuminen viikoittaisiin etämittauksiin vaihteli tutkimusten välillä kohtuullisesta 
(III) korkeaan (I ja II). Potilaat toteuttivat etämittauksia keskimäärin 93 % (I), 90 % (II) 
ja 66 % (III) viikoista. Sitoutumisen aste ei huomattavasti laskenut seuranta-ajan kuluessa. 
Etämittausinterventio tutkimuksessa I johti glykohemoglobiinin tilastollisesti merkitse-
vään vähenemiseen. HbA1c oli 0,44 prosenttiyksikköä matalampi etämittausryhmässä. 
Verenpaineessa ei ollut eroa ryhmien välillä. Tutkimuksessa II etämittausinterventio ei 
vähentänyt sydämen vajaatoimintaan liittyvien sairaalapäivien määrää. Itse asiassa terve-
ydenhuollon resurssien käyttö lisääntyi; sydänhoitajan vastanottoaikoja ja puhelinkontak-
teja oli 2–5 kertaa enemmän etämittausryhmässä. Etämittausryhmässä oli myös enemmän 
ennakoimattomia poliklinikkakäyntejä. Etämittausinterventio tutkimuksessa III, jossa 
yhdistettiin etämittaukset sekä henkilökohtainen terveysvalmennus, ei johtanut elämän-
laadun parantamiseen. Myöskään glykohemoglobiini ei vähentynyt tyypin 2 diabeetikoil-
la.
Kaikissa kolmessa tutkimuksessa potilaiden sitoutuminen viikoittaisten etämittaus-
ten tekemiseen oli suhteellisen korkea eikä se vähentynyt ajan kuluessa. Nämä havainnot 
viittaavat siihen, että viikoittainen etämittaaminen on toteutettavissa. Korkea sitoutumi-
nen ei kuitenkaan johtanut positiivisiin terveysvaikutuksiin; kahdessa tutkimuksista ei 
havaittu positiivisia terveysvaikutuksia, vaikka potilaat tekivät aktiivisesti etämittauksia. 
Etämittaaminen itsessään ei välttämättä ole riittävää kroonisten sairauksien hoitotulosten 
parantamiseksi. Positiivisia terveysvaikutuksia saavutettiin ainoastaan tutkimus I:ssä, jos-
sa osallistujat saivat etämittaustensa pohjalta käyttäytymisteoriaan perustuvia palautevies-
tejä. Palauteviestit sisälsivät tiivistettyä tietoa potilaan pitkäaikaismittauksista sekä moti-
voivat muutokseen ja tarjosivat keinoja muutoksen saavuttamiseksi. Tämän työn tulokset 
ovat linjassa aiempien tutkimustulosten kanssa, jotka korostavat käyttäytymisteorioihin 
perustuvien interventioiden tärkeyttä. Väitöskirjan yhteenvetona todetaan, että etämit-
tauksista saatavalla palautteella on keskeinen rooli. On tärkeää antaa reaaliaikaisuutta ja 
sisältörikasta palautetta, jotta voidaan tukea pitkäaikaissairaiden potilaiden omahoitoa ja 
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saavuttaa positiivisia terveysvaikutuksia. Etämittausinterventiot saattavat kasvattaa tervey-
denhuollon resurssien käyttöä, erityisesti sairaanhoitajien työkuormaa, joten tarvittavat 
resurssit tulisi varmistaa ja etämittausintervention mahdolliset hyödyt punnita muiden 
tulosten valossa. Lisäksi on tärkeää suunnitella etämittausinterventiot huolellisesti ja koh-
distaa ne potilaille, jotka sitoutuvat käyttöön ja todennäköisesti hyötyvät interventiosta. 
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1 Introduction
Chronic conditions—diseases of long duration and generally slow progression—have 
become a major health threat globally as the leading cause of mortality and morbidity and 
adversely affecting health-related quality of life (HRQoL), especially when poorly managed 
(Bauer, Briss, Goodman, & Bowman, 2014; World Health Organization, 2014). As of 
2012, 68% of deaths globally, of which more than 40% were premature, were attributable 
to chronic conditions (World Health Organization, 2014). In Finland, 93% of deaths were 
due to chronic conditions in 2017 (World Health Organization, 2017). Besides increasing 
premature mortality and morbidity, chronic conditions are highly prevalent and pose a 
significant strain on individual health and well-being and healthcare resources. In the US, 
more than 50% of adults have at least one chronic condition (Ward, Schiller, & Goodman, 
2014), and in 2012 chronic conditions were the primary reason for adults seeking healthcare 
services and accounted for 86% of total healthcare costs in the United States (Gerteis et al., 
2014). In Finland, 52% of women and 56% of men had at least one chronic condition in 
2017, and the prevalence increased up to 64% and 65%, respectively, among adults over 60 
years old (Koponen, Borodulin, Lundqvist, Sääksjärvi, & Koskinen, 2018).
The chronic disease burden can, however, be reduced. Many share common risk factors, 
behavioral and genetic, that account for a substantial amount of the chronic disease burden, 
and play a major role in managing chronic conditions (World Health Organization, 2002; 
2009). Managing long-term conditions requires maintained lifestyle changes, adherence 
to treatments and care seeking behaviors, posing self-management as the key element 
in managing chronic conditions. However, as few as 50% of individuals with a chronic 
condition adhere to long-term treatment guidelines (World Health Organization, 2003). 
Insufficient adherence exposes individuals to poor health outcomes and complications, and 
is further associated with reduced quality of life and excess healthcare costs (Donkin et al., 
2011; World Health Organization, 2003).
There is considerable interest in developing effective approaches to improve self-
management and chronic disease outcomes. Information and communication technologies 
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(ICT) have the potential to overcome some of these challenges. Leveraging ICT provides 
possibilities to intensify the delivery of healthcare through remote collection and 
transmission of health-related data, and to connect individuals with healthcare providers 
outside of healthcare facilities. Moreover, technology-assisted interventions have great 
potential to support individuals’ self-management efforts (Hanlon et al., 2017). The 
interventions have increasingly included education and information provision components, 
and mechanisms for providing feedback for patients. Typically, the feedback has involved 
healthcare providers who review the patient’s data and provide feedback accordingly 
(Kitsiou, Paré, & Jaana, 2015). More recently, there has been considerable interest in the 
potential of automatic feedback systems to improve self-management through personalized 
feedback and recommendations.
Telemonitoring (TM) interventions involve individuals measuring and reporting their 
health-related information remotely and transferring these data to healthcare providers in 
order to tailor care to individual needs (Pare, Jaana, & Sicotte, 2007). TM interventions 
have been widely studied with positive results among a variety of chronic conditions 
including diabetes, hypertension, chronic obstructive pulmonary disease and heart failure, 
and have been shown to reduce mortality and hospitalizations, improve glycemic control, 
lower blood pressure, and increase HRQoL and individuals’ knowledge of their condition 
(Hanlon et al., 2017; Inglis, Clark, Dierckx, Prieto-Merino, & Cleland, 2015; Jaana & Paré, 
2007). However, a growing number of studies show that TM interventions are not effective, 
specifically those involving heart failure (HF) patients (Chaudhry et al., 2010; Koehler et 
al., 2011; Ong et al., 2016). Moreover, the quality of evidence of TM studies and related 
systematic reviews has been criticized, and several authors have called for high-quality 
RCTs to make further conclusions including rigorous study designs, detailed description of 
adherence, and bigger sample sizes (Eysenbach, 2005; Inglis et al., 2015; Kitsiou et al., 2015).
The objective of this thesis was to investigate TM interventions in individuals with 
chronic conditions focusing on secondary prevention. As a part of this work, three 
randomized controlled trials were conducted across Finland to assess the effect of the 
TM interventions on health-related outcomes in individuals with type 2 diabetes (T2D), 
heart failure (HF) and coronary artery disease (CAD). Each study included a differential 
feedback component linked to TM which contributes to the understanding of their role 
in TM interventions. This thesis is based on four original articles from the three separate 
clinical trials.
19
 &RQFHSW'H¿QLWLRQV
Chronic conditions have an impact on patients’ physical, mental and social well-being. 
Chronic disease management is multifaceted and involves multiple components at both 
the patient and provider level, and requires system-level involvement for organizing care in 
a way that is it proactive rather than reactive. The following sections define the concepts 
central to the TM interventions developed and assessed in this work.
2.1 Self-management
Living with a chronic condition requires ongoing efforts by the individuals to adjust their 
behavior and to develop skills to cope with the illness. Typically, individuals meet with a 
healthcare provider only a few times a year, thus placing the responsibility for managing 
chronic conditions mainly on the patient. Self-management is therefore essential (Barlow, 
Wright, Sheasby, Turner, & Hainsworth, 2002; Martz, 2018).
Self-management has been conceptualized and defined in many ways. According to 
Corbin and Strauss, self-management involves three components: (i) medical management, 
such as adhering to medication regimes, (ii) behavioral management, such as maintaining 
or adopting new life roles after the onset of a condition, (iii) emotional management, such 
as dealing with emotional reactions to the onset of a chronic condition (Corbin & Strauss, 
1988). Clark et al. (1991) refers to self-management as “day to day tasks an individual 
must undertake to control or reduce the impact of disease on physical health status”. In 
addition, self-management requires psychosocial coping to react to problems generated or 
exacerbated by the condition (Clark et al., 1991.) Parsons et al. defined self-management as 
“actions individuals and others take to mitigate the effect of a long-term condition and to 
maintain the best possible quality of life” (Parsons et al., 2010). Richard and Shea refer to 
self-management as “the ability of the individual, in conjunction with family, community, 
and healthcare professionals, to manage symptoms, treatment, lifestyle changes, and 
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psychosocial, cultural, and spiritual consequences of health conditions” (Richard & Shea, 
2011). 
Self-management differs from self-care, although the concepts are sometimes used 
interchangeably (Richard & Shea, 2011). Self-management encompasses the ability to take 
actions to cope with a chronic condition, whereas self-care refers to the ability to care for 
oneself and perform activities to achieve, maintain or promote optimal health rather than 
managing a condition (Grady & Gough, 2014; Richard & Shea, 2011). Self-care is a broad 
concept subsuming self-management (Richard & Shea, 2011). 
The ability to decide which actions to take to manage one’s condition involves specific 
skills (Martz, 2018). There are five core self-management skills: problem solving, decision 
making, resource utilization, forming a collaborative partnership between individuals and 
the healthcare providers, and taking action (Bodenheimer, 2005; Lorig & Holman, 2003). 
Other skills needed are more disease-specific; for example, individuals with heart failure 
should restrict their fluid intake. The collaboration between the patient and the healthcare 
providers is important. Although individuals with a chronic condition have the main 
responsibility for the daily management of their condition, they need information and 
education from healthcare professionals on how to perform evidence-based care in order to 
avoid complications (Martz, 2018).
To summarize, self-management involves individuals taking an active role in managing 
their condition; they should not be viewed, nor see themselves, as passive recipients 
of healthcare but actively participate in managing their condition while collaborating 
with healthcare personnel. Self-management encompasses the skills needed to choose 
appropriate health promoting behaviors and adhere to them, as well as collaboration 
with the healthcare professionals who provide the information and education needed for 
successful self-management.
Self-management interventions are complex and multifaceted involving both the 
patient and the healthcare providers and need to be tailored according to individual and 
condition-specific needs (Hanlon et al., 2017). Pearce et al. developed a taxonomy that 
identified 14 components to be used to support self-management (Pearce et al., 2016). 
Hanlon et al. further defined six categories of self-management support components that 
could be specifically targeted through telehealth interventions. These include: patient 
education and information provision, remote monitoring with feedback and action 
plans, telehealth-facilitated clinical review, adherence support, psychological support, and 
lifestyle intervention (Hanlon et al., 2017).
2.2 Self-monitoring
Self-monitoring is an aspect of self-management (Richard & Shea, 2011) that involves 
systematic self-observation, periodic measurement and recording of target behaviors 
(Burke, Wang, & Sevick, 2011; Kanfer, 1970). Conscious attention to certain behaviors 
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increases self-awareness, which is an essential step in promoting behavior change (Burke, 
Swigart, Warziski Turk, Derro, & Ewing, 2009). Self-monitoring originates from Kanfer’s 
self-regulation model, which includes three stages of promoting behavior change; self-
monitoring, self-assessment and self-reinforcement (Kanfer, 1970). Self-monitoring is 
expected to improve self-management.
In the context of chronic conditions, self-monitoring involves the individual 
undertaking the following: self-measurement of vital signs, symptoms, or behaviors, ii) 
self-interpretation of data, and iii) self-adjustment of medication, lifestyle or care-seeking 
behaviors as a result of increased awareness (McBain, Shipley, & Newman, 2015; Wilde & 
Garvin, 2007). The optimal intensity of self-monitoring is not defined, but self-monitoring 
patterns, including the intensity, timing and method of self-monitoring and the target 
behaviors, are subject to the chronic condition and to individual care plans. Regardless of 
the intensity of self-monitoring, most important are the actions taken in response to self-
monitoring efforts rather than intensively gathering comprehensive data (Inglis et al., 2015; 
Mattila, 2010).
2.3 Telehealth and telemonitoring
Telemonitoring (TM) is a particular form of self-monitoring and a particular form of 
telehealth. Telehealth refers to the use of ICT to provide healthcare to individuals at a 
distant location (World Health Organization, 2010). It is often used interchangeably with 
telemedicine. eHealth in turn refers to organizing and delivering of health services and 
information using the Internet and related technologies (Eysenbach, 2001). Telehealth may 
be synchronous or asynchronous. Asynchronous telehealth involves a store-and-forward 
approach that allows data to be recorded at one point in time and viewed by a healthcare 
provider at another time and location (Whitten, Holtz, & Laplante, 2010; World Health 
Organization, 2010). In contrast, synchronous approaches refer to more conventional 
telehealth involving delivery of information in real-time where all individuals are present 
simultaneously for immediate exchange of information (Whitten et al., 2010). A typical 
example of synchronous services is videoconferencing.
TM is, as defined by Pare et al. (2007), an automated process for the transmission of data 
on an individual’s health status from a distant location to the healthcare provider where 
the individual is responsible for uploading and transmitting the data without the help of 
the healthcare provider. TM moves patients’ care out of a clinical setting into the patient’s 
home. TM is thus sometimes referred to as home TM. However, in this work, TM is used 
without reference to the patient’s home. TM involves remote monitoring of physiological 
data specific to a chronic condition, such as blood glucose monitoring in diabetes patients or 
blood pressure monitoring in individuals with hypertension, and using monitoring devices 
for transferring the data for use by the healthcare providers. Sharing the monitored data 
with the healthcare professionals has potential to intensify the collaboration and influence 
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professionals’ decision making. In addition, TM is assumed to improve self-management 
by increasing awareness and knowledge of one’s health condition through self-monitoring 
(Inglis et al., 2015).
TM has been typically referred to as asynchronous telehealth; patients monitor their 
vital signs and store the data in a database that can be accessed by the healthcare providers. 
As such technology is used as a passive medium that enables remote access and delivery of 
care. Yet, TM interventions have increasingly included mechanisms that involve interaction 
between the patient and technology. Such interventions include both synchronous and 
asynchronous components. Patients upload their data, which is further processed, and 
algorithms generate responses based on specific parameter values. Interactive systems tailor 
the content of the responses based on the data provided by the patient. However, such 
systems do not involve information processing, which is a specific feature of active assistance 
technology. Active assistance technology takes a step further, serving as an active tool for 
automated processing of health information in an ongoing manner as the user interacts 
with the technology (Kennedy et al., 2012). The active information processing affects 
semantic content of the responses provided, which is a distinctive feature of interactive 
systems (Kennedy et al., 2012.).
2.4 Adherence
Interventions can be effective only if participants adhere to them. According to WHO, 
adherence defines “the extent to which a person’s behavior corresponds with agreed 
recommendations from a healthcare provider” (World Health Organization, 2003). 
Adherence, contrary to compliance, emphasizes the collaborative relationship between the 
individual and the healthcare provider in which treatment goals have been jointly agreed. 
Compliance refers more to the authority of healthcare professionals who set up treatment 
regimens that individuals are required to follow (World Health Organization, 2003). 
Attrition is closely related to adherence and refers to discontinuation of an intervention 
(Eysenbach, 2005). While adherence is measured throughout the intervention, attrition 
refers to a specific time point when the participant stops using the intervention (Eysenbach, 
2005).
Adherence is always context-specific depending on the components and specific 
requirements of an intervention and the technology used. Unlike medication, self-
management is not uniform treatment but encompasses multiple components and typically 
targets multiple behaviors such as following a diet, executing lifestyle changes, or taking 
medications. While in pharmacology sufficient adherence is typically defined as taking 
80% or more of prescribed doses (Nieuwlaat et al., 2014), in self-management interventions 
sufficient exposure is multifaceted and should be defined study-wise or even on a patient 
level depending on individual needs.
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Studies exploiting ICT produce log data that allow accurate and objective description 
of adherence to interventions (Sieverink, Kelders, Poel, & van Gemert-Pijnen, 2017). The 
log data provides possibilities to investigate participants’ exposure to the intervention 
from different perspectives by using metrics such as number of logins, duration of sessions, 
intensity of use, uploaded self-measurements, and page visited (Couper et al., 2010). 
Thorough description of adherence combined with feedback from users helps determine 
the efficacy of different components, which would not necessarily be possible with more 
conventional interventions. 
The consort statement for eHealth interventions recommends detailed description of 
usage data including an attrition diagram showing the proportion of adherent participants 
over time (Eysenbach & CONSORT-EHEALTH Group, 2011). As an individual’s 
involvement with an intervention typically decreases over time, single aggregated measures 
may provide misleading information on adherence (Nelson, Coston, Cherrington, & 
Osborn, 2016). Thus, a time varying description of adherence has been recommended. 
Nonetheless, adherence remains poorly reported in the eHealth interventions. One possible 
reason might be high attrition, which is a typical feature of eHealth interventions, especially 
those without human involvement (Eysenbach, 2005). As high attrition and low adherence 
rate are linked to intervention failure, this might contribute to such interventions being 
underreported, thus posing a bias in the literature. However, it is important to measure 
adherence, not only to shed light on non-usage, but also to ensure that possible health 
benefits achieved can be attributed to the intervention used (World Health Organization, 
2003).
Currently, adherence is an improperly used concept in eHealth interventions 
in particular. It is frequently insufficiently defined or completely undefined, and is 
interchangeably used with actual use (Sieverink, Kelders, & van Gemert-Pijnen, 2017). It has 
been recognized that sufficient exposure to an intervention is challenging to determine for 
behavioral interventions in particular because effective usage patterns might differ across 
individuals, and individuals do not necessarily have to be exposed to all of the elements of 
an intervention to achieve positive health outcomes (Donkin et al., 2011). Therefore, higher 
engagement with an intervention does not necessarily constitute improved outcomes, 
and discontinuation with an intervention does not mean failure, but may also reflect 
sufficient mastery and thus continued exposure to the intervention is no longer needed. 
Yardly et al. have proposed effective engagement as meaning sufficient engagement with 
the intervention to achieve intended outcomes. Effective engagement is based on the 
purpose of a particular intervention and based on individual needs. (Yardley et al., 2016.) 
Nevertheless, it is recommended that adherence and associated measures are clearly defined 
in the design phase, and should preferably be justified by using theory, evidence or rationale 
(Sieverink, Kelders, & van Gemert-Pijnen, 2017).
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3 Background on the Chronic Conditions Studied
This work focuses on three chronic conditions: type 2 diabetes (T2D), heart failure (HF) 
and coronary artery disease (CAD). Each condition is described in the following sections 
followed by a summary of the self-management guidelines for each disease. This short 
overview provides a background for the TM interventions developed and assessed in this 
work.
3.1 Heart failure
Heart failure (HF) results from cardiac dysfunction that impairs the ability of the ventricle 
to fill with or eject blood. As a result, too little blood is delivered, and the organs and 
other tissues do not receive enough oxygen to meet their needs (Ponikowski et al., 2016; 
Yancy et al., 2013). Ejection fraction determines how well the ventricle pumps out blood 
on each contraction. Left ventricular ejection fraction (LVEF) is used in the classification 
of individuals with HF. Systolic heart failure refers to reduced ejection fraction (HFrEF) 
when the LVEF < 40%. A normal LVEF is 50–75%. (Ponikowski et al., 2016.) HF decreases 
individuals’ functional status and impairs HRQoL with typical symptoms including 
breathlessness, ankle swelling, fatigue with limited exercise tolerance, and fluid retention 
(Nieminen et al., 2015; Yancy et al., 2013). The New York Heart Association (NYHA) 
functional classification is frequently used to describe the functional severity of HF; the 
NYHA assigns individuals to one of four classes based on exercise capacity and symptoms: 
I=no limitation of physical activity, II=slight limitation of physical activity, III=marked 
limitation of physical activity, IV=unable to carry on any physical activity without 
symptoms of HF (Yancy et al., 2013). 
HF is associated with high mortality and high hospitalization rates, which makes it 
a serious and costly disease. One-year mortality is approximately 30% varying according 
to the severity of the condition; among recently hospitalized HF patients mortality 
rates can increase up to 43%, whereas for stable HF 1-year mortality is 7% (Blackledge, 
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Tomlinson, & Squire, 2003; Chen, Normand, Wang, & Krumholz, 2011; Maggioni et al., 
2013). Without appropriate treatment, HF has a poorer survival rate than many forms of 
cancer  (Stewart, MacIntyre, Hole, Capewell, & McMurray, 2001). HF is characterized by 
periodic acute decompensations that require treatment intensification. Frequent hospital 
admissions are typical for individuals with HF; after initial hospital admission 19–25% are 
readmitted within 30 days, and the 1-year hospitalization rate is 32–44% (Maggioni et al., 
2013; Ross et al., 2010). These hospitalizations pose a heavy economic burden on society, 
accounting for 60–70% of the total cost of HF care (Stewart, 2005). Approximately half of 
the hospitalizations are preventable (Braunstein et al., 2003; Vinson, Rich, Sperry, Shah, & 
McNamara, 1990). Factors contributing to preventable admissions include nonadherence 
to medications and diet, inadequate discharge planning or follow up, and failure to seek 
medical care promptly when symptoms occur (Vinson et al., 1990).
The prevalence of HF is approximately 1–2% rising to ≥10% among people >70 years of 
age (Ponikowski et al., 2016). In Finland, approximately 3% of adults under 70 years have 
HF, and the prevalence increases up to 27% among people >80 years of age (Koponen et 
al., 2018).
The management of HF requires a multidisciplinary approach that encompasses 
structured follow-up, education, optimized medical treatment, psychosocial support and 
improved access to care where HF practitioners and other experts collaborate (Lainscak et 
al., 2011; Yancy et al., 2013). Self-management in HF involves regular monitoring of HF-
related disease parameters and acting on early symptoms to decrease the risk of hospital 
admission (Lainscak et al., 2011; Yancy et al., 2013). Specific self-management behaviors 
include medication taking, weight and symptom monitoring, dietary adherence, fluid 
and alcohol restriction, weight management, exercise, smoking cessation, and engaging in 
preventative behaviors such as travel safety and immunization (Lainscak et al., 2011). Self-
monitoring of weight is recommended as body weight is an indicator of fluid retention that 
often predicts decompensated HF (Chaudhry, Wang, Concato, Gill, & Krumholz, 2007). 
Daily information on body weight may help in detecting high-risk periods where appropriate 
intervention (such as medication adjustment) could be provided. A sudden unexpected 
weight gain of >2 kg in 3 days is an indicator of a need for an increased diuretic dose, which 
requires alerting the healthcare provider (Ponikowski et al., 2016). Other recommended 
self-monitoring parameters include blood pressure and heart rate (Lainscak et al., 2011) to 
allow the detection of episodes of arrhythmias and hypotension which also might precede 
decompensation (Zile et al., 2008). Regular symptom monitoring may shorten the delay for 
seeking care for worsening symptoms (Evangelista, Dracup, & Doering, 2000). Restriction 
of fluids and sodium are recommended for maintaining euvolemia because volume overload 
can worsen the symptoms of HF and lead to hospitalization (Lainscak et al., 2011). 
Unfortunately, adherence to self-management recommendations is frequently 
suboptimal; adherence to a low sodium diet, weight monitoring, fluid restriction and 
exercise recommendations has been as low as 5–10% (Jaarsma et al., 2013; van der Wal & 
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Jaarsma, 2008). HF is associated with old age, presence of multiple chronic conditions, and 
an increased prevalence of anxiety, depression and impaired cognition that may contribute 
to poor adherence rates (Braunstein et al., 2003; Freedland et al., 2016; Riegel et al., 2009; 
Yancy et al., 2013).
3.2 Type 2 diabetes
Diabetes is a chronic condition that occurs when the human body does not produce enough 
insulin, or the body is unable to use insulin effectively to regulate blood glucose. As a result, 
blood sugar builds up in the blood leading to high levels of blood glucose, hyperglycemia 
(International Diabetes Federation, 2017a). Chronic hyperglycemia strains blood vessels 
and reduces blood flow, which can further damage several body organs over time. Diabetes 
complications include cardiovascular complications, foot ulcers, retinopathy and kidney 
failure, amongst others (International Diabetes Federation, 2017a; World Health 
Organization, 2016). In addition, abnormally low blood glucose, hypoglycemia, can occur 
in diabetes patients and may result in seizures or loss of consciousness (World Health 
Organization, 2016).
Type 2 diabetes (T2D) is the most common form of diabetes and accounts for over 
90% of all diabetes cases globally (Rydén et al., 2013). Although T2D and type 1 diabetes 
are heterogeneous diseases, the global estimated of diabetes are often combined for both 
types (World Health Organization, 2016). In 2014, the prevalence of diabetes was 8.5% 
(World Health Organization, 2016). Approximately 420 million adults had diabetes in 
2014 and this figure is estimated to increase to 552 million by 2030 (Rydén et al., 2013; 
World Health Organization, 2016). In Finland, 300,000 people have T2D, and further 
150,000 are estimated have the condition but remain undiagnosed (Diabetesliitto, 2018).
Glycosylated hemoglobin (HbA1c) is an indirect measure of long-term blood glucose 
concentration, referring to the process by which hemoglobin, a protein within red blood 
cells, combines with glucose in the blood stream to form the glycosylated hemoglobin. The 
more glucose in the blood, the more HbA1c is present. As red cells survive for 8–12 weeks, 
the amount of HbA1c present reflects the blood glucose concentration over that duration 
(World Health Organization, 2011.) HbA1c is a commonly used outcome variable in 
diabetes studies because it provides a useful biomarker for average long-term blood glucose 
concentration and does not require fasting (Quinn et al., 2009). Although low HbA1c does 
not necessarily mean that diabetes is being well-managed, well-controlled blood glucose 
levels are characterized by normal or close to normal HbA1c levels (Quinn et al., 2009). 
Healthy individuals have HbA1c typically below 6% (47mmol/mol) (American 
Diabetes Association, 2018a). Individuals with T2D should maintain a glycemic level as 
close to normal as possible to prevent complications. The recommended target for HbA1c 
is <7.0% (53mmol/mol) (American Diabetes Association, 2018a; Montalescot et al., 2013; 
Suomalaisen Lääkäriseuran Duodecimin Suomen Sisätautilääkäreiden yhdistyksen ja 
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Diabetesliitos Lääkärineuvoston asettama työryhmä, 2018). For T2D individuals with 
short disease duration and no significant cardiovascular disease, an HbA1c target of <6.5% 
can be used if it can be achieved without significant hypoglycemia (American Diabetes 
Association, 2018a). 
Lifestyle changes are recommended in the first instance for newly diagnosed T2D 
individuals. Even a modest weight reduction of 5–10% improves glycemic control and 
reduces cardiovascular risk factors (Inzucchi et al., 2012). If the HbA1c target is not 
achieved with lifestyle changes, Metformin is added as the first-line drug. For individuals 
with hyperglycemic symptoms and/or HbA1c >10.0%, insulin therapy should be considered 
(American Diabetes Association, 2018b). In addition, hypertension should be treated and 
all individuals should have a blood pressure target of <140/90 mmHg unless individually 
defined (American Diabetes Association, 2018c). Individuals with high risk and very high 
risk of cardiovascular events should have a low-density-lipoprotein (LDL) cholesterol level 
below 2.5mmol/L and 1.8mmol/L, respectively (Rydén et al., 2013).
Self-monitoring of blood glucose (SMBG) is a central component of self-management 
for individuals with diabetes. SMBG involves collecting detailed information on glucose 
levels at different times during the day. The SMBG data guides individuals in adjusting 
medication, insulin doses in particular, and preventing or confirming hypoglycemia, thus 
improving the patient’s own recognition of severe events (Malanda, 2013). SMBG also 
helps understand the impact of lifestyle on blood glucose variation, thus helping to guide 
nutrition therapy and physical activity (American Diabetes Association, 2018a. While 
SMBG is especially important for insulin-treated individuals to prevent hypoglycemia and 
hyperglycemia, there has been controversy about the value of SMBG among non-insulin 
T2D individuals (Farmer et al., 2012; Malanda et al., 2012). Promoting SMBG alone does 
not improve glycemic control, instead SMBG should be combined with individual and 
provider education to ensure patients have the appropriate skills to do SMBG and that the 
data is correctly interpreted and effectively used in decision making (Polonsky & Fisher, 
2013). In addition, structured SMBG profiles that include a pre-specified frequency and 
timing of SMBG in accordance with individual SMBG goals are recommended (American 
Diabetes Association, 2018a). In Finland, the SMBG for non-insulin dependent patients 
is recommended on an individual basis depending on the patient’s needs, skills, glycemic 
control and individual risk of hypoglycemia (Suomalaisen Lääkäriseuran Duodecimin 
Suomen Sisätautilääkäreiden yhdistyksen ja Diabetesliitos Lääkärineuvoston asettama 
työryhmä, 2018).
3.3 Coronary artery disease
Coronary artery disease (CAD) refers to a heart disease in which the blood flow is restricted 
or reduced due to narrowing of the coronary arteries that supply oxygen-rich blood to the 
heart muscle. CAD develops when plaque, cholesterol-containing deposits, builds up inside 
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the coronary arteries (Montalescot et al., 2013). Typical symptoms of CAD include chest 
pain or shortness of breath, or heart attack if the supply of blood is completely blocked by 
a sudden rupture of plaque and formation of a blood clot (Montalescot et al., 2013). Over 
time, CAD can weaken the heart muscle and lead to HF and arrhythmias.
CAD is estimated to affect 4–7% of 45–64-year-olds and 10–14% 65–84-year-olds 
(Montalescot et al., 2013). In Finland, 9% of men and 7% of women >50 years of age had 
CAD in 2017 (Koponen et al., 2018). Ischemic heart disease is the single largest cause of 
death and illness in the world (World Health Organization, 2018). In 2016, ischemic heart 
disease caused 9 million deaths globally accounting for 17% of all deaths. In Finland the 
condition was attributable to 20% of all deaths and was the most common cause of death 
in 2016 (Official Statistics of Finland, 2016). In high-risk individuals one-year mortality is 
3.8%, whereas in individuals with non-obstructive plaques within the coronary arteries, the 
annual mortality rate is 0.6% (Montalescot et al., 2013). 
The management of CAD encompasses lifestyle modification, controlling the risk 
factors, pharmacological therapy and patient education (Fihn et al., 2012; Montalescot et 
al., 2013). The goal is to reduce plaque buildup and lower the risk of blood clots forming, 
and relieve symptoms. Medical procedures including laser surgery, coronary bypass surgery 
and stent placement are considered if the arteries are very narrow (Montalescot et al., 2013). 
Management of the risk factors for damage to the coronary arteries is essential to 
avoiding cardiovascular complications. These risk factors include smoking, high levels of 
sugar and certain fats and cholesterol in the blood, high blood pressure, and blood vessel 
inflammation (Montalescot et al., 2013; National Heart Lung and Blood Institute, 2018). 
The target levels for blood pressure are <140/90 mmHg, or within 130–139/80–85 mmHg 
as suggested recently (Montalescot et al., 2013). The goal for LDL cholesterol is below 1.8 
mmol/L or a 50% reduction when the target level cannot be reached. As diabetes increases 
the progression of CAD, target for HbA1c is <7.0%, or <6.5–6.9% on an individual basis 
(Montalescot et al., 2013). 
Lifestyle recommendations include heart-healthy eating, maintaining a healthy weight 
(BMI 18.5–24.9 kg/m2), regular physical activity and smoking cessation (Montalescot et 
al., 2013). In addition, individuals with CAD are encouraged to take up regular physical 
activity, including both moderate-intensity aerobic exercise and muscle training (Fihn et 
al., 2012; Montalescot et al., 2013). Cardiac rehabilitation, which encompasses structured 
exercise counselling and training is a class I recommendation for all individuals with CAD 
(Anderson et al., 2016; Anderson & Taylor, 2014; Montalescot et al., 2013). In addition, 
introducing and educating self-monitoring skills and encouraging patients towards regular 
self-monitoring of blood pressure and glucose, tracking daily calories and physical activity, 
are recommended to support lifestyle changes (Fihn et al., 2012).
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4 Review of Literature on Telemonitoring 
Interventions in Heart Failure, Type 2 
Diabetes and Coronary Artery Disease
The underlying idea of TM interventions is to promote the management of chronic 
conditions by encouraging individuals to monitor their health parameters remotely and 
to share the data with healthcare professionals, thus providing them with accurate and 
up-to-date patient information (Pare et al., 2007). The self-monitoring data is recorded in 
a natural setting and constitutes longitudinal information that cannot be obtained during 
brief clinic visits. Exploiting this data, healthcare providers can remotely detect indicators 
of poor or worsening health and modify the patient’s management plan accordingly 
in a timely manner to avoid complications, for example through medication or lifestyle 
adjustments (Greenwood, Young, & Quinn, 2014).
Besides informing the healthcare providers with the patient’s health data, TM 
interventions also have potential to support individuals’ self-management efforts and 
aid their decision making based on the TM data. There are a variety of self-management 
support components that could be targeted through telehealth interventions (Hanlon et 
al., 2017). One of the components, specifically relevant for TM interventions, is the remote 
monitoring with feedback and action plans (Hanlon et al., 2017). In fact, a complete 
feedback loop is considered essential to produce positive health outcomes (Jimison et al., 
2008). The complete feedback loop encompasses a combination of five stages: (i) monitoring 
and transmission of data about the current status of the patient; (ii) interpretation of these 
data in light of established treatment goals; (iii) adjusting the management plan as needed; 
(iv) timely communication back to the patient with tailored recommendations or advice, 
and (v) regular repetition of this cycle (Jimison et al., 2008).
Feedback in TM interventions has typically involved healthcare providers who review 
the TM data and provide feedback accordingly (Kitsiou et al., 2015). Consequently, the 
feedback is frequently provided intermittently rather than in real time. However, in 
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response to the growing demand for healthcare services TM interventions have increasingly 
included mechanisms for providing automatic feedback. Such automatic feedback systems 
involve reminders and feedback messages automatically delivered to the patients based on 
their data and individual treatment targets. Processing TM data in real time enables timely 
responses to the data, which is one of the elements in a complete feedback loop (Jimison et 
al., 2008).
To achieve optimal outcomes, interventions promoting self-management and health 
behavior changes should be grounded on behavioral theories and use specific behavior 
change techniques. Theories can help identify key determinants of the target behaviors 
and associated behavior change strategies needed to achieve the desired health outcomes 
(van Vugt, de Wit, Cleijne, & Snoek, 2013; Winter, Sheats, & King, 2016). These principles 
apply to telehealth interventions. Providing feedback on performance is consistently found 
to be important in promoting behavior change (van Vugt et al., 2013). It has been shown 
that interventions that used behavioral theory achieved better health outcomes (Sharon, 
Esser, & Hofmann, 2018; Webb, Joseph, Yardley, & Michie, 2010). Accordingly, extensive 
use of behavior change techniques produces larger effects than interventions with fewer 
techniques (van Vugt et al., 2013; Webb et al., 2010). 
Chronic disease management requires organizing the delivery of care in a way that 
is proactive and supports long-term management rather reacting to acute episodes. The 
Chronic Care Model is a widely accepted and validated framework for developing the care 
of chronic diseases in a such way (Bodenheimer, Wagner, & Grumbach, 2002; Coleman, 
Austin, Brach, & Wagner, 2009; Davy et al., 2015). The model identifies six components to 
be included in efficient management of chronic diseases: self-management support, health 
system support, clinical information systems, delivery system design, decision support, 
and community resources. More recently, the eHealth enhanced Chronic Care Model, 
framework has been published to guide the organization of care when integrating eHealth 
technologies (Gee, Greenwood, Paterniti, Ward, & Miller, 2015). This, in particular, is 
applicable to TM interventions. According to this model, eHealth education, eHealth 
support and a complete feedback loop are critical to assure efficient patient-provider 
collaboration. 
The next three chapters review RCTs investigating TM interventions in individuals 
with T2D, HF and CAD. Studies published mainly after 2008 are included summarizing 
the evidence from the past ten years to avoid major technological differences that may 
influence the results. The interventions are summarized by separately describing the 
TM component and feedback provided in response to TM. The effectiveness of the TM 
interventions is summarized using the primary outcomes and HRQoL to link the findings 
of this thesis to the existing literature.
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4.1 Telemonitoring interventions in individuals with heart failure
In individuals with HF, TM interventions have involved remote patient monitoring of 
HF-specific symptoms and vital signs typically including weight, symptoms and blood 
pressure, and sharing the data with healthcare professionals to provide them with increased 
information about the individuals’ clinical status. Besides increasing the individual’s own 
awareness and thus improving their self-management, the TM interventions focus on 
predicting decompensation episodes that usually correlate with fluid retention and require 
treatment intensification. Gathering longitudinal data on weight and blood pressure is 
expected to enable early recognition of such deterioration. (Gyllensten et al., 2016.)
TM interventions in individuals with HF have been extensively studied during the last 
two decades, and the results have been summarized in multiple reviews (Inglis et al., 2015; 
Kitsiou et al., 2015; Pandor et al., 2013; Paré, Moqadem, Pineau, & St-Hilaire, 2010), and a 
meta-analysis summarizing evidence from 15 reviews by Kitsiou et al. (2015). Both reviews 
concluded that TM reduces mortality and HF-related hospitalization and improves 
HRQoL. However, many of the studies included in the meta-analyses were criticized for 
poor to moderate quality, and the authors called for additional, well-designed, randomized 
controlled trials to confirm the results (Inglis et al., 2015; Kitsiou et al., 2015; Pandor et al., 
2013). 
Table 1 summarizes 13 RCTs published after 2008 that investigated TM interventions 
with HF patients. One important study from 2005 is also included in this review as it 
is one of the first well-designed RCTs to assess the effectiveness of TM interventions 
and is frequently cited in the literature (Cleland et al., 2005). TM interventions and the 
feedback provided in response to TM data are summarized. The effectiveness of the studies 
is presented by including adherence, mortality, hospitalizations and HRQoL outcomes.
Participants of TM studies were typically recently hospitalized patients with HF with 
mean ages varying from 54 to 76 years, and the majority being men. Participants frequently 
had HFrEF with LVEF varying from 25% to 40%, and a NYHA class of II–IV indicating 
at least a marked limitation of physical activity. The length of the studies varied from 6 to 
26 months. The largest studies included 1653 and 1437 participants, whereas the smallest 
study had 80 participants.
The TM interventions typically involved daily TM of weight, blood pressure, heart 
rate and symptoms. Some studies included additional monitoring parameters such as 
ECG (Cleland et al., 2005; Koehler et al., 2011; Mortara et al., 2009; Seto et al., 2012), 
psychological assessment (Bekelman et al., 2015; Chaudhry et al., 2010; Villani et al., 2014) 
or medication adherence (Cleland et al., 2005; Villani et al., 2014). In one study (Mortara 
et al., 2009), participants self-monitored their health parameters on a weekly basis. The 
monitoring data were reviewed by the study personnel on a daily or weekly basis but no 
less frequently. Seven studies relied on alerts; the healthcare providers received an alert if 
patients’ recordings exceeded the predefined thresholds (Cleland et al., 2005; Dar et al., 
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2009; Dendale et al., 2012; Lyngå et al., 2012; Olivari et al., 2018; Ong et al., 2016; Seto et 
al., 2012). 
Patient feedback components varied substantially, if provided at all. In one study, 
participants received automatic feedback messages coupled with instructions; after each 
measurement participants received instructions on what to do after taking the measurement 
(Seto et al., 2012). In another study TM was combined with monthly health coaching (Ong 
et al., 2016). Other studies did not provide feedback or health counselling. Instead, the 
healthcare providers were typically informed if the TM data exceeded the predefined target 
values and they took appropriate actions. Only in two studies it was specifically clarified 
that the HF-nurse called the patient and provided self-management support if the target 
values were exceeded (Dar et al., 2009; Dendale et al., 2012). In four studies participants 
were also contacted if they did not adhere to the TM plan (Chaudhry et al., 2010; Lyngå et 
al., 2012; Ong et al., 2016; Seto et al., 2012). Three TM interventions included collaboration 
with the research team and the patients’ local physicians (Cleland et al., 2005; Dendale et 
al., 2012; Koehler et al., 2011).
Adherence to the daily TM was relatively high with adherence rates of approximately 
80% or higher across the studies. However, the definitions of adherence were heterogeneous. 
For example, in two studies the researchers reported the percentage of participants who 
adhered to making daily recordings, whereas another study reported the percentage of 
participants who used the system but without detailing the intensity of use (Cleland et 
al., 2005; Olivari et al., 2018; Seto et al., 2012). Particularly low adherence rates were seen 
in the studies by Chaudhry et al. and Ong et al. In the former study, 14% of participants 
never used the system, and 55% were adherent at the end of the study although participants 
received automatic reminder calls if they did not submit data. In the latter study, adherence 
was 52%. Both of these studies had large sample sizes, 1653 and 1437, respectively (S. 
Chaudhry et al., 2010; Ong et al., 2016).
It seems that TM interventions were not effective in reducing mortality. Of the twelve 
studies that reported mortality outcomes, only two studies showed a statistically significant 
decrease in mortality rates (Bekelman et al., 2015; Dendale et al., 2012). In addition, in the 
study by Cleland et al. participants receiving either TM or structured telephone support 
showed significantly lower mortality than participants receiving standard care, although 
no statistical test was reported comparing the TM group only with the standard care 
group (Cleland et al., 2005). Although only two studies reached statistical significance in 
mortality outcomes, the overall trend was that TM improved survival, as the majority of the 
studies reported lower mortality rates in the TM arm. However, those reductions were not 
statistically significant. The HF-related hospitalization admissions were lower in the TM 
arms in two studies (Dendale et al., 2012; Villani et al., 2014) with 0.24 vs 0.42 admissions 
per patient, and 58% vs. 30% of patients hospitalized, respectively. Similarly, the general 
tendency was that hospitalization rates were slightly lower in the TM arms; however, the 
differences between the treatment arms were small and not statistically significant.
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HRQoL in individuals with HF has been assessed using different instruments, 
including the Minnesota Living with Heart Failure questionnaire (Riegel et al., 2002), 
the SF-12/36 (McHorney, Ware, & Anastasia, 1993) or the Kansas City Cardiomyopathy 
questionnaire (Green, Porter, Bresnahan, & Spertus, 2000). In five studies (in total 
nine studies investigated HRQoL), participants in the TM group reported significantly 
improved HRQoL (Jayaram et al., 2017; Olivari et al., 2018; Ong et al., 2016; Seto et al., 
2012; Villani et al., 2014). HRQoL was the primary outcome in only one study (Seto et al., 
2012). Thus, studies that did not reach statistical significance may have been unpowered to 
detect differences between the groups. The HRQoL results suggest that TM interventions 
may have potential for treating psychological aspects and improving HRQoL rather than 
reducing hospitalization and mortality.
The reviewed TM interventions were heterogeneous with differential outcomes and 
patient populations, making it difficult to identify effective components. However, some 
were identified. TM intervention components that were associated with positive health 
outcomes included providing feedback that included advice in response to TM data, 
monitoring psychological parameters, and intense collaboration between clinic and general 
practitioner (GP) (Bekelman et al., 2015; Dendale et al., 2012; Jayaram et al., 2017; Seto et al., 
2012; Villani et al., 2014). In one study where participants experienced improved HRQoL, 
the TM system provided immediate automatic instructions on how to act in response 
to the recorded data (Seto et al., 2012). Intense collaboration between the HF clinic and 
the patient’s GP was included in one TM intervention where TM data were shared with 
patients’ GPs to support their decision making, and the GPs also received back-up support 
for their decisions from the HF clinic. This intervention significantly reduced mortality 
and HF-related hospitalizations (Dendale et al., 2012). Focusing on psychological aspects 
as a part of the TM intervention was associated with improved HRQoL in particular 
(Jayaram et al., 2017; Villani et al., 2014), and with reduced mortality (Bekelman et al., 
2015) and hospitalization (Villani et al., 2014).
Researchers have sought to identify subgroups of patients who are most likely to 
benefit from TM interventions. Dendale and colleagues found that neither LVEF nor 
N-terminal pro brain natriuretic peptide correlated with study outcomes (Dendale et al., 
2012). Similarly Ong et al. (Ong et al., 2016) and Villani et al. (Villani et al., 2014) found 
no interaction between demographical and clinical variables, and the TM intervention. 
Koehler et al. reported that depression scores correlated with mortality and days lost to 
death or hospitalization (Koehler et al., 2012). Overall, the patients’ characteristics seem to 
have small effect on outcomes in TM interventions. Factors related to the etiology of the 
HF, healthcare system -related components, TM intervention components, and perceived 
benefit from the patient’s perspective may prove more informative for improving the health 
outcomes of TM interventions with individuals with HF (Krumholz et al., 2016; Webb et 
al., 2010).
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4.2 Telemonitoring interventions in individuals with type 2 diabetes
In individuals with T2D, TM interventions have typically involved self-monitoring of 
blood glucose (SMBG) and lifestyle related behaviors such as weight, diet and physical 
activity. The promise of TM interventions lies in increasing awareness of the effect that 
lifestyle behaviors have on blood glucose, thus further encouraging patients to make 
behavioral changes to control the risk factors. In addition, TM has potential to increase 
purposeful exploitation of SMBG data. SMBG provides detailed information about 
blood glucose variation, including events of hypoglycemia and hyperglycemia, especially 
when monitored in a structured manner at regular times and frequencies. With the TM 
technology healthcare providers can use the data obtained to inform decisions regarding 
the adjustment of insulin dosage, use of other drugs, or lifestyle behaviors that may need 
to be modified, such as meals and physical activity, to achieve better glycemic outcomes 
(American Diabetes Association, 2018a; Farmer et al., 2012).
TM interventions in diabetes patients have been summarized in three reviews, all 
covering studies published before 2010 (Health Quality Ontario, 2009; Paré et al., 2010; 
Polisena et al., 2009). The first two reviews covered individuals with both type 1 diabetes 
and T2D, and the latter T2D only. The reviews concluded that TM resulted in a small to 
moderate reduction in HbA1c varying from 0.2 to 0.5 percentage points. A more recent 
review by Greenwood et al. summarized telehealth interventions with a specific focus on 
the elements of structured SMBG. The review concluded that telehealth interventions that 
incorporated at least five elements of structured SMBG improved glycemic control more in 
individuals with T2D (Greenwood et al., 2014).
Table 2 summarizes 15 RCTs that investigated TM interventions in individuals 
with T2D published after 2008. TM interventions and feedback components provided 
in response to TM data are summarized. The effectiveness of the TM interventions is 
presented by including the following outcomes: HbA1c, body weight, blood pressure, 
cholesterol, and HRQoL.
TM studies in individuals with T2D mainly used HbA1c for inclusion by recruiting 
participants if their HbA1c was above a certain threshold. The threshold values varied from 
6.5% to 9% across studies. Patients were frequently included regardless of poor glycemic 
control; only four studies excluded participants if their HbA1c was above a certain threshold, 
typically > 10.0% or > 11.0%, whereas other studies did not define the upper thresholds for 
HbA1c. Most TM studies did not distinguish between insulin-requiring and non-insulin 
requiring individuals, with participants recruited regardless of their medication regimen. 
Participants were typically 50–60 years old with a BMI above 30 kg/m2, with the 
exception of studies conducted in Japan and South Korea where participants’ BMI was 
above 25 kg/m2. The baseline levels of HbA1c varied from 7% to 9%. The proportion of 
participants who were using insulin was between 9–53%, if reported. Information on 
insulin use was available only in nine studies. The duration of the studies varied from 6 
to 12 months, and the sample sizes were typically between 100 to 300 participants. The 
41
largest study was conducted by Tang et al. in the US in 2013 with 415 participants who were 
followed for 12 months (Tang et al., 2013).
All interventions involved TM of blood glucose. Blood glucose was typically measured 
daily or several times a week. However, six studies did not specify the monitoring frequency 
or the intensity was subject to the individual care plans (Dario et al., 2017; Holmen et al., 
2014; Lindberg, Torbjørnsen, Söderberg, & Ribu, 2017; Quinn et al., 2011; Tang et al., 
2013; Wakefield et al., 2011). In four studies, structured SMBG was applied indicating that 
participants were instructed to measure their pre- and postprandial glucose levels at certain 
times a day, such as in the morning and/or at bedtime (Crowley et al., 2016; Greenwood, 
Blozis, Young, Nesbitt, & Quinn, 2015; Lim et al., 2011; Wild et al., 2016). In seven studies, 
participants were advised to monitor and report their blood pressure and/or weight in 
conjunction with blood glucose (Lindberg et al., 2017; Nicolucci, Cercone, Chiriatti, 
Muscas, & Gensini, 2015; Stone et al., 2010; Tang et al., 2013; Wakefield et al., 2011; Waki 
et al., 2014; Wild et al., 2016). Other TM parameters used in the studies included physical 
activity, insulin dose, and diet-related parameters.
The TM data were reviewed regularly, typically on a weekly basis by the healthcare 
providers. In five studies, regular times for the data review were not described, or 
automatic alerts were used to notify if the recordings exceeded the pre-defined thresholds 
(Bujnowska-Fedak, Puchała, & Steciwko, 2011; Dario et al., 2017; Holmen et al., 2014; 
Lim et al., 2011; Waki et al., 2014). In seven studies medication adjustments were done on 
the basis of SMBG data (Crowley et al., 2016; Greenwood et al., 2015; Jeong et al., 2018; 
Lim et al., 2011; Stone et al., 2010; Tang et al., 2013; Wild et al., 2016). In a study by Lim 
et al. (2011) participants were taught how to interpret their glucose data and they received 
recommendations for adjusting their medication doses themselves. In the other studies, the 
SMBG data were reviewed by the healthcare providers who further made changes to the 
medications if needed. In six studies the responsible care providers were informed about 
medication changes and/or the TM data were shared with them (Bujnowska-Fedak et al., 
2011; Greenwood et al., 2015; Jeong et al., 2018; Nicolucci et al., 2015; Stone et al., 2010; 
Tang et al., 2013).
In almost all TM interventions, participants received feedback in response to their TM 
measurements. Typically, the healthcare providers were involved in providing feedback. 
In ten studies, the feedback and/or recommendations were tailored to patients’ TM data 
(Bujnowska-Fedak et al., 2011; Greenwood et al., 2015; Lim et al., 2011; Lindberg et al., 
2017; Nicolucci et al., 2015; Quinn et al., 2011; Stone et al., 2010; Tang et al., 2013; Waki et 
al., 2014; Wild et al., 2016), whereas in another two studies participants received counselling 
that did not specifically exploit the TM data (Crowley et al., 2016; Holmen et al., 2014). 
In one study participants did not receive any feedback but clinicians were contacted if the 
TM data exceeded the thresholds, and they took appropriate actions (Dario et al., 2017). 
Automatic feedback messages were used in nine studies (Bujnowska-Fedak et al., 2011; 
Greenwood et al., 2015; Holmen et al., 2014; Jeong et al., 2018; Lim et al., 2011; Quinn 
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et al., 2011; Tang et al., 2013; Wakefield et al., 2011; Waki et al., 2014), and two of these 
studies relied on automatic feedback messages solely (Bujnowska-Fedak et al., 2011; Lim 
et al., 2011). 
The automatic feedback messages were typically information-oriented messages 
summarizing the TM data. In four studies participants were provided with more enhanced 
feedback. In a study by Quinn et al. participants received real-time educational, behavioral 
and motivational messages specific to their submitted data (Quinn et al., 2011). Tang et 
al. provided diabetes status collating reports that included all important elements for self-
managing T2D based on TM data (Tang et al., 2013). In the study by Lim et al. (2011)
feedback was generated by combining information from TM data, electronic health 
records, and diet and exercise records. A feedback loop was implemented in the study of 
Greenwood et al. where participants were taught how to interpret their blood glucose data 
and received a computer-assisted pattern analysis of their glucose data (Greenwood et al., 
2015). However, in that study the feedback was not provided in real time, whereas in the 
other former three studies the participants received feedback messages immediately after 
each data submission.
Adherence to TM varied typically between 60–80% in studies that reported TM 
adherence. Two studies showed lower adherence rates with approximately 40% of 
participants being adherent to the TM plans (Holmen et al., 2014; Jeong et al., 2018). Five 
studies did not report adherence-related measures at all (Dario et al., 2017; Greenwood 
et al., 2015; Lindberg et al., 2017; Quinn et al., 2011; Wild et al., 2016). In some studies 
the TM frequency was not determined, and thus adherence to TM intervention was not 
possible to measure (Dario et al., 2017; Holmen et al., 2014; Lindberg et al., 2017; Quinn et 
al., 2011; Tang et al., 2013). Moreover, some studies reported usage-related measures rather 
than adherence (Bujnowska-Fedak et al., 2011; Crowley et al., 2016; Holmen et al., 2014; 
Nicolucci et al., 2015). Definitions of adherence also varied considerably across studies. For 
example, Tang et al. reported the percentage of participants uploading glucose data, whereas 
Jeong et al. reported the percentage of participants who were 90% adherent to weekly TM 
of blood glucose and weight (Jeong et al., 2018; Tang et al., 2013). Interestingly, in one study 
41% of participants were unable to use the system alone (Bujnowska-Fedak et al., 2011). The 
heterogeneous definitions of adherence and the high rate of missing adherence measures 
thus make it difficult to compare patients exposure to the TM interventions across studies. 
The results of the studies reviewed indicate that TM interventions improve glycemic 
control in individuals with T2D. In eight studies, HbA1c levels were statistically 
significantly lower in the TM arm with reductions varying from 0.4 to 0.6 percentage 
points (Crowley et al., 2016; Greenwood et al., 2015; Lim et al., 2011; Nicolucci et al., 2015; 
Quinn et al., 2011; Stone et al., 2010; Waki et al., 2014; Wild et al., 2016). The magnitude 
is similar, or somewhat higher, to those reported in the systematic reviews (Health Quality 
Ontario, 2009; Paré et al., 2010; Polisena et al., 2009). 
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Evidence of TM interventions improving HRQoL is weaker; HRQoL was investigated 
in six studies, of which two showed small but statistically significant improvement (Dario 
et al., 2017; Nicolucci et al., 2015). Other clinical outcomes were not as frequently improved 
in the TM studies; three studies showed decreased blood pressure levels in the TM arm 
(Crowley et al., 2016; Wakefield et al., 2011; Wild et al., 2016), and one study showed a 
significant reduction in weight (Lim et al., 2011). All of these results except one (Wakefield 
et al., 2011) were found in conjunction with reductions in HbA1c. 
Of the six TM interventions that did not improve glycemic control, in two studies 
participants did not receive feedback on their TM data at all, and the patients were 
contacted rarely or only if data was above the pre-defined thresholds (Dario et al., 2017; 
Lindberg et al., 2017). In the other four studies, participants received brief information-
oriented feedback consisting of a numerical and/or graphical summary of the TM data 
(Bujnowska-Fedak et al., 2011; Holmen et al., 2014; Jeong et al., 2018; Wakefield et al., 
2011). These findings indicate that a lack of support and feedback or provision of solely 
information-oriented feedback may be associated with failure to improve glycemic control 
in TM studies.
Providing feedback that contains tailored advice and recommendations for the patient 
might contribute to positive health outcomes in TM interventions in patients with T2D. 
Studies that included educational components and/or lifestyle advice showed significant 
improvements in glycemic control (Greenwood et al., 2014; Lim et al., 2011; Quinn et al., 
2011; Waki et al., 2014). However, in the study by Tang et al. (2013) where participants 
received tailored diabetes status reports, regular advice from study personnel, educational 
tips, and intensified medication management, the TM group did not show improvements 
in any of the clinical outcomes except LDL cholesterol. One relevant component missing 
in that study was structured SMBG; the TM frequency for blood glucose or for any other 
health parameters used in the study was not determined. Consequently, the researchers did 
not report adherence to the TM intervention but described that 88% of the participants 
uploaded blood glucose data. All interventions (expect Tang et al. and Jeong et al.) that 
included medication adjustment based on the TM data showed improved glycemic control 
(Crowley et al., 2016; Greenwood et al., 2015; Lim et al., 2011; Shea et al., 2009; Stone et al., 
2010; Wild et al., 2016).
It seems that patients’ clinical characteristics were not associated with study outcomes. 
Wild et al. conducted a subgroup analysis and showed that age, sex, socio-economic status, 
BMI, baseline HbA1c, and baseline blood pressure did not modify the change in HbA1c in 
their intervention (Wild et al., 2016). The study by Crowley et al., which showed the biggest 
reduction in HbA1c of 1 percentage point (and reduced blood pressure levels) included 
insulin-requiring individuals only and the baseline level for HbA1c was 10.5% (Crowley et 
al., 2016). These results suggest that TM might be most beneficial for those whose blood 
glucose levels are poorly managed and use insulin. However, in contrast, Bujnowska-Fedak 
et al. reported that glycemic control improved only among non-insulin-requiring T2D 
44
individuals (Bujnowska-Fedak et al., 2011). Regarding the baseline level of HbA1c, the 
studies included in this review showed no correlation between the baseline HbA1c and 
study outcomes. However, a recent review recommended that telehealth interventions for 
T2D patients should recruit individuals whose HbA1c ≥ 7.5% (Greenwood et al., 2014), 
and a similar recommendation was earlier made regarding SMBG for non-insulin treated 
T2D patients (Klonoff et al., 2011).
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4.3 Telemonitoring interventions in individuals with coronary artery disease
Interventions promoting self-management in individuals with CAD typically involve 
cardiac rehabilitation programs that focus on structured exercise training. The programs 
may be center-based or home-based, both of which have been shown to be equally effective 
(Anderson et al., 2017). However, cardiac rehabilitation programs suffer from low uptake 
and poor adherence (Kotseva et al., 2016). Recently, telehealth technologies have also been 
introduced to cardiac rehabilitation to further increase the uptake of the programs and 
adherence to them while enabling more individualized counselling. These programs have 
been shown to be at least equally effective with center-based and home-based programs 
(Rawstorn, Gant, Direito, Beckmann, & Maddison, 2016). Typically the telehealth 
rehabilitation interventions involve telephone counselling (Rawstorn et al., 2016). To 
the best knowledge of the author, there are only few studies that have investigated TM 
interventions in CAD patients, or the interventions have focused on TM of physical 
activity only. Moreover, such interventions are rarely evaluated in randomized controlled 
settings.
Frederix et al. (2012) evaluated the effect of a physical activity TM program in a RCT 
including eighty CAD patients. Participants in the TM arm wore a motion sensor, and 
each week they received personalized feedback and a renewed step count goal. Patients in 
the control group wore a modiﬁed motion sensor for one week during the ﬁrst, sixth and 
18th week of the study. However, the motion sensors were modiﬁed to hide all information 
from the control patients. After 18 weeks, the TM program demonstrated increased oxygen 
uptake capacity but no improvements in other cardiovascular risk related outcomes. Re-
hospitalization rates also remained unchanged.
In another RCT, individuals with acute coronary syndrome received a TM intervention 
which consisted of patients monitoring their weight, heart rate and blood pressure weekly, 
and capillary plasma lipid profile and glucose monthly. A cardiologist reviewed the data 
and sent recommendations. Patients in the TM group experienced improvement in 
cardiovascular risk factors and achieved their treatment goals for blood pressure and HbA1c 
more frequently. In addition, they had significantly lower BMIs. The TM intervention had 
no effect on smoking cessation or LDL cholesterol (Blasco et al., 2012).
A study by Kraal et al. evaluated a home-cased cardiac rehabilitation with TM guidance 
to improve lifestyle behaviors and long-term health effects (Kraal et al., 2017). Fifty 
individuals participated in the study and were allocated to the TM and control groups. The 
intervention group was provided with supervised training sessions and a heart rate monitor 
and received individual telephone coaching based on the training data. The results showed 
no differences in adherence, physical fitness, physical activity or HRQoL after 12 weeks 
between the study arms. 
Another RCT by Skobel et al. introduced a smartphone-guided training system that 
involved TM of breathing rate and an ECG that transmitted information on training 
intensity, arrhythmias and adherence to the training prescriptions (Skobel et al., 2017). 
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Based on the data, participants received feedback from a medical team who further 
adjusted the training sessions. The study included 118 participants and followed them for 
six months. The intervention faced technical problems; almost 30% of participants in the 
TM group withdrew from the study, and technical problems prevented a further 38% from 
participating. For those who completed the study, their exercise capacity improved more.
In addition, one study, which used a pre-post design, evaluated a TM surveillance system 
involving 25 individuals with CAD to improve adherence to medication and lifestyle 
recommendations (Ammenwerth et al., 2015). The intervention included education, self-
monitoring with goal-setting, feedback, and regular clinical visits. Participants monitored 
their blood pressure and steps daily, and provided information on their medication 
intake. In addition, individuals with T2D were provided with glucose meters and obese 
participants with scales. Based on the data provided, participants received automatic, 
individualized feedback messages once a week. The results showed high adherence with 
77% of daily measurement completed, high self-reported adherence to medication intake, 
and the pre-defined goals for physical activity were reached.
TM interventions in individuals with CAD typically involve promoting physical 
activity. Yet, the potential of TM interventions concentrating on risk factor management 
was demonstrated in the studies by Blasco et al. (2012) and Ammenwerth et al. (2015). 
Similarly, studies in other patient populations have shown that such interventions have 
potential to promote weight loss and decrease blood pressure and cholesterol, which are 
known risk factors for CAD (Lim et al., 2011; Luley et al., 2014; Tang et al., 2013; Wakefield 
et al., 2011). However, not all CAD patients suffer from such comorbidities, which might be 
one reason why such TM interventions have not been applied to CAD patients. Therefore, 
the TM interventions should be tailored according to individual risk profiles.
4.4 Summary of the literature
TM interventions are heterogeneous across chronic conditions and across individual studies 
of conditions. In HF patients, TM interventions typically involved measuring weight, blood 
pressure and vital signs, and the TM data were shared with the healthcare professionals 
who reviewed the data frequently. The emphasis of these interventions was on exploiting 
the data in clinical work to predict decompensation and further avoid hospitalizations. 
Although HF studies consistently reported high adherence rates, the majority of the 
studies did not statistically significantly reduce hospital admissions or mortality in patients 
with HF. However, TM interventions frequently improved HRQoL. In individuals with 
T2D, the TM interventions focused on TM of blood glucose and other lifestyle behaviors 
that are known risk factors of T2D and its complications. These interventions frequently 
included feedback and instructions for patients provided in response to the TM data to 
promote self-management, whereas in HF studies patients rarely received feedback on their 
TM data. In patients with T2D, TM interventions improved glycemic control by reducing 
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HbA1c by 0.4–0.6 percentage points. Specifically, those interventions that provided 
versatile feedback to their participants achieved positive outcomes. 
TM interventions were heterogeneous and included different components, which 
makes it difficult to compare them and to identify factors that constitute an effective 
TM intervention. However, some were found. TM intervention components that were 
associated with positive health outcomes included providing feedback in response to 
TM data, providing lifestyle counselling and recommendations, education, monitoring 
psychological parameters, intense collaboration with the patient’s GP, and using TM data 
to adjust medication in T2D patients.
TM studies in individuals with CAD were scarce and focused more on telehealth 
rehabilitation, which typically involved TM of physical activity only.
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5 Aims of the Study
The aim of the current study was to assess the effect of TM interventions on health-related 
outcomes in individuals with type 2 diabetes (T2D), heart failure (HF) and coronary artery 
disease (CAD). This work adds knowledge on the role of patient decision support provided 
in response to TM as each of the three TM interventions studied included a differential 
feedback component linked to TM.
The specific objectives were as follows:
◆ to assess whether a TM intervention that combined automatic, real-time, behavioral 
theory based feedback messages improved glycemic control and reduced blood 
pressure among individuals with T2D (I, the Mobile Sipoo study),
◆ to assess whether a TM intervention that combined automatic, real-time, 
information-oriented feedback messages reduced HF-related hospitalizations in 
individuals with HF (II, the Heart at Home study),
◆ to assess whether a TM intervention that combined monthly telephone-based health 
coaching improved HRQoL in individuals with T2D, CAD and HF, and improved 
glycemic control in individuals with T2D (III, the Renewing Health study),
◆ to investigate participants’ long-term adherence to the TM interventions as 
sustained adherence is a prerequisite for achieving the intervention effects (IV).
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6 Methods
The objectives of this thesis were addressed with three experimental studies. Three 
randomized controlled trials were conducted to assess the effectiveness of TM interventions 
among individuals with T2D, HF or CAD. The aim of the TM interventions was to 
promote self-management by encouraging participants to actively self-monitor their 
disease-specific health parameters and share their self-monitoring data remotely with 
health care professionals in order to enable care to be tailored to the individual needs of the 
patient. All three studies were two-arm randomized controlled trials where the comparison 
groups consisted of individuals receiving standard care. The studies were conducted across 
Finland; the Mobile Sipoo and Renewing Health studies were conducted at the health 
care centers of Sipoo and South Karelia, respectively, and the Heart at Home study was 
conducted at the cardiology outpatient clinic of Helsinki University Central Hospital. The 
design of each study is described in detail in the following chapters and summarized in 
Table 3.
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Table 3. Summary of study designs, participants, telemonitoring interventions and primary outcomes of the three studies
Mobile Sipoo (I) Heart at Home (II) Renewing Health (III, IV)
Design 2-arm randomized controlled 
trial
2-arm randomized controlled 
trial
2-arm randomized controlled 
trial separately for two 
disease groups; T2D and 
heart disease
Setting Healthcare center Cardiology outpatient clinic Healthcare center
Follow-up 10 months 6 months 12 months
Participants 53 patients with T2D 94 patients with HF 250 patients with T2D
42 patients with HF
227 patients with CAD
Intervention Weekly TM of blood pressure, 
body weight, steps and blood 
glucose.
Access to online PHR account 
for reviewing TM data and 
health related information.
Weekly TM of blood pressure, 
body weight, heart rate and 
symptoms.
Weekly TM of blood pressure, 
body weight, steps and blood 
glucose.
Access to online PHR account 
for reviewing TM data.
Feedback component Individualized, behavioral 
theory-based feedback 
messages.
Short, information-oriented, 
feedback messages.
Telephone-based health 
coaching every 4–6 weeks.
Standard care Diabetes education at the 
time of diagnosis, annual 
check-ups and laboratory 
tests.
Multidisciplinary care, 
self-monitoring of signs and 
symptoms with pen and paper 
recommended.
Disease management booklet 
at the time of diagnosis, 
annual appointment or a 
phone call and laboratory 
tests, CAD patients offered 
group intervention sessions to 
promote physical activity and 
self-management.
Primary outcome HbA1c
Systolic and diastolic blood 
pressure
HF-related hospitalizations Health-related quality of life 
(HRQoL)
HbA1c in patients with T2D
CAD=coronary artery disease, HbA1c=glycosylated hemoglobin, HF=heart failure, HRQoL=health-related quality of life, PHR=personal 
health records, TM=telemonitoring, T2D=type 2 diabetes
6.1 Study design
6.1.1 Mobile Sipoo (I)
The Mobile Sipoo study was a two-arm randomized controlled pilot trial designed to test 
the feasibility of an automatic feedback system, and to assess the clinical effectiveness of a 
TM intervention that incorporated the feedback system in patients with T2D. The trial 
was conducted at the healthcare center of Sipoo. The follow-up time was 10 months. The 
municipality of Sipoo is located in Southern Finland and has 18,000 (in 2010) inhabitants, 
of whom approximately 30% are Swedish-speaking.
The Mobile Sipoo intervention was designed to be tested separately in two groups: 
patients with T2D and hypertension. Sample size calculations were done separately for 
both groups assuming a power of 90% and an alpha level of 0.05. In the T2D group, the TM 
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intervention was assumed to reduce HbA1c by 1% with a standard deviation of 1%. For 
hypertensive patients, systolic blood pressure was assumed to decrease by 5 mmHg with 
a standard deviation of 6.5 mmHg. In total, 120 patients (46+74) needed to be recruited. 
However, patient recruitment entailed practical challenges. Potential participants 
were difficult to contact and patients declined to participate for reasons that were not 
systematically collected. Eventually only one group of patients with T2D were recruited.
Stratified randomization was used to allocate participants to the TM and standard care 
arms with an allocation ratio of 1:1. Participants were stratified by sex and dichotomized 
age (< 65 years and ≥ 65 years).
6.1.2 Heart at Home (II)
Heart at Home was a matched-pair randomized trial that took place at the cardiology 
outpatient clinic of Helsinki University Central Hospital. The clinic examines and treats 
patients who require demanding cardiological clarifications or treatment. It deals with 
approximately 600 individuals with cardiological complications, of whom 150–200 require 
regular follow-up. The study population consisted of HF patients with HFrEF who were 
followed for six months.
The TM intervention was expected to decrease the number of HF-related hospitalizations 
by 3 days with a standard deviation of 6. Using a power of 90% and a two-sided α-level of 
0.05, 44 participants per treatment arm needed to be recruited.
Eligible patients were matched in pairs according to their sex, age, LVEF and NYHA 
classification. The study nurse called potential participants, informed them about the study 
and asked about their initial willingness to participate. Patients who agreed to participate 
were further randomized by the study nurse assigning one of the pair to the TM group and 
one of the pair to the standard care group. On a subsequent baseline visit participants were 
assessed on the remaining inclusion criteria (such as not attending other clinical trials) and 
eligible participants were recruited for the study.
6.1.3 Renewing Health (III)
The Renewing Health study was a two-arm randomized controlled trial designed to assess 
the effectiveness of a TM intervention combined with health coaching in two separate 
disease groups: T2D and heart disease. The study was conducted in the South Karelia Social 
and Health Care District in Finland, which provides primary and secondary healthcare for 
approximately 100,000 inhabitants living in the region. The study population consisted 
of individuals with T2D or a heart disease, with the latter specifically defined as being 
diagnosed with either HF or ischemic heart disease. Both disease groups were separately 
recruited, and both had a TM arm and a standard care arm. Potential participants were 
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screened using electronic health records using their diagnosis codes. Patients recruited with 
a diagnosis of ischemic heart disease had a CAD. The follow-up time was 12 months. 
The TM intervention was expected to improve HRQoL by increasing the SF-36 scores 
by 3 points (with a standard deviation of 8). With a statistical power of 80%, a two-sided 
α-level of 0.05, and an allocation ratio of 2:1, 163 TM participants and 61 control participants 
were required. Predicting a dropout rate of up to 20%, at least 200 intervention participants 
and 75 control participants needed to be randomized. The numbers were applied to the 
T2D and heart disease groups separately resulting in 550 participants in total. 
Stratified randomization was used to assign patients to the TM and standard care 
arms with an allocation ratio of 2:1, respectively. Participants were stratified by sex and 
dichotomized age (< 65 years and ≥ 65 years). The allocation sequence was concealed in an 
opaque and sealed envelope until the baseline visit. The randomization procedure was done 
separately for the T2D and heart disease groups.  
The Finnish Renewing Health study was a part of a large European research project, 
Renewing Health, including nine regions across Europe to implement and evaluate the 
effectiveness of telehealth services for treating chronic conditions including diabetes, 
chronic obstructive pulmonary and cardiovascular diseases. Approximately 7,000 patients 
were recruited in randomized controlled trials in the nine regions to assess the effect of 
telehealth interventions (Kidholm et al., 2014). 
6.2 Ethical considerations and trial registrations
The Heart at Home and Mobile Sipoo studies were reviewed and approved by the Ethics 
Committee of the Hospital District of Helsinki and Uusimaa. Renewing Health was 
approved by the Ethics Committee of the Social and Health Care District of South Karelia. 
All participants provided informed written consent. 
Each of the studies is registered at clinicaltrials.gov: Mobile Sipoo NCT01547156, 
Heart at Home NCT01759368, Renewing Health NCT01310491.
6.3 Participants
The study population consisted of patients with at least one chronic condition. Participants 
had a diagnosis of either T2D or HF or CAD. Secondary diagnoses were not investigated. 
The study-specific inclusion and exclusion criteria are presented in Table 4. 
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Table 4. Inclusion and exclusion criteria of the three studies
Mobile Sipoo (I) Heart at Home (II) Renewing Health (III)
Inclusion criteria
• Diagnosis of T2D at least 6 
months prior
• HbA1c > 6.5%
OR 
• Diabetes medication 
combined with elevated 
blood pressure (systolic > 
130mmHg or diastolic >80 
mmHg)
• Age 30–70 years
• Systolic heart failure
• 1<+$FODVV
• /9()
• Age 18–90 years
• Need for regular check-up 
visits
• Time from last visit less 
than six months
• Diagnosis of T2D at least 
three months prior AND
• HbA1c > 6.5% (test taken 
within 1 year before 
screening) 
OR
• Diagnosis of ischemic heart 
disease or heart failure
• Age 18 years or older 
• Being able to walk
Exclusion criteria
• Poor technology literacy 
or reluctant to do self-
monitoring
• Pregnancy
• Life expectancy of less than 
one year
• Major elective surgery 
planned within six months 
or having had major surgery 
within the previous two 
months
• Psychiatric disorder e.g. 
depression
• Alcohol or narcotics misuse
• Excluded by the healthcare 
physician
• Planned major medical 
operation/surgery
• Severe comorbidity such 
as cancer
• Participation in another 
clinical trial during the last 
three months
• Expected poor compliance 
due to inability to use 
technical devices 
• ,QFDSDEOHRI¿OOLQJRXWWKH
questionnaires in Finnish
• Incapable of using the 
remote patient monitoring 
system devices
• Inadequate cognitive 
capacity to participate
6.4 Telemonitoring interventions and standard care
In all studies, the intervention was aimed at improving management of a chronic condition 
by introducing TM as a part of patient’s care (Table 3). The TM intervention consisted 
of making an individual self-management plan in agreement with the patient and the 
healthcare provider, the patient measuring condition-specific health parameters at home, 
and reporting the measurements to the healthcare professionals using a mobile phone. The 
general architecture of the TM interventions is described in Figure 1. Blood pressure and 
body weight were used as self-monitored health parameters in all studies. Additionally, 
participants were instructed to monitor their blood glucose, steps, heart rate, health status 
and/or symptoms. Measuring and reporting of health parameters was done on a weekly 
basis. Participants received a TM toolbox that included measurement devices and a mobile 
phone with a pre-installed application for reporting purposes. 
In all studies, the TM data were stored on a secure remote monitoring server. Study 
personnel were able to access the data through a web-based browser. They were instructed 
to review the data on a regular basis and exploit the data in their work. With the help of the 
self-monitoring data, the personnel were expected to be able to tailor the care to individual 
needs and intervene if the measurements indicated a need for an additional appointment. 
Details of each TM intervention are described in the following sections.
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6.4.1 Mobile Sipoo (I)
The Mobile Sipoo intervention consisted of weekly TM of weight, blood pressure, blood 
glucose and steps linked with automated feedback messages, Table 3. All study participants 
received standard care, which included diabetes education at the time of diagnosis, annual 
check-ups and laboratory tests, and diabetes guidance and education given by a physician or 
nurse during patient-initiated appointments to the healthcare center. In addition, patients 
were able to contact healthcare providers any time they needed.
At the baseline visit, participants agreed together with the study nurse on a self-
management plan that included selecting relevant health parameters to be monitored and 
setting target values for those parameters. Participants were given a mobile phone with a 
pre-installed self-monitoring application and measurement devices (blood pressure meter, 
scale, pedometer and blood glucose meter, if needed). They were instructed to measure 
their weight and blood pressure at least once a week. The pedometer was advised to be 
used on a regular basis, but the intensity of optimal use was not specified. In addition, 
blood glucose meters were given to six participants who were instructed to measure their 
blood glucose three times a week including pre- and postprandial measurements—before 
and 1–2 hours after a meal. However, one of these patients proved not to have T2D and 
was thus excluded from the analyses. After each measurement, the patients uploaded their 
data to the mobile application and sent it to the server. After each reported measurement, 
the patient received a personalized feedback message. Participants also received access to 
an online personal health records (PHR) account where they could enter and view their 
self-monitoring data, view their data graphically, review the feedback messages sent as a 
Figure 1. Architecture for the telemonitoring interventions
PHR=personal health records
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response to their measurements, review their self-management plan, and review individual 
clinical information including prescriptions and laboratory tests.
The feedback messages were short, text-message like messages, the content of which was 
based on the self-monitoring data, Finnish Current Care Guidelines (www.kaypahoito.
fi), and the Information-Motivation-Behavior Skills (IMB) model (Fisher & Fisher, 1992; 
Fisher, Fisher, & Harman, 2003). The Finnish Current Care Guidelines are evidence-
based clinical practice guidelines developed by the Finnish Medical Society Duodecim in 
association with medical specialist societies. They are published to support management 
of different diseases and to benefit both professionals and citizens. The IMB model is a 
behavioral theory that specifies determinants of behavior that are potentially amenable 
to change. The IMB model states that an individual needs to be informed about his or 
her health situation, motivated to make a change, and behaviorally skilled to adjust their 
behavior towards healthier habits (Fisher & Fisher, 1992. Fisher et al., 2003). Information 
is a prerequisite for changing behavior, but in itself is insufficient to achieve the change. 
Motivation and behavioral skills are critical for behavior change (Fisher & Fisher, 1992; 
Fisher et al., 2003; World Health Organization, 2003). The IMB model guided the structure 
of the feedback messages. The feedback messages were built accordingly to include all three 
dimensions: information, motivation, and behavioral skills. The information part was 
based on the Finnish Current Care Guidelines or individual guideline-based target values 
that provided thresholds for normal or elevated parameter values to be combined with TM 
data. The motivation part provided positively-oriented feedback about the measurement 
whenever possible. If not possible, neutral feedback content was provided. Negative feedback 
was never given. The behavioral skills part provided detailed low-threshold instructions on 
how to achieve better outcomes. The objective of the feedback messages was to encourage 
individuals to initiate and maintain lifestyle changes (see Table 5). The feedback messages 
were available in Finnish and Swedish depending on the patient’s preferences.
The pool of feedback messages included 265 messages on body weight, blood pressure, 
pre- and postprandial blood glucose, steps, a combination of these health parameters. Each 
message had a set of rules that defined a condition under which they were to be delivered to 
an individual. The content of a feedback message was tailored according to its conditions 
(e.g. whether the reported parameter was within or outside target levels, or how many times 
it had exceeded the target levels). Whenever a new measurement was reported, as a first step 
the algorithm scanned through all messages and selected those that fulfilled their rules. 
Messages that were found to be eligible in the current context were scored based on their 
importance (high priority for those with suspected measurement error or alert), history 
(how frequently they had been sent), and positivity (messages with positive, reinforcing 
nature had higher scores). In addition, for each summary score the algorithm added random 
variation to add unpredictability. The message with the highest score was sent to the user. 
Certain messages had a high priority—these messages were always delivered in the first 
instance. Such messages included extremely high/low blood glucose and blood pressure 
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values. In these cases, the user was instructed to repeat the measurement and if it was still 
alarmingly low or high, immediate contact with a healthcare professional was instructed. 
All high priority messages delivered to the study participants were also shared with the 
healthcare professionals involved, who were instructed to review the data on a weekly 
basis. At the beginning of the study it was agreed that the participants themselves had the 
responsibility to seek help if the feedback messages indicated that this was necessary.
Table 5. Examples of automatic feedback messages in the Mobile Sipoo study
You have managed to keep 
your blood pressure at your 
target level of below 130/80 
mmHg for 2 months. Well 
done! Please remember to 
continue monitoring your 
blood pressure.
Your blood sugar levels were 
above the target levels of 8 
mmol/L seven times out of the 
12 after-lunch measurements 
made during the past 2 
months. Please keep your 
meal times regular and 
manage the content of your 
lunches to avoid excessive 
variation in your blood sugar 
levels.
You have lost 4% of your 
weight. That’s great, keep 
up the good work! A 5–10% 
ZHLJKWORVVLVEHQH¿FLDOLQ
preventing weight-related 
illnesses and in treating them. 
Please remember to maintain 
a balanced diet and regular 
exercise.
Your blood pressure has 
risen 5/3 mmHg in the past 
month. Please pay attention 
to healthy lifestyle choices; 
increased endurance 
exercise, for example, 
will help lower your blood 
pressure.
6.4.2 Heart at Home (II)
The intervention of the Heart at Home study involved weekly TM of weight, blood 
pressure, heart rate and symptoms that were further sent to the HF nurse to be reviewed and 
exploited to optimize the patients’ care. In response to the TM data, participants received 
individualized short, information-oriented feedback messages (Table 3). In addition, all 
participants received standard care at the cardiology clinic. Standard care encompassed 
multidisciplinary care including a cardiac team comprising two physicians and a 
specialized HF nurse as well as a physiotherapist who assisted after hospitalization periods. 
The cardiac team was responsible for the care and bi-annual check-ups at the cardiology 
clinic. In addition, participants were able to contact the HF nurse at any time. As part of 
the standard care, individuals capable of carrying out self-monitoring were encouraged to 
regularly measure their blood pressure, heart rate and weight at home. These monitoring 
data were further reviewed during the appointments or with scheduled calls. However, 
systematic collection and exploitation of this data was challenging as it was recorded with 
pen and paper and patients often forgot to bring their records or lost their notes between 
appointments. 
At the baseline visit, the participants were given a TM toolbox which included a blood 
pressure meter, a scale and a mobile phone with a pre-installed application for reporting 
purposes. They received instructions on how to use the devices and the mobile phone 
application and practiced their use together with the nurse. The duration of the baseline 
visit was approximately 10–20 minutes per patient. Individual target values for blood 
pressure and weight were agreed together with the patient and the nurse during the baseline 
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visit. Participants were instructed to measure their blood pressure, body weight, heart 
rate, experienced health status (deteriorated/same/improved) and symptoms (dizziness, 
dyspnea, palpitation, weakness and edema) at least once a week. The self-monitoring data 
were reported via the touch-based mobile phone. After sending the data, the user received 
feedback on whether the measured value was within their individual target values, and a 
graphic showing their measurement history (Figure 2). One nurse oversaw all of the study 
participants. If the patient experienced technical problems, (s)he was instructed to contact 
the nurse. Six contacts were made due to technical problems. 
TM data were stored on a secure remote patient monitoring server where the information 
could be accessed by the study personnel. The patient’s whole measurement history was 
made available each time the data were reviewed. The study nurse reviewed the data of 
each participant on a weekly basis. The nurse was instructed to call the participant and 
assess whether (s)he needed an appointment at the clinic for the following reasons: 1) the 
reported value was beyond the target values, 2) the reported value was clearly different from 
previous values, or 3) the patient reported any of the symptoms. During the first months 
of the study participants were contacted if the reported measurement exceeded the target 
values. Later, the measurement history played a bigger role, and the participant was not 
necessarily contacted on the basis of a single measurement. If the participant did not adhere 
to the weekly reporting plan, the nurse called and encouraged him or her to continue with 
the monitoring. 
6.4.3 Renewing Health (III)
The Renewing Health intervention consisted of two components: weekly TM of weight, 
blood pressure, and blood glucose or steps, and structured telephone-based health coaching 
(Table 3). All study participants received standard care. As a part of standard care, patients 
with T2D, HF and CAD received a disease management booklet at the time of diagnosis. 
Laboratory tests were taken once a year and patients were scheduled with one appointment 
Figure 2. Screenshots of the reporting process with the mobile application in the Heart At Home study
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or a phone call with a nurse or physician. In addition, individuals were able to contact 
healthcare providers any time they need. Individuals with CAD were encouraged to 
take part in the group intervention sessions that provided information about CAD and 
encouraged regular exercise. 
Intervention participants received a TM toolbox that consisted of a touch screen mobile 
phone with a pre-installed application for monitoring purposes, an account for a PHR 
application and a set of measurement devices connected to the PHR account. An expert 
evaluation by one usability expert as well as usability evaluations with five participants of 
the pilot study were done prior to the main study to ensure the ease of use of the technology. 
Participants were instructed to measure their weight and blood pressure at least once a 
week. Additionally, patients with T2D measured their blood glucose, and patients with 
heart disease measured their steps on at least a weekly basis. However, the individual self-
management plan altered the monitored health parameters in some cases (e.g. TM of 
blood glucose was recommended only for those who were already advised for SMBG). The 
reporting of the health parameters was done with the mobile application which transferred 
the data to the participant’s PHR account. Using the PHR account, the participants were 
able to review their data and the self-management plan entered by the health coach. The 
TM system was provided by Medixine Ltd.
The health coaching program was designed to increase patients’ abilities to self-manage 
their condition while empowering the patients and increasing their self-efficacy for active 
self-management. The health coaching program had been previously used in the TERVA 
study, which provides a detailed description of the program (Patja et al., 2012). Briefly, the 
health coaching program was a solution-oriented model that integrated behavior change 
techniques. The program consisted of eight topics, each of which provided tools essential 
for managing chronic conditions. Each topic was introduced to participants using a five-
stage care process (Figure 3). The health coaching calls covered one topic at a time, and 
the content of each call was modified for a specific condition and further tailored to the 
individual’s needs. Six nurses who previously worked in outpatient care or in a hospital 
were hired to provide the health coaching. The recruited health coaches received specific 
training, after which they continued working as a health coach one day per week throughout 
the study. For quality control and educational purposes, each health coach recorded some 
of the coaching calls and the calls were assessed together with a behavioral professional 
once every three months. The health coaching framework was provided by Pfizer Health 
Solutions Oy.
Each intervention participant was assigned to a personal health coach. During the 
first call the health coach and the participant agreed on a self-management plan according 
to the individual’s needs, and they set low-effort goals to improve the patient’s lifestyle. 
The health coach and the participant also agreed on a self-monitoring plan depending 
on the condition and skills of the patient. The health coach called on a monthly basis, 
approximately every 4-6 weeks. During each call, the health coach and the participant 
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reviewed the previous goals and set a new goal related to the topic of the call, and the 
health coach provided information and support to aid adherence to the self-management 
plan. Health coaches had access to the participants’ PHR accounts; before each call the 
coach reviewed the participant’s self-monitoring data. The health coach and the patient 
discussed the data, and the coach advised the patient to take appropriate actions to balance 
their health outcomes if the data indicated a change in the patient’s condition. If needed, 
participants were advised to make an appointment with their physician. The duration of 
each health coaching call was approximately 30 minutes. 
6.5 Adherence and outcomes
Table 6 summarizes the primary outcomes, selected secondary outcomes and adherence 
metrics used in the three studies. The next paragraphs describe the outcome measures in 
detail.
Adherence In all studies, the TM system stored time-stamped self-monitoring data 
from participants’ measurement devices. Adherence to the TM intervention was measured 
using the log files. Adherence was defined as the percentage of weeks that included at 
least one recorded measurement. Each week was analyzed separately and was relative to 
the individual follow-up time. Adherence to glucose TM in the Mobile Sipoo study (I) 
was defined as the percentage of weeks with at least three preprandial and at least three 
postprandial glucose measurements. In the Renewing Health study (III) adherence to 
health coaching was defined as the total number of answered health coaching calls. As the 
)LJXUH)UDPHZRUNIRUWKHKHDOWKFRDFKLQJSURJUDPLQWKH5HQHZLQJ+HDOWKVWXG\)LJXUHPRGL¿HGIURP3DWMDHWDO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coaching calls were made at 4–6 week intervals, each participant was to receive a total of 7 
to 11 calls excluding the baseline and end-point calls. The baseline and end-point calls were 
excluded from the calculations because all study participants received those calls and thus 
they did not reflect adherence to the intervention. 
Primary outcomes The primary aim of the Mobile Sipoo study (I) was to improve 
glycemic control and reduce the blood pressure of individuals with T2D measured with 
HbA1c and systolic and diastolic blood pressure, respectively. The HbA1c was obtained 
from EHR if the test was no more than one month old. Otherwise, patients were scheduled 
with a new laboratory test. The Heart at Home study (II) aimed primarily at reducing HF-
related hospital admissions during the 6-month follow-up. Information on hospitalizations 
was obtained from EHR, and supplemented by interviewing the patient. The primary aim 
in the Renewing Health study (III) was to improve HRQoL and to improve glycemic 
control in individuals with T2D by reducing HbA1c. HRQoL was assessed using SF-36 
version 2 translated into Finnish. SF-36v2 is a 36-item questionnaire including statements 
on physical and mental health that are assessed on a 5-level response scale (Ware & 
Sherbourne, 1992). The responses are summarized in eight dimensions and two summary 
scores scaled 0 to 100 with a high score corresponding to more favorable health status. 
A 3–5 point difference is considered a minimum clinically important difference (Hays 
& Morales, 2001). The two component scores: the physical component score (PCS) and 
mental component score (MCS) were compared between the study arms.
Secondary outcomes In the Mobile Sipoo study (I), all clinical outcomes were measured by 
the study nurse and subsequently recorded in an online lifestyle survey by the participants in 
the intervention arm. Patients in the standard care arm filled out the same survey using pen 
and paper. In the Heart at Home study (II), clinical outcomes were measured by the nurse. 
LVEF was measured by echocardiography. Adherence to HF-specific lifestyle behaviors 
was assessed using the European Heart Failure Self-Care Behavior Scale (EHFSBS) 
questionnaire (Jaarsma, Strömberg, Mårtensson, & Dracup, 2003). EHFSBS is a 12-item 
self-administered questionnaire specifically designed and tested for individuals with HF. 
The questionnaire included statements regarding self-management behaviors essential to 
the care of HF, such as ‘If I experience increased fatigue, I contact my doctor and nurse’, 
‘I exercise regularly’, and ‘I take my medication as prescribed’. The statements were scored 
from 1 to 5; the lower the score, the better the self-management performance. A summary 
score was used in the analysis. The number of appointments with nurse and physician, 
and the number of unplanned visits to the  cardiology clinic were retrieved from EHR. 
The number of patient-initiated and nurse-initiated calls were recorded by the study nurse 
and the calls were analyzed separately. In the Renewing Health study (III), the secondary 
outcomes were measured during the baseline and follow-up visits and recorded in the TM 
database by the health coaches who conducted the baseline and end-point visits for the 
patients in the standard care arm.
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6.6 Statistical methods
All analyses were performed according to the Intention-To-Treat principle. Imputations 
were not done for missing outcome data, but participants whose outcome was available at 
baseline and at follow-up were included in the analyses. An α-level of 0.05 was considered 
statistically significant.
Participants’ baseline characteristics were presented according to the treatment groups. 
Adherence was described with a line chart where the x-axis represents time in weeks. In 
addition, the median number of adherent weeks with an interquartile range was calculated 
individually. The adherence data in the Renewing Health study (III and IV) were further 
analyzed to investigate the association between adherence and primary outcomes by 
calculating either Pearson’s or Spearman’s correlation between adherence and the change 
score in PCS, MCS and HbA1c. 
The differences in the clinical and behavioral outcome variables between the study arms 
were analyzed using the analysis of covariance. The follow-up measures were compared 
between the study arms by adjusting for the outcome baseline level. The results were 
presented as the mean difference between groups with 95% confidence intervals (Cls) 
and p-values. The p-values for the model coefficients were obtained from Wald’s test. The 
outcome variables in the Renewing Health study (II) were presented separately for each 
chronic condition (T2D, CAD and HF) to make the results comparable with the Mobile 
Sipoo and Heart at Home studies. The differences between the treatment arms were 
compared by combining all disease groups in the Renewing Health study. An additional 
analysis was done by adding an interaction term condition x treatment arm to the model 
to investigate whether the treatment effect differed across individuals with T2D, HF and 
CAD.
Data related to the use of healthcare resources were analyzed using Poisson regression 
and Zero Inflated Poisson (ZIP) regression models. The models were adjusted for individual 
follow-up times by adding them to the model as an offset variable. The distributions of 
the resource-related variables were skewed to the right with a significant proportion 
of participants having zero values. The data was therefore presented as a percentage of 
participants who had zero values combined with the mean (standard deviation) number 
of events. The excess proportion of zero values led to an assumption that ZIP regression 
models may better fit the distribution. The superiority between the Poisson regression 
model and the ZIP regression model was assessed using Vuong’s test (Vuong, 1989). Finally, 
the following variables were analyzed using ZIP regression: number of HF-related hospital 
days, number of unplanned visits to the clinic, and number of phone calls initiated by the 
patients. The incidence rate ratios (IRR) with 95% Cls and p-values were reported for the 
Poisson regression models, and odds ratios (ORs) with 95% Cls for analyzing the proportion 
of participants with zero counts. The other resource-related variables were analyzed using 
Poisson regression; the IRRs, their 95% Cls and p-values were reported to describe the 
differences between treatment arms. It should be noted that the ORs differ from risk 
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ratios (RR), especially when the initial risk is high. In such cases the OR overestimates 
the RR and, thus, the interpretation of OR should not be confused with RR (Schmidt & 
Kohlmann, 2008).
In the Heart at Home study, where the primary outcome was proportional, the number 
needed to treat (NNT) and its 95% Cl were calculated for the HF-related hospitalization 
rate. NNT refers to the number of patients that need to be treated to achieve the outcome 
in one patient who would not have benefited otherwise (Schechtman, 2002). The NNT was 
calculated according to the following formula: 1 / (rstandard care – rtelemonitoring) where r was 
the risk of hospitalization, i.e. the percentage of patients being hospitalized.
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7 Results
7.1 Enrollment, withdrawal and completion
7.1.1 Mobile Sipoo (I)
One hundred individuals confirmed an initial agreement to participate in the Mobile Sipoo 
study (Figure 4a). Of those, 35 did not meet the inclusion criteria and nine subsequently 
declined to participate. Fifty-six individuals were randomized, and scheduled with a 
baseline visit. Fifty participants completed the study, of whom two were further excluded 
from the analyses because they proved not to have T2D. Recruitment started in December 
2010 and ended in April 2011. The study was completed in April 2012.
Figure 4a. Eligibility, randomization and follow-up in the Mobile Sipoo study
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7.1.2 Heart at Home (II)
A total of 123 HF patients were found eligible for the Heart at Home study; these were 
further matched in pairs according to their sex, age, LVEF and NYHA classification 
(Figure 4b). Fifty-one pairs were formed, and 21 patients were excluded as a matched pair 
was not found. Invitation letters were sent to 102 individuals, of whom three declined to 
participate and one had a changed diagnosis. Respectively, their matched counterparts 
were excluded from the study. Finally, 94 HF individuals were randomized and included 
in the study. The baseline visits were conducted between November 2010 and August 2011, 
and the study was completed in February 2012 with 93 participants.
7.1.3 Renewing Health (III)
Invitation letters were sent to 2,084 individuals, of whom 595 (29%) agreed to participate 
and were further randomized to the TM and the standard care groups with an allocation 
ration of 2:1 (Figure 4c). Of those, 519 completed the baseline visit and were included in 
the study. The drop-out rate was 8% in the TM group and 9% in the standard care group. 
Eventually, 337 and 134 participants in the TM and standard care groups, respectively, 
completed the study. Recruitment started in August 2010 and ended in December 2011. 
The study was completed in December 2012.
Figure 4b. Eligibility, randomization and follow-up in the Heart at Home study
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The drop-out analysis showed that not being familiar with mobile phones increased the 
risk of withdrawal; 86% of drop-outs vs. 98% of study completers reported being familiar 
with mobile phones (p-value obtained from Fisher’s exact test was < 0.001). No other 
baseline characteristic was associated with withdrawal. Moreover, the drop-out rates did 
not differ between the three conditions (p=0.918).
7.2 Baseline characteristics
Table 7 shows the baseline characteristics of the participants in the three studies, and the 
findings are summarized below.
7.2.1 Mobile Sipoo (I)
The mean age was 62 years, 53% of participants were male and the mean BMI was 32.1 
kg /m 2. The mean level of HbA1c was 7.0%. Participants in the TM group had a lower BMI 
(30.5 kg/m2) than those in the standard care group (33.7 kg/m2) and also higher blood 
pressure, 157/89 mmHg vs. 146/85 mmHg, respectively (see Table 9 for blood pressure 
and HbA1c). In addition, there were fewer patients on insulin medication in the TM 
group. Almost all participants (98%) had either elevated blood pressure or blood pressure 
medication. Sixty-four percent of the participants in the TM group used mobile phones 
and the internet at least on a weekly basis.
Figure 4c. Eligibility, randomization and follow-up in the Renewing Health study
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7.2.2 Heart at Home (II)
In the Heart at Home study, 83% of participants were male with a mean age of 58 years and 
a BMI of 28.1 kg/m2. The mean LVEF was 28.0%, and 62% of participants had a NYHA 
classification of III or IV indicating at least marked limitation of physical activity (see Table 
9 for LVEF). Eighty-one percent of participants in the TM group reported using mobile 
phones at least on a weekly basis, and 75% used the internet at least on a weekly basis. There 
were more smokers in the TM group; in the TM and SC groups, 24% and 11% smoked, 
respectively.
7.2.3 Renewing Health (III)
Of the 519 individuals who started in the study, 250 participants were T2D patients, and 
269 individuals had a heart disease. Of the heart disease patients, 227 (84%) had CAD and 
42 (16%) had HF. The mean age of the whole study group was 68 years, the mean BMI was 
29.7 kg/m2, and the majority (61%) were male. Eighty-nine percent of the participants were 
familiar with a mobile phone, and 55% were familiar with a computer.
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7.3 Adherence
Figure 5 shows the percentage of adherent participants, that is, those reporting at least 
one recorded measurement on a given study week. Adherence was highest in the Mobile 
Sipoo (I) and Heart at Home (II) studies with adherence rates of approximately 80% or 
higher. In the Renewing Health study (III) the percentage of adhering participants varied 
between 50–60%. There was no major attrition towards the end of the follow-up in either 
of the studies.
7.3.1 Mobile Sipoo (I)
The percentage of adherent participants varied from 75% (week 29, 30 and 34) to 100% 
(week 18 and 19). The median percentage of weeks with at least one recorded measurement 
was 93%; the 25th and 75th percentiles were 79% and 98%, respectively. 
For the five participants who were instructed to monitor their blood glucose, the 
percentage of weeks in which at least three pre- and postprandial glucose measurements 
recorded were 4%, 62%, 60%, 57%, and 63%. The participant whose adherence was 4% did 
not report three pre- and postprandial measurements weekly, however, the participant 
monitored his/her blood glucose on a regular basis until the follow-up visit. The median 
number of recorded blood glucose measurements per participant was 49. 
Figure 5. Adherence to weekly telemonitoring in the three studies over time; from the baseline 
(week 0) to the end of the study. Adherence is presented as the percentage of participants in the 
intervention group who recorded at least one measurement on a given week.
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7.3.2 Heart at Home (II)
The percentage of adherent participants varied from 80% (week 17 and 23) to 96% (week 
8) (Figure 5). The median percentage of weeks with at least one recorded measurement was 
90% with 25th and 75th percentiles of 79% and 100% (Figure 6).
7.3.3 Renewing Health (III and IV)
The percentage of adherent participants varied from 51% (week 37) to 68% (week 6). The 
median percentage of adherent weeks per individual was 65%; the 25th and 75th percentiles 
were 27% and 85%, respectively.
The mean number of health coaching calls was 7.5 when baseline and end-point calls 
were excluded. Sixty-six percent of participants received 7–11 calls, which corresponds to 
the predefined coaching schedule. Eighty-nine percent received at least 6 calls. The mean 
duration of calls was 27 minutes. 
Figure 7 illustrates the relationship between adherence to TM and change in HbA1c 
and HRQoL, measured as PCS and MCS. Adherence to TM did not correlate with change 
Figure 6. Patient-level adherence to weekly telemonitoring in the three studies, showing the median 
(thick black line) and interquartile ranges (left and right sides of the boxes) for the percentage of 
ZHHNVZLWKDWOHDVWRQHUHFRUGHGKHDOWKSDUDPHWHU:KLWHFLUFOHVGHQRWHVLQJOHGDWDSRLQWVGH¿QHGDV
outliers.
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in PCS (ρ=0.02, p=.67) or MCS (ρ =0.08, p=0.17), or with change in HbA1c in individuals 
with T2D (ρ =0.08, p=0.34). Correspondingly, the number of answered health coaching 
calls did not correlate with any of the primary outcomes: r=0.06 (p=0.32) for PCS; r=0.03 
(p=0.58) for MCS; and r=0.003 (p=0.97) for HbA1c in T2D patients. 
7.4 Outcomes
Table 8 shows the baseline and follow-up measures, and the study-wise differences between 
the treatment arms in the selected clinical and behavioral outcomes, and in HRQoL. Table 
9 presents the utilization of healthcare resources in the Heart at Home study. The results 
are summarized below.
7.4.1 Primary outcomes
7.4.1.1 Mobile Sipoo (I)
At 10 months, the baseline adjusted difference in HbA1c was 0.44 percentage points 
lower in the TM arm (95% CI: -0.81; -0.07), p=0.02. The difference remained statistically 
significant after further adjusting for the baseline BMI and insulin medication with a 
difference of 0.44 percentage points (95% CI: -0.83; -0.05), p=0.03. 
)LJXUH6FDWWHUSORWVLOOXVWUDWLQJWKHUHODWLRQVKLSEHWZHHQDGKHUHQFHWRWHOHPRQLWRULQJGH¿QHG
as a percentage of weeks per patients with at least one recorded health measurement, and the 
change in health-related quality of life, measured as Physical Component Score of SF-36 (7a) and 
Mental Component Score of SF-36 (7b), and change in HbA1c in type 2 diabetes patients (7c) in the 
5HQHZLQJ+HDOWKVWXG\3DUWLFLSDQWVLQWKHWHOHPRQLWRULQJJURXSRQO\DUHLQFOXGHGLQWKH¿JXUHV
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Reductions in blood pressure levels did not differ between the study arms at 10 months; 
the baseline adjusted difference in systolic blood pressure was 3.6 mmHg lower in the 
TM arm (95% CI: -14.5; 7.3), p=0.51, and 2.2 mmHg lower (95% CI: -7.1; 2.8), p=0.38, in 
diastolic blood pressure (Table 8).
7.4.1.2 Heart at Home (II)
HF-related hospitalizations did not differ between the study arms, Table 9. Eight (17%) and 
13 (28%) participants in the TM and standard care groups, respectively, were hospitalized 
due to HF. The likelihood of not being hospitalized was 1.9 measured with OR (95% CI for 
OR: 0.7; 5.1), and the difference between groups was not statistically significant (p=0.22). 
Moreover, the number of hospital days among those who were hospitalized did not differ 
between the treatment arms (IRR=0.8, 95% CI: 0.5–1.3, p=0.35). 
The absolute risk difference for HF-related hospitalization was 10.3% with a 95% CI 
from -0.067 to 0.271. The NNT to prevent one HF-related hospitalization was 10, with a 
95% CI of -15 to 4.0. The NNT should be interpreted with caution, because the confidence 
interval for the absolute risk difference included zero, which, in theory, increased the NNT 
to infinity, and the lower threshold for the interval was negative. Such CIs are challenging 
to interpret, and it has been recommended that in such cases the confidence intervals is 
separated into two parts; number needed to harm (NNH) and number needed to benefit 
(NNB). (Altman, 1998; Schechtman, 2002; Uhari, 2001.) For HF-related hospitalizations, 
the NNH is 15–∞ and the NNB is 4–∞. The NNH result indicates that when 15 patients 
receive TM intervention, one patient may benefit from the standard care more, and the 
NNB result indicates that at least 4 patients need to be treated with TM intervention to 
avoid one HF-related hospitalization.
The risk of HF-related hospitalization was assessed using ORs obtained from the ZIP 
regression models. The ORs should be interpreted with caution when the initial risk is high 
and in such cases ORs tend to overestimate the actual risk (Schmidt & Kohlmann, 2008). 
In this study 83% of TM patients and 72% of standard care patients were not hospitalized 
at all during the follow-up. These numbers constitute a RR of 1.2, whereas the OR for not 
being hospitalized was 1.9. One can see that there is a discrepancy between the RR and OR; 
however, neither the interpretation nor conclusions regarding HF-related hospitalization 
are affected by this discrepancy. Similar comparisons between the ORs and RRs were done 
for the other resource-related variables that were analyzed using ZIP regression models 
and no major differences were observed between the measures. The RR results are not 
specifically presented in this work, although their figures can be obtained from Table 9.
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7.4.1.3 Renewing Health (III)
At 12 months, there were no statistically significant differences in either of the summary 
scores of SF-36; the PCS differed by 0.5 points (95% CI: -0.7; 1.6, p=0.40), and the MCS 
by -0.7 points (95% CI: -2.4; 1.0, p=0.52) between the study arms when adjusted for the 
corresponding baseline levels. Adding the interaction term condition x treatment group to 
the model did not change the results in either of the summary scores, indicating that the 
intervention effect on HRQoL was not different across the three chronic conditions, as 
demonstrated by the absolute values in Table 9. Neither was there a difference in HbA1c in 
participants with T2D. At 12 months the baseline adjusted difference was -0.1 percentage 
points with a 95% CI of -0.3 to 0.1 and a p-value of 0.3.
According to the study protocol, individuals with T2D were eligible if their HbA1c 
was > 6.5% within 12 months from screening. However, there were 81 T2D patients whose 
HbA1c at baseline was lower or equal to 6.5% because their HbA1c had changed since 
screening. To further investigate the effect of low baseline values on glycemic outcomes, 
the analyses regarding HbA1c were repeated by excluding participants whose HbA1c at 
baseline was < 6.5%. The results remained similar, with a difference of 0.1 percentage points 
between arms (p=0.49), and a 95% CI of -0.4 to 0.2.
7.4.2 Secondary outcomes
In the Mobile Sipoo study (I), the TM group had significantly lower weight and waist 
circumference at 10 months. The difference in weight was -2.5 kg (95% CI: -4.7; -0.4), with 
a p-value of 0.02, and in waist circumference -4.8 cm (95% CI: -8.9; -0.8) with a p-value of 
0.02. 
In the Heart at Home study (II), none of the clinical and behavioral outcomes including 
weight, blood pressure, LVEF, and EHFSBS scores differed between the TM and standard 
care groups at 6 months (Table 8). In addition, none of the participants died during the 
6-month follow-up. However, the TM intervention resulted in increased use of healthcare 
resources (Table 9). Use of nurse resources increased, with the number of appointments 
being 1.7 (95% CI: 1.4; 2.2, p < 0.001) times higher in the TM group, and the number of 
nurse-initiated and patient-initiated calls being 5.6 (95% CI 3.4; 7.6, p < 0.001) and 1.6 
(95% CI: 1.0; 2.7, p=0.05) times higher, respectively. Moreover, the number of unplanned 
visits to the cardiology clinic was 3.3 (95% CI: 2.2; 5.1, p<0.001) times higher in the TM 
group among those who had at least one visit. Use of physician’s time did not increase in the 
TM group (IRR=0.95, 95% Cl: 0.7; 1.3, p=0.74).
85
Table 9. Use of health care resources in the Heart at Home study (II)
TM
n=46
SC
n=47
Mean 
difference 
between 
groups 
(95% Cl)
IRR 
(95%Cl)
p-value 
for IRR
OR 
(95%Cl)
p-value 
for OR
HF-related hospital daysa 0.7(2.4)
1.4
(3.5)
-0.6
(-1.9; 0.6)
0.8
(0.5; 1.3)b
0.35
% of patients with zero counts 83 72 1.9(0.7; 5.1)c
0.22
Number of appointments with nursea 4.5(2.2)
2.7
(1.0)
1.8
(1.0; 2.5)
1.7
(1.4; 2.2)
< 0.001
Number of appointments with 
physiciana
1.9
(0.9)
2.0
(0.8)
-0.2
(-0.5; 0.2)
0.95
(0.7; 1.3)
0.74
Number of calls initiated by the nursea 3.0(2.4) 
0.6
(0.9) 
2.3
(1.6; 3.1)
5.6
(3.4; 7.6) 
0.001
% of patients with zero counts 15 57
Number of calls initiated by the 
patienta
2.3
(2.1)
0.6
(1.5) 
1.6
(0.9; 2.4)
1.6 
1.0; 2.7)b 
0.05
% of patients with zero counts 30 72 0.2(0.1; 0.5)c
< 0.001
Number of unscheduled visits to the 
clinica
3.7
(2.6) 
1.0
(1.5) 
2.7
(1.8; 3.6)
3.3
(2.2; 5.1)b 
0.001
% of patients with zero counts 13 47 0.4(0.1; 2.2)c
0.31
&, FRQ¿GHQFHLQWHUYDO,55 LQFLGHQWUDWHUDWLR25 RGGVUDWLR6& VWDQGDUGFDUH70 WHOHPRQLWRULQJ
a mean (standard deviation)
b,55LVFDOFXODWHGIRUWKRVHZKRKDGDWOHDVWRQHFDOOYLVLW
c25IRUKDYLQJQRFDOOVYLVLWV
In the Renewing Health study (III), the TM intervention did not reduce weight, systolic 
pressure, diastolic pressure or LDL cholesterol. Waist circumference was significantly lower 
in the TM group differing by -1.7 cm (95% Cl; -2.9; -0.4), and the p-value was 0.01. There 
were no statistically significant interactions between the chronic condition (T2D/CAD/
HF) and the treatment group in any of the clinical outcomes.
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8 Discussion
 6XPPDU\RIPDLQ¿QGLQJV
The purpose of this thesis was to investigate the effect of TM interventions, which 
combined TM with differential patient decision support components, on health-related 
outcomes in individuals with T2D, HF or CAD. The three RCTs, conducted as a part of 
this work, demonstrated the following results:
◆ Adherence to the TM interventions was moderate to high. In the Mobile Sipoo 
(I) and Heart at Home (II) studies 80–90% of participants adhered to weekly TM 
throughout the follow-up. In the Renewing Health study (III, IV) participants 
monitored their health parameters on 65% of the weeks, and 66% of participants 
received health coaching calls as scheduled.
◆ TM combined with automatic, real-time, behavioral theory based feedback messages 
improved the glycemic control of individuals with T2D with a reduction of 0.44 
percentage points in HbA1c. However, there was no significant difference in blood 
pressure levels between the TM and the standard care arms (I).
◆ TM combined with automatic, real-time, information-oriented feedback messages 
did not reduce HF-related hospital admissions in individuals with HF. Instead, the 
TM arm demonstrated increased use of healthcare resources reflected as a higher 
number of appointments and phone calls with the HF nurse and more unscheduled 
visits to the cardiology clinic (II).
◆ TM combined with monthly telephone-based health coaching did not improve the 
HRQoL of individuals with T2D, HF or CAD or glycemic control of individuals 
with T2D (III).
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8.2 Methodological considerations
8.2.1 Study design
Randomization is the gold standard design for clinical trials, and one of the strengths of 
the present study. When properly conducted, it eliminates selection bias, and balances the 
groups with respect to many known and unknown confounding factors (Schulz & Grimes, 
2002). Designing studies as RCTs also helps to avoid bias caused by the Hawthorne effect, 
that is, the control arm showing improvements in their health outcomes because the patients 
know they are being followed. In this work, the use of a pre-post study design would have 
resulted in biased conclusions about the superiority of TM intervention, underlining the 
importance of controlled designs.
It has been estimated that studies with inadequate or unclear randomization procedures 
tend to overestimate treatment effects up to 40% compared with those that use proper 
randomization (Schulz, Chalmers, Hayes, & Altman, 1995). To reduce the selection bias 
and the likelihood of such biased positive results, the generation of random sequence 
and concealing the allocation should be ensured and described transparently (Schulz & 
Grimes, 2002). In all three studies of the present work, the randomization was done after 
the initial agreement from potential participants was obtained. In the Renewing Health 
(III) and Mobile Sipoo (II) studies, the study personnel created a list of eligible participants 
that was further sent to the statistician for randomization. The statistician was not involved 
in clinical work or recruitment. Thus, there was no chance that clinical staff could have 
intervened in the allocation based on their prior knowledge about the individuals. The 
concealment procedure was conducted only in the Renewing Health study (III), where the 
allocation information was concealed in a closed envelop and opened at the baseline visit. 
In the Heart at Home study (II), the HF nurse identified potential participants using the 
database and formed matched pairs according to the most important prognostic factors. 
The nurse further conducted the randomization of each pair. To minimize the theoretical 
risk that the nurse could have interfered with the allocation and thus biased the selection, 
structured instructions were given and the process was made as transparent as possible. 
8.2.2 Baseline characteristics
To avoid baseline differences that may be sources of confounding in small studies in 
particular (Senn, 1994), stratified randomization was used in the Mobile Sipoo (I) and 
Renewing Health (III), and a matched pair design in the Heart at Home study (II). Despite 
the randomization, the baseline characteristics slightly differed between the treatment arms 
in the Mobile Sipoo study (I). In the TM group there were fewer individuals with insulin 
medication and they had lower BMIs and higher levels of blood pressure. All analyses were 
done by adjusting for the baseline level of the outcome variable to control for confounding. 
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Further adjustments for baseline imbalances did not change the results. The baseline level 
of HbA1c, which was the primary outcome, was similar between the TM and standard 
care groups
In the Heart at Home study (II), the HF nurse screened eligible participants using the 
database and formed matched pairs according to prognostic factors including sex, age, 
LVEF and NYHA classification. This approach resulted in balanced groups with respect 
to the important prognostic factors. However, there was a considerable reduction in the 
sample size; approximately 10% of patients were excluded because no matched pair was 
found.
In the Renewing Health study (III) no imbalances were observed between the 
treatment arms in any of the prognostic variables in the three conditions (T2D, HF, CAD). 
Patients with T2D had higher BMIs and a lower proportion of them were male compared 
to the patients with HF and CAD. However, these differences did not affect the outcome 
variables.
The ceiling effect, which refers to a point at which the health status of a patient is 
already so good at baseline that any further improvement becomes hard to detect (Frost 
et al., 2005), might be a factor that contributed to the neutral findings in the Heart at 
Home (II) and Renewing Health (III) studies. In the Heart at Home (II) participants 
received multidisciplinary care at the university hospital and they were residents of the 
capital area. Given the high quality of the standard care and availability of the healthcare 
services, there was little room for improvement. Moreover, the HF patients were relatively 
stable, which was reflected in low hospitalization rates and no deaths during the 6-month 
follow-up. The results showed that the weekly monitoring of vital signs did not provide 
benefits over the standard care at the cardiology clinic. TM could be more beneficial for 
patients whose health condition is poorly managed. For example, newly diagnosed patients 
who are starting to learn to monitor and interpret their health parameters may benefit 
from such TM intervention. It has also been suggested that TM might be more effective 
among high risk patients with poor prognosis (Cleland et al., 2005; Dendale et al., 2012). In 
the Renewing Health study, as well as in the Mobile Sipoo study, the inclusion criteria for 
all individuals with T2D was HbA1c > 6.5%, and the baseline levels of HbA1c were 7.3% 
and 7.1%, respectively. According to the guideline recommendations, the target level for 
HbA1c in T2D patients is < 7.0%, or < 6.5% for individuals without additional risk factors 
(American Diabetes Association, 2018a; International Diabetes Federation, 2017b). Thus, 
both the Renewing Health study and the Mobile Sipoo study likely included participants 
whose HbA1c was already so low that they had little room to improve their glycemic 
control. In fact, it has been recommended that remote patient monitoring interventions 
in T2D patients should target individuals whose HbA1c is above 7.5% (Greenwood et al., 
2014). Nevertheless, significant improvements have been seen in other TM studies where 
the baseline level of HbA1c has been close to 7% (Waki et al., 2014), and the results of the 
Mobile Sipoo (I) study are in line with these findings; despite the relatively well-balanced 
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glycemic control of the Mobile Sipoo participants, the TM group showed an improvement 
in HbA1c and in weight and waist circumference (I).
8.2.3 Validity of outcomes
The use of SF-36 in assessing HRQoL in the Renewing Health study (III) requires 
further discussion. The motivation for the use of SF-36 was to include a generic outcome 
in the European Renewing Health project to simultaneously assess heterogeneous patient 
populations that do not share common targets for optimal management or a common 
measure to reflect positive health status. However, SF-36 might have been too generic 
to reflect changes in HRQoL in individuals with different chronic conditions. Instead, 
disease-specific instruments that include aspects closely related to a specific condition, such 
as the Minnesota Living with Heart Failure questionnaire (Riegel et al., 2002), the Kansas 
City Cardiomyopathy Questionnaire (Green et al., 2000), and the Diabetes Distress 
Scale (Polonsky et al., 2005), could have provided more robust outcomes by being more 
sensitive to changes in patients’ health. Of the five HF studies that reported significant 
improvements in HRQoL, four used instruments other than SF-36 (Jayaram et al., 2017; 
Ong et al., 2016; Seto et al., 2012; Villani et al., 2014).
8.2.4 Generalizability
All studies were pragmatic trials conducted parallel with routine clinical practice, which 
is one of the strengths of this work. Incorporating the intervention components into the 
standard care provision increases the external validity of the studies, the lack of which is 
a frequent criticism of highly controlled clinical trials conducted in specialized research 
settings with a carefully selected patient population (Rothwell, 2006). The implementation 
of the TM intervention required additional efforts to educate healthcare providers to use 
the technology and to incorporate it as part of their care routines. Sufficient resources 
should be ensured when designing pragmatic trials.
The generalizability of the findings in the Renewing Health study (III) is limited by 
the low participation rate and the majority of participants in the heart disease group being 
CAD patients. The low number of HF patients indicates selective participation. Potential 
participants were screened using individuals’ diagnosis codes and individuals with CAD 
and HF were invited accordingly. Nonetheless, 84% of the participants in the heart disease 
group were CAD patients. Individuals with HF are typically older with poorer prognosis, 
which might have affected their willingness and ability to partake in the study. In addition, 
TM required experience in using a mobile phone, which is less common among older 
individuals. The importance of having appropriate IT skills is also supported by the findings 
of the drop-out analysis, which showed that individuals who were not familiar with mobile 
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phones were more likely to drop out. The overall response rate in the recruitment phase 
of the Renewing Health study was 29%, which is lower than seen in some TM studies 
(Bekelman et al., 2015) but not in all (Stone et al., 2010). These findings imply that the 
results of the Renewing Health study may not be generalized to all patients with T2D 
or CAD but to a subgroup of those who are able to conduct self-monitoring and have 
the ability to use mobile phones to report their measurement data. These individuals are 
presumably more motivated to improve their self-management. Furthermore, the results 
for individuals with HF represent a specific subgroup of individuals who are presumably 
healthier with a better prognosis. The low response rate in the Renewing Health study 
and the difficulties with patient recruitment in the Mobile Sipoo study demonstrate 
the challenges in recruiting participants to clinical trials. This is not always anticipated 
by researchers, who tend to assume that their new treatment/technology will appeal to 
potential participants. Sufficient resources and time for recruitment should be therefore 
ensured and carefully-defined inclusion criteria used to maximize participation rates.
In the Heart at Home study (II) participants were customers at the cardiology clinic 
at the Helsinki University Central Hospital where each patient received multidisciplinary 
care. They were all residents of the Helsinki metropolitan area and thus had better access to 
healthcare services than individuals living in remote areas. Generalization of the findings of 
the Heart at Home study is therefore limited to exclude other parts of Finland where access 
to such high quality healthcare is generally not as readily available. Typically, individuals 
with HF are customers at the healthcare centers where resources and the possibility to 
provide multidisciplinary are relatively limited, as was the case in Renewing Health study, 
the participants of which likely had a lower standard of care compared to Heart at Home 
study participants.
In the Mobile Sipoo (I) and Heart at Home (II) studies, no information was available 
concerning the number and characteristics of patients who were screened but not enrolled 
in the studies. In the Heart at Home study, all participants who were contacted agreed 
to participate in the study (compare to the response rate of 29% in the Renewing Health 
study). In addition, the lack of information on the reasons for exclusions prevents further 
assessment of potential selection bias.
An important consideration in the Mobile Sipoo study (I) is the small sample size of 51 
participants. Although the findings on the positive effect of the automatic feedback system 
are appealing, the results need to be confirmed with a larger sample to ensure the feasibility 
of such a system when applied large scale and in different sites.
8.3 Results in relation to other studies
The Mobile Sipoo intervention that linked TM data with automatic, real-time, behavioral 
theory based feedback messages improved glycemic control of individuals with T2D by 
reducing HbA1c by 0.44 percentage points (I). The observed difference is comparable with 
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glycemic outcomes in other TM studies in T2D patients where the reductions typically 
varied from 0.4 to 0.6 percentage points (Greenwood et al., 2015; Lim et al., 2011; Nicolucci 
et al., 2015; Stone et al., 2010; Waki et al., 2014; Wild et al., 2016). Effect of similar magnitude 
has also been found in a systematic review by Marcolino et al. (2013) that demonstrated a 
decrease 0.44 percentage points. The improvement in the present study was higher than 
0.3 percentage points, which is accepted to be of clinical importance (Klonoff et al., 2008). 
However, some guidelines consider 0.5 percentage points to be of clinical relevance (Little, 
Rohlfing, Sacks, & National Glycohemoglobin Standardization Program (NGSP) Steering 
Committee, 2011).
The Mobile Sipoo intervention (I) was similar to the intervention by Quinn et al. where 
participants received real-time educational, behavioral and motivational messaging and 
consistently demonstrated a decreased HbA1c of 1.2 percentage points (Quinn et al., 2011). 
Furthermore, neither of these studies improved blood pressure, although individuals in the 
Mobile Sipoo study were specifically instructed to monitor their blood pressure. Similarly, 
some other studies of T2D patients that have included TM of blood pressure have shown 
improved glycemic control without decreasing blood pressure levels (Nicolucci et al., 2015; 
Stone et al., 2010; Waki et al., 2014). In the Mobile Sipoo study (I), the reduction in systolic 
blood pressure was 3.6 mmHg that is comparable to the effects typically observed with 
lifestyle changes (Whelton et al., 2018). However, the variability across individuals was 
high. The reductions in weight and waist circumference, in conjunction with HbA1c, 
imply that the improved glycemic control was attributable to lifestyle changes rather than 
adjustments in diabetes medication. This is also supported by the fact that only five patients 
telemonitored their blood glucose, and thus only these patients provided healthcare 
providers with additional data to adjust their diabetes medication.
The TM intervention in the Heart at Home study (II) did not result in a statistically 
significant reduction in hospital admissions, which is in line with results seen in the 
majority of TM studies in individuals with HF (Bekelman et al., 2015; Chaudhry et al., 
2010; Dar et al., 2009; Koehler et al., 2011; Kotooka et al., 2018; Lyngå et al., 2012; Mortara 
et al., 2009; Ong et al., 2016; Seto et al., 2012). Although the reduction was not statistically 
significant, the magnitude of the effect imply that the TM intervention had a protective 
effect on HF-related hospitalization with an IRR of 0.8. The effect was of similar magnitude 
to the pooled effect reported in a systematic review where the risk reduction for HF-related 
hospitalizations was 0.71 (95% Cl: 0.60 to 0.93) (Inglis et al., 2015). Moreover, none of the 
participants died during the 6-month follow-up in the Heart at Home study. This was 
contrary to expectations given that one third of individuals with HF die within one year 
(Chen et al., 2011) and even 1-month mortality can be as high as 7% (Savarese & Lund, 
2017). The participants in the Heart at Home study (II) were not recruited from hospital 
but invited to the study regardless of the time since their last hospital admission. Thus, 
the participants may have had better prognosis when compared to the recently admitted 
patients. Their clinical characteristics nevertheless indicated poor prognosis; mean LVEF 
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was 28% and 60% of participants had NYHA class III or IV. In one study, patients whose 
LVEF was below 40% had a 1-month mortality of approximately 4%, with the risk of death 
increasing linearly with decreasing LVEF (Toma et al., 2014). 
The number needed to treat with the TM intervention to prevent one HF-related 
hospitalization was 10 in the Heart at Home study (II). Given the non-invasive nature of the 
TM intervention, ease of delivery and the potential for increased availability of healthcare 
services through TM, the NNT number seems to be appealing. However, the substantial 
increase in the use of nurse resources outweighs the potential benefits. The intervention 
almost doubled appointments with the HF nurse, tripled the number of unscheduled visits 
to the clinic, and initiated more phone contacts with the patient. Treating ten patients 
with such intervention would result in 18 additional nurse appointments, 40 additional 
phone calls, and 27 more unscheduled visits to the clinic. These figures suggest that such 
an investment of resources is not cost-effective, especially as the reduction in HF-related 
hospitalization could be due to chance, as the p-value of 0.22 indicates. Moreover, the 
confidence interval of the NNT showed that if 15 patients were treated with TM, one 
patient is likely to benefit more from the current care.
The increased use of healthcare resources found in the Heart at Home study (II) has 
also been seen in other TM studies regardless of the chronic condition studied (Cleland 
et al., 2005; Wakefield et al., 2011; Wild et al., 2016). These results suggest that additional 
resource investment is required if TM is implemented as part of standard care. Whereas 
nurse-initiated calls were mainly attributable in the present study to promoting adherence 
and assessing the need for an additional appointment, the reasons for patient-initiated calls 
are likely to be multifaceted. Patients called the nurse to ask for help with interpreting their 
TM data (II). However, TM may in some cases increase dependence on the healthcare 
professionals, reinforcing the sick role and creating dependence on TM rather than 
promoting self-management (Fairbrother et al., 2013). The increased number of contacts 
might also reflect patients’ loneliness and need for social contact. It has been proposed that 
patients find the presence of TM comforting and that it reduces anxiety and depression, 
which are common in HF patients in particular (Inglis et al., 2015; Ponikowski et al., 2016). 
These aspects are important considerations and should be investigated more detailed in the 
future TM studies. Although increasing the burden of the HF nurse, increased contacts 
might improve HRQoL, which was not measured in the Heart at Home study (II).
The intervention that combined TM with health coaching did not improve HRQoL 
or glycemic control in patients with T2D (III). This result is in line with other studies, 
in particular those conducted under the European Renewing Health project (Kidholm 
et al., 2014). The TM interventions by Holmen et al. and Lindberg et al. involved blood 
glucose TM and health counselling, and neither of these studies showed improved HRQoL 
outcomes or glycemic control (Holmen et al., 2014; Lindberg et al., 2017). Both authors 
discussed whether the ceiling effect regarding HbA1c (the inclusion criteria for Holmen 
et al. and Lindberg et al. was HbA1c > 6.5% and ≥ 7.1%, respectively) had contributed 
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to their results. On the other hand, some TM interventions have enhanced HRQoL 
(Dario et al., 2017; Nicolucci et al., 2015; Olivari et al., 2018; Ong et al., 2016; Seto et al., 
2012). One study showed a statistically significant improvement in the MCS of SF-36 but 
not in the PCS of SF-36 in patients with T2D (Nicolucci et al., 2015). Dario et al. and 
Olivari et al. demonstrated increased HRQoL. However, both of these findings lacked 
clinical significance as the SF-36 scores differed by less than the three points needed to 
be considered of clinical relevance (Dario et al., 2017; Olivari et al., 2018). The study by 
Ong et al. combining TM with health counselling improved HRQoL in individuals with 
HF. However, in that study the authors reported that the survey non-respondents differed 
from the survey respondents in their baseline characteristics, which may have affected 
the outcomes (Ong et al., 2016). One possible factor contributing to the positive HRQoL 
effects in the study by Seto et al. could be the automatic instructions sent immediately after 
each data submission (Seto et al., 2012). The timely instructions likely improved patients’ 
self-management which further improved the HRQoL as discussed by the authors (Seto et 
al., 2012). In the present study (II), two common reasons for patient-initiated calls to the 
HF nurse included asking for help interpreting measurements and asking for help making 
changes to diuretic medication (II). To minimize confusion, the provision of instructions, 
such as those provided by Seto et al., might result in improved HRQoL. 
The health coaching component in the Renewing Health study (III) was similar to the 
TERVA trial that was conducted four years earlier, and which showed no difference in 
any clinical outcomes except diastolic blood pressure, which more frequently improved in 
the intervention arm (Patja et al., 2012). In the present study (III), the only statistically 
significant difference was observed in waist circumference. However, the difference of 
-1.7cm in waist circumference lacked clinical significance, and could be attributable to 
measurement error (Verweij, Terwee, Proper, Hulshof, & van Mechelen, 2013). Moreover, 
the finding may have come about due to multiple testing rather than reflecting a true 
positive effect of the intervention.
8.4 Adherence to the telemonitoring interventions
Adherence to an intervention is a key determinant of its efficacy (World Health 
Organization, 2003). Adherence to the TM intervention was high in the Mobile Sipoo 
(I) and Heart at Home (II) studies with 80–90% of participants recording their health 
parameters on a weekly basis. In both of these studies, and in line with several other TM 
studies, adherence was specifically promoted (Chaudhry et al., 2010; Lim et al., 2011; 
Lyngå et al., 2012; Nicolucci et al., 2015; Ong et al., 2016; Seto et al., 2012; Waki et al., 
2014). In the Heart at Home study (II), the HF nurse was responsible for all participants 
and for all practicalities, and was thus actively involved with the intervention. The HF 
nurse contacted the patients if they did not submit data, whereas in the Mobile Sipoo 
study the feedback messages encouraged patients to continue with TM. In both of these 
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studies, the number of participants was rather small. When applied large-scale, as in the 
Renewing Health study (III), the possibility of the healthcare professionals to intervene 
and actively promote self-management is limited and resource-intensive. In the Renewing 
Health study (III), efforts to improve patients’ adherence to the TM intervention were 
made through monthly health coaching calls rather than promptly reacting to missing 
data. Consequently, adherence rates were lower than in the other two studies (I and II), 
varying from 51% to 68% during the 12-month intervention (IV). Typically, TM studies 
have shown adherence rates of approximately 80% in patients with HF, and from 40–80% 
in individuals with T2D. In the Renewing Health study, adherence to health coaching was 
66%, i.e. two thirds responded to the calls as scheduled. Adherence to health coaching was 
similar to the study by Ong et al. (2016), but clearly lower than the adherence to monthly 
health counselling in the study by Holmen et al. in which all participants received health 
counselling as scheduled (Holmen et al., 2014).
High attrition rates that increase towards the end of the follow-up are typical of 
eHealth interventions in particular (Eysenbach, 2005). Interestingly, there was no major 
attrition in any of the three studies of this work (I–IV), and the percentage of adherent 
participants remained at approximately the same level until study completion. Adherence 
measures in TM studies frequently rely on aggregated parameters, as reported for instance 
in (Koehler et al., 2011; Seto et al., 2012; Waki et al., 2015), or on reporting the proportion 
of patients who never used the system (Chaudhry et al., 2010) or used the system at least 
once (Tang et al., 2013). Often, adherence is not reported at all, which is more common in 
TM studies in T2D (Holmen et al., 2014; Lindberg et al., 2017; Quinn et al., 2011). The 
aggregated adherence rates do not necessarily reflect sustained use which has been linked 
with improved outcomes (Bradway et al., 2018; Mattila et al., 2013). One of the strengths 
of the current work is its time-varying description of adherence as recommended in the 
eHealth consort statement (Eysenbach, 2011).
The adherence analysis of the Renewing Health data (IV) showed that adherence to 
TM was not associated with changes in HRQoL or HbA1c. In other words, the health 
outcomes remained similar regardless of whether the participants were actively involved 
with the weekly TM or did not record their health parameters at all, or with low intensity. 
These findings are in line with many TM studies of individuals with HF that have shown 
high adherence rates without improved survival or reduced hospitalization (Kotooka et al., 
2018; Lyngå et al., 2012; Mortara et al., 2009; Olivari et al., 2018). Similarly, in a study by 
Stone et al. (2010) the intensity of TM of blood glucose was not associated with changes in 
HbA1c. These results suggest that TM per se might not be effective in improving clinical 
outcomes.
A notable difference between the studies of this work and the majority of other TM 
interventions is the intensity of TM. In this work, participants were instructed to measure 
and report their health parameters on a weekly basis (except glucose monitoring in the 
Mobile Sipoo study, which was done three days per week), whereas other TM studies have 
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typically used daily TM. While adherence rates were high in the Mobile Sipoo and Heart 
at Home studies (I, II), the absolute intensity of self-monitoring remained lower than in 
other TM studies. It is open to further investigation whether more intense TM would have 
resulted in improved outcomes. An optimal frequency for self-monitoring is rarely defined 
and depends on the condition and exploitation of the self-monitored data. For example, 
weight monitoring for patients with HF is assumed to provide signs of fluid retention and 
enable early intervention if needed. Therefore, daily weight monitoring is recommended 
to provide sufficient data to distinguish fluid retention from normal weight variation 
(Ponikowski et al., 2016). The weight monitoring intensity in the Heart at Home study 
(II) deviated from the guideline recommendations, which might be a reason for the lack of 
change in hospitalization rates. It is possible that weekly weight recordings did not provide 
accurate information to further prevent hospitalizations in the TM arm. Regarding other 
health parameters, there are no guideline recommendations for optimal monitoring 
frequency. For example, regular self-weighing at a specified intensity is recommended to 
support weight loss, and frequent (weekly or more often) self-weighing is recommended to 
support weight loss maintenance (Jensen et al., 2014). Regarding T2D, individual skills, 
treatment recommendations and the exploitation of the TM data in clinical decision making 
are emphasized rather than intensity as such (American Diabetes Association, 2018a). 
Moreover, rather than focusing on the intensity of TM, other aspects such as educational 
components, long-term adherence, or efforts made in response to the self-monitored data 
might be more relevant in promoting health outcomes in TM interventions (Bradway et 
al., 2018; Donkin et al., 2011). 
It is important to note that adherence measures used in this study likely underestimated 
the true exposure to the TM interventions. In all three studies, the TM intervention 
involved measuring 3–5 health parameters once a week. However, the monitored health 
parameters were individually defined in each patient’s self-management plan based on their 
needs and treatment targets. Patients did not necessarily monitor all health parameters if 
they were not expected to gain benefit from TM. The individual self-management plans 
were not available for the analysis, and, thus, adherence was defined as monitoring and 
reporting at least one health parameter once in a week. The intensity of TM was likely to be 
higher when multiple health parameters were monitored.
8.5 Patient decision support in telemonitoring interventions
It seems that TM studies in individuals with HF have focused on collecting data and 
transmitting the data to the providers’ use rather than supporting individuals’ self-
management efforts along TM. Only one study included automatic feedback messages sent 
to the participants (Seto et al., 2012). Instead, the feedback involved healthcare professionals 
who contacted the patient if the data exceeded the target values (Dar et al., 2009; Lyngå et 
al., 2012), or, more frequently, only the healthcare professionals were informed about the 
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data and took appropriate actions (Chaudhry et al., 2010; Cleland et al., 2005; Dendale et 
al., 2012; Kotooka et al., 2018; Mortara et al., 2009; Olivari et al., 2018; Seto et al., 2012). 
The lack of feedback and specific recommendations to patients might be reflected in the 
results as the majority of the TM interventions in HF patients did not achieve positive 
health outcomes. On the contrary, the TM interventions in individuals with T2D included 
differential feedback components, delivered either automatically or by involving healthcare 
professionals, and these TM interventions achieved improved health outcomes more 
frequently (Crowley et al., 2016; Greenwood et al., 2015; Lim et al., 2011; Nicolucci et al., 
2015; Quinn et al., 2011; Waki et al., 2014).
In the Heart at Home study (II), TM invoked patients’ interest in their condition 
and raised questions that resulted in an increase in the use of healthcare resources: the 
number of appointments and phone calls with the HF nurse were two to five times higher 
in the TM group. Each time the patient submitted data, (s)he was provided with a short 
feedback message illustrating longitudinal trends and guiding the patient as to whether 
their measurements were within the predefined target values. It seems however that these 
feedback messages did not provide sufficient decision support and that patients needed 
more detailed advice in order to understand their data and manage their condition. 
More intense exploitation of the TM technology could have lessened, at least to some 
extent, the increased workload of the HF nurse seen in the Heart at Home study (II). In 
that study, the HF nurse called the patient if TM data was missing, indicating that the 
high number of nurse-initiated phone calls were partly attributable to efforts to promote 
adherence. To lessen this workload, automatic reminders could be used to remind patients 
of the importance of the TM and encourage them to continue with it. Yet, only one TM 
study has used automatic reminder messages to advance adherence (Lim et al., 2011). 
Instead, low adherence or missing TM data have generated calls to the patients and/or 
healthcare providers (Chaudhry et al., 2010; Seto et al., 2012). Furthermore, the content 
of the automatic feedback messages could be enhanced with recommendations and self-
management instructions (such as adjustments to diuretics) to overcome possible confusion 
arising from self-measurements. The results of the Mobile Sipoo study (I) demonstrate the 
potential of tailored feedback messages with more enhanced content. Each time the patient 
submitted data, (s)he received a feedback message that included information summarizing 
the longitudinal trends in their self-monitoring data along with content aimed at motivating 
the patient to act on this information and helping foster the behavioral skills needed for 
them to act on their self-management efforts. This TM intervention improved glycemic 
control and reduced weight and waist circumference in individuals with T2D. However, 
it is important to note that although positive results in clinical outcomes were achieved in 
the Mobile Sipoo study (I), it is not known whether healthcare utilization remained similar 
or lower, or even increased, when automatic decision support was introduced because these 
data was not analyzed. 
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The content of the feedback messages in the Mobile Sipoo study were built on the IMB 
model. Theory-based interventions are known to increase the efficacy of interventions 
(Webb et al., 2010) and the importance of including a theoretical framework in technology-
assisted interventions is emphasized (Burke et al., 2015; Winter et al., 2016). Building an 
automatic feedback system according to the behavioral principles of the IMB model was a 
novel approach when the automatic feedback system was developed in 2011. Still in 2018, 
TM studies rarely describe the behavioral theories behind the feedback components; 
instead, the theoretical grounds or behavioral techniques of TM studies have been typically 
reported in the context of health counselling programs (Holmen et al., 2014; Lindberg et 
al., 2017).
Besides building the content of the feedback messages on the IMB model, another 
aspect that likely contributed to the positive health outcomes in the Mobile Sipoo study 
was the timely delivery of the feedback messages (I). An immediate feedback response to 
self-monitored data is important (Gee et al., 2015; Jimison et al., 2008). In the Mobile Sipoo 
study, each time the patient submitted data, they received a feedback message guiding and 
motivating them to take action in response to their TM data (I). In the Heart at Home and 
Renewing Health studies participants received either an information-oriented feedback 
message sent immediately in response to their recorded data, or did not receive immediate 
feedback at all; neither of the studies improved health outcomes. In those studies, support 
and instructions to take action in response to the TM were subject to the patient’s own 
activity or were provided with a delay. In the Heart at Home study (II), the participants 
contacted the HF nurse themselves if they had a question or needed advice, which was 
reflected in a two times higher number of patient-initiated calls in the TM arm. In the 
Renewing Health study (III), the participants received health coaching calls every 4–6 
weeks, which is a considerably long response delay to possible questions arising from weekly 
TM. These findings emphasize the importance of delivering feedback in a timely manner 
rather than reacting to data when there is a need for an intervention, or delivering delayed 
feedback, thus, increasing the risk of losing so-called teachable moments, when feedback 
would be most relevant and beneficial.
8.6 Integrating telemonitoring as a part of standard care
The importance of the interoperability of different components in organizing chronic care 
is highlighted in the Chronic Care Model (Bodenheimer et al., 2002). Integrating TM as a 
part of current care and enabling efficient use of the TM data is one of the pre-requisites of 
efficient chronic care management. 
In the Mobile Sipoo study, the TM data and the feedback messages sent to the patients 
were shared with the healthcare professionals who were instructed to review the data on a 
weekly basis (I). High priority feedback messages typically triggered in response to alarming 
values were specifically highlighted. However, the responsibility to seek care remained with 
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the patient. In the Heart at Home study (II), the HF nurse was responsible for managing 
all study participants and worked full-time at the cardiology clinic. The HF nurse reviewed 
the patients’ TM data and contacted them if needed. The nurse was able react to the TM 
data and advise individuals on, for example, adjusting diuretics or making an appointment 
with an HF physician. 
In the Renewing Health study (III), the TM data was underutilized. Access to the TM 
data was available only to the patients and their health coaches and not to the clinicians 
who remained responsible for the patients’ care. The health coaches reviewed the TM data 
prior to each coaching call and discussed them with the patient during the call. If the data 
indicated problems with self-management or a need to intensify treatment, the health coach 
advised the patient to make an appointment with their clinician for further assessment. 
Changes in medication, for example, were not suggested or approved by the health coach 
even if the self-monitoring data indicated such a need. The patients’ own clinicians did not, 
however, have access to this TM data, and were therefore unable to directly assess the need 
for changes in treatment regimens. This lack of integration and subsequent underutilization 
of the TM data might have influenced the neutral health effects seen in the Renewing 
Health study (III). Many studies have shown that TM interventions are effective when 
TM data are exploited for adjusting medications for glycemic control (Crowley et al., 2016; 
Greenwood et al., 2015; Lim et al., 2011; Shea et al., 2009; Stone et al., 2010; Wild et al., 
2016). As the clinicians have better pre-existing knowledge about their patients, sharing the 
TM data with them could have led to more efficient use of the data.
Nevertheless, it should be noted that despite the fact that the TM data was integrated 
with clinical work in the Heart at Home study, neither self-care behaviors nor clinical 
outcomes were improved and hospital admissions were not reduced. However, more 
medication changes were made in the TM arms (II), which might reflect effective 
exploitation of the TM data.
8.7 Future research
Based on this work, the use of automatic feedback systems in combination with TM 
interventions has the potential to promote the management of chronic conditions. More 
research is needed to develop TM interventions with automatic feedback systems that retain 
high adherence and deliver meaningful support and recommendations beyond 12 months. 
It should be studied whether automatic feedback messages with enhanced content could 
lessen the workload of healthcare professionals rather than increasing the use of healthcare 
resources, as was seen in the Heart at Home study (II), and what kind of content the 
feedback messages should have. Investigating the reasons for the increased contacts would 
guide the development of the feedback messages so that they contain tailored support for 
individual needs and concerns. 
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Achieving sustained adherence through technology without human involvement 
is not a simple task. In one study almost 30% of participants withdrew from the study 
and technological problems related to algorithm safety prevented a further 38% from 
participating (Skobel et al., 2017). In another study, 40% of participants requested 
receiving feedback messages before the end of the study (Arambepola et al., 2016). Novel 
aspects are needed to provide patients with relevant, appealing and helpful feedback 
and recommendations in a way that the messages do not repeat themselves but support 
individuals’ self-management efforts long-term. To enrich the content of the feedback 
messages, one possibility is to identify individual patterns in the TM data that correlate 
with changes in the patient’s health status. One such approach is the analysis of missing 
data. Major declines in adherence or non-usage attrition might indicate a change in patient 
health status (Sperrin et al., 2016) which, in fact, would call for patient support or review, 
rather than a boost in adherence. Feedback messages may also target aspects other than 
physical health and related behaviors, which were the focus in the Mobile Sipoo study. 
For example, assessing and enhancing self-efficacy and confidence with self-management 
behaviors, both of which mediate behavior change, could be a valuable feature of automatic 
feedback messages.
Future studies should also consider adaptive study designs. As technology evolves 
rapidly over time, the use of adaptive designs that include pre-specified modifications of 
the design or statistical procedures of an on-going trial based on the data generated (Chow, 
Chang, & Pong, 2005) would be beneficial for telehealth studies. The use of multi-arm 
trials with pre-defined interim analyses to modify or stop treatment would be an efficient 
approach to assess intensity trials with different telehealth components. Based on pre-
defined rules, components that do not work would be accordingly dropped while the 
others are retained and possibly developed further (Law & Wason, 2014). In addition, it is 
important to acknowledge the complex nature of telehealth interventions, which typically 
include and target multiple behaviors and multiple parties. The pharmacological analogy 
should be avoided in such interventions; instead, for example, sample size calculations 
and expected outcomes should be based on similar multifaceted interventions to ensure 
sufficient power for the studies. Also, effective engagement (Yardley et al., 2016) should be 
thoroughly studied and defined accordingly. Adherence could be an outcome in telehealth 
studies rather than a process variable, as used in this work.
Many studies conduct per-protocol analyses post hoc to assess the efficacy of the 
intervention by investigating the effect among those participants who were adherent and 
completed the study. This is common in telehealth studies where detailed information on 
adherence is available through log data. While such per-protocol analyses are important 
and guide the development of effective treatment components, they have weaknesses. Per-
protocol analyses might overestimate the effect of optimal use as there is no randomized 
control group, and thus the comparison may be biased towards factors that contribute to 
attrition in the first phase, such as low motivation or poor health status. An appealing 
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approach for investigating efficacy is the use of the Run-in and Withdrawal Design originally 
proposed by Eysenbach in 2005 (Eysenbach, 2005). Briefly, Run-in and Withdrawal Design 
involves two randomization phases where the first phase refers to the conventional approach 
in which effectiveness is assessed by comparing participants assigned to the intervention 
arm to those assigned to the control arms. After the follow-up, individuals who continue 
to adhere to the intervention are further randomized into two groups: those who continue 
to receive the intervention and those from whom the intervention is withdrawn. The 
second randomization phase provides information on efficacy that is not biased towards 
unmeasured factors related to attrition. Moreover, using the Run-in and Withdrawal 
design, the health effects would not be limited to a single group but compared with control 
patients who are willing and capable of continuing with the intervention. The challenge for 
such designs is to achieve a sample size that retains sufficient power for the second-phase 
analyses. Well-designed pilot studies are clearly needed to obtain sensitive estimates of the 
proportion of participants who are likely to adhere to the intervention and continue to the 
second phase.
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9 Conclusions
◆ Combining TM with real-time, behavioral theory based feedback messages enriched 
with tailored self-management information as well as motivational and behavioral 
skills enhancing content improved glycemic control of individuals with T2D with 
a reduction of 0.44 percentage points in HbA1c, and decreased body weight and 
waist circumference. However, blood pressure levels were not affected by the TM 
intervention. 
◆ Combining TM with real-time, information-oriented feedback messages did not 
reduce HF-related hospital admissions in individuals with HF. Instead, the TM 
intervention demonstrated increased use of healthcare resources reflected in a higher 
number of appointments and phone calls with the HF nurse and more unplanned 
visits to the cardiology clinic.
◆ A combination of TM and individualized monthly health coaching did not improve 
the HRQoL of individuals with T2D, HF and CAD. Neither did it improve 
glycemic control of individuals with T2D.
◆ Adherence to weekly TM was moderate to high in all of the studies, and there were 
no major declines in adherence rates over time. These results imply that weekly TM 
of chronic condition related health parameters is feasible.
◆ Nevertheless, high adherence does not guarantee positive health effects. Two of the 
studies showed no improvement in health outcomes despite the participants’ active 
engagement in weekly TM. Moreover, adherence to TM did not correlate with 
improved health outcomes, i.e. health outcomes remained similar regardless of the 
intensity of TM.
◆ Putting the results together, the findings suggest that the positive health effects 
in TM studies may be related to differential patient decision support components 
provided in response to the TM data. Improvements in health outcomes were seen 
only in one of the studies where individuals received real-time tailored feedback 
messages that motivated and guided them to take actions in response to their 
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self-monitoring data. These findings suggest that delivering timely feedback with 
enriched content is important.
◆ Moreover, the positive findings of the Mobile Sipoo study (I) emphasize the 
importance of building TM interventions on a theoretical basis, even to be applied 
when developing automatic feedback systems. However, the sample size in the 
Mobile Sipoo study was small, and thus the results need to be confirmed in larger 
RCTs.
◆ TM might increase the use of healthcare resources, particularly nurse contacts. 
Therefore, sufficient resources should be ensured when implementing TM as a 
part the care chain. Moreover, the benefits gained through TM should be carefully 
evaluated in the light of other findings and the requirement for investment in 
additional resources. In the Heart at Home study (II) the increase in the use of 
healthcare resources was substantial and was unlikely to be compensated by reduced 
hospitalization rates.
◆ More intense exploitation of TM technology has the potential to lessen, at least 
to some extent, the increased workload of healthcare professionals. By enhancing 
the content of the automatic feedback messages with tailored recommendations 
for individual needs and concerns, and preferably building on behavioral theory, 
individuals’ self-management efforts could be further supported and their knowledge 
and skills enhanced, and the workload of healthcare providers thus also potentially 
minimized. 
◆ It is important to target TM interventions at patients who are likely to adhere to 
them and likely to benefit from them. If the quality of the care is high and the 
chronic condition well managed, TM interventions are however unlikely to be 
superior to standard care.
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Abstract
Background: Type 2 diabetes is an individual health challenge requiring ongoing self-management. Remote patient reporting
of relevant health parameters and linked automated feedback via mobile telephone have potential to strengthen self-
management and improve outcomes. This research involved development and evaluation of a mobile telephone-based
remote patient reporting and automated telephone feedback system, guided by health behavior change theory, aimed at
improving self-management and health status in individuals with type 2 diabetes.
Subjects and Methods: This research comprised a randomized controlled trial. Inclusion criteria were diagnosis of type 2
diabetes, elevated glycosylated hemoglobin (HbA1c) levels (range, 6.5–11%) or use of oral diabetes medication, and 30–70
years of age. Intervention subjects (n= 24) participated in remote patient reporting of health status parameters and linked
health behavior change feedback. Control participants (n = 24) received standard of care including diabetes education and
healthcare provider counseling. Patients were followed for approximately 10 months.
Results: Intervention participants achieved, compared with controls and controlling for baseline, a signiﬁcantly greater mean
reduction in HbA1c of - 0.40% (95% conﬁdence interval [CI] - 0.67% to - 0.14%) versus 0.036% (95% CI - 0.23% to 0.30%)
(P < 0.03) and signiﬁcantly greater weight reduction of - 2.1 kg (95% CI - 3.6 to - 0.6 kg) versus 0.4 kg (95% CI - 1.1 to 1.9 kg).
Nonsigniﬁcant trends for greater intervention compared with control improvement in systolic and diastolic blood pressure
were observed.
Conclusions: Sophisticated information technology platforms for remote patient reporting linked with theory-based health
behavior change automated feedback have potential to improve patient outcomes in type 2 diabetes and merit scaled-up
research efforts.
Introduction
Diabetes is an individual and public health challengethat has signiﬁcant medical1,2 and ﬁnancial1,2 conse-
quences and rapidly expanding prevalence worldwide.2–4
Importantly, type 1 and type 2 diabetes are chronic conditions
that require ongoing healthcare professional and self-
management efforts, which are crucial to reducing disease-
related morbidity and mortality.5–8 Because healthcare
professional and self-management of diabetes are essential,
but time-, effort-, and cost-intensive,9management of diabetes
is often suboptimal.6,10 For this reason, the search for efﬁcient
and effective means to improve management of diabetes has
been a focus of research efforts.11–16 The rapid evolution of
sophisticated information technologies and mobile commu-
nication devices in the past decade has made it possible to
exploit technology to facilitate healthcare professional and
self-management of diabetes.17,18
Information technology and mobile communication de-
vices can be used to support diabetes management in several
1VTT Technical Research Centre of Finland, Helsinki, Finland.
2University of Eastern Finland, Kuopio, Finland.
3Bayer Diabetes Care, Tarrytown, New York.
4Mediconsult Ltd., Helsinki, Finland.
5Departments of Psychology and Obstetrics and Gynaecology, University of Western Ontario, London, Ontario, Canada.
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ways. Remote patient reporting of relevant health parameters
such as blood glucose levels, blood pressure, weight, physical
activity, and nutrition can be linked, via mobile telephone,
intermittently or in real time, with human healthcare per-
sonnel or with automated feedback. Such remote reporting
supported with feedback systems may prove to be efﬁcient
and effectivemeans to improvemedical and self-management
of diabetes and to improve patient outcomes in this chronic
disease state.
Tatara et al.17 have reviewed 28 studies of mobile com-
munication device interventions to support diabetes man-
agement. Most of the studies reviewed reported on mobile
communication applications developed by investigators (as
opposed to commercially available applications), and most
of the studies involved individuals with type 1 diabetes
compared with type 2 diabetes (when diabetes type was
speciﬁed). In addition, most of the studies involved direct
healthcare provider involvement: healthcare providers
themselves gave feedback to patients (on an asynchronous
basis), reviewed patient data, or were notiﬁed by research
teams if deemed medically necessary on the basis of patient
data. In half of the studies Tatara et al.17 reviewed, patients’
blood glucose data were automatically transmitted from their
blood glucose meter via wireless technology, and in half of
the research reports patients manually entered their blood
glucose values. Across studies, activity data (pedometer
measurements), weight, blood pressure, and food intake in-
formation were reported via mobile telephones as well. A
signiﬁcant decrease in glycosylated hemoglobin (HbA1c) was
observed in about half of the mobile device intervention
studies reviewed, and ﬁndings for acceptability of this tech-
nology by patients participating in the studies were generally
positive. (See also systematic reviews by Fjeldsoe et al.19 and
Wei et al.20 for discussion of additional mobile telephone
device intervention research focused on improving manage-
ment of diabetes and other conditions.)
Individual studies in the active assistance literature include
work by Quinn et al.,21 who used WellDoc (Baltimore, MD)
software. WellDoc was designed by endocrinologists and
diabetes educators, and it provided real-time feedback, based
on remote patient reports, which were responded to on the
basis of proprietary algorithms. In this mobile technology-
based study of individuals with type 2 diabetes, a signiﬁcant
decrease in HbA1c in intervention compared with control
participants was observed across a 3-month trial. Additional
studies using mobile phone technology for remote reporting
of patient data and feedback with recommendations for self-
management have also shown positive impact. Kim22 con-
ducted a 12-week study involvingmobile telephone reporting
of blood glucose and receipt of feedback with individuals
with type 1 diabetes, and Yoon and Kim23 reported a similar
12-month study with individuals with type 2 diabetes. Both
studies reported signiﬁcant reductions in HbA1c. The recent
DIABEO study provided automated feedback concerning
medication adjustment, based on carbohydrate intake, pre-
meal blood glucose, and anticipated physical activity, to in-
dividuals with type 1 diabetes and reported signiﬁcantly
lowered HbA1c levels compared with controls.24 In related
work concerning individuals with type 2 diabetes and un-
controlled hypertension,25 mobile telephone-based remote
patient reporting of blood pressure resulted in a signiﬁcant
decrease in ambulatory blood pressure across the study pe-
riod. We note that not all individual studies of mobile tele-
phone and information technology report signiﬁcant change
in HbA1c or other clinical end points (see studies by Franklin
et al.26 and studies reviewed by Fjeldsoe et al.,19 Wei et al.,20
and Tatara et al.17 for examples of studies that did not achieve
clinical end points.)
Intervention research usingmobile telephone technology to
support healthcare provider and patient management of di-
abetes has thus employed both healthcare provider (most
often) or automatic (less often) feedback to patients who use
mobile telephones for remote reporting of relevant diabetes
parameters (e.g., blood glucose, blood pressure, weight, and
activity). Feedback is more often provided in asynchronous
and intermittent format than in real time, and research sam-
ples have generally been small. Recent studies of mobile
telephone-mediated interventions to improve diabetes man-
agement reviewed by Fjeldsoe et al.19 and Wei et al.20 had a
median sample size of 51. It is notable that mobile telephone-
based diabetes management interventions appearing in the
scientiﬁc literature have rarely been formally based on rele-
vant health behavior theory and research, despite the fact that
information technology interventions based on health be-
havior models have considerable potential to support health
behavior change. The current study, in contrast, involved
development and evaluation of a mobile telephone-based
remote patient reporting and automated feedback system that
is based on the Information-Motivation-Behavioral Skills
Model,11,27–31 a well-researched and well-validated model of
health behavior change and adherence.
According to the Information-Motivation-Behavioral Skills
Model,11,27–29,31 diabetes self-management information that is
easy for the individual to translate into appropriate self-
management action is a necessary prerequisite of optimal self-
management. In addition, diabetes self-management motivation,
including positive attitudes toward personally enacting dia-
betes self-management actions and perceptions of social
support for undertaking self-management actions, is essential
to incline even well-informed individuals to initiate and
maintain diabetes self-management practices. Finally, diabetes
self-management behavioral skills, including objective skills for
carrying out complex patterns of diabetes self-management
action (e.g., selecting appropriate foods and reminding one-
self to be active, to monitor weight, to test blood glucose, etc.),
and perceived self-efﬁcacy for doing so, are essential so that
even well-informed and well-motivated individuals will be
capable of acting effectively in diabetes self-management
efforts.
The current research involved development and evaluation
of a mobile telephone-based remote patient reporting system,
linked to automated feedback and guided by the Information-
Motivation-Behavioral Skills Model11,27–29,31 and evidence-
based patient care guidelines.18 In this study, knowledge-based
reasoning based on the user’s health data was linked in a
dynamic process to the delivery of self-management infor-
mation, motivation, and behavioral skills messages. Assess-
ment of HbA1c, weight, and blood pressure at baseline and
follow-up of a 10-month study period, in intervention and
control patients, was used to gauge intervention impact on
diabetes health-related end points.
A conference presentation that was based on the ﬁndings
reported in this article has been published previously in ab-
stract form.32
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Subjects and Methods
Participants
The current research comprised an initial randomized
controlled trial to establish proof of concept for theory based
active assistance technology to promote diabetes self-
management and improve HbA1c, body weight, and blood
pressure. General inclusion criteria for this research program
included the following: age range of 30–70 years combined
with HbA1c >6.5%, systolic blood pressure >140mm Hg, or
diastolic blood pressure >90mm Hg. Speciﬁc inclusion cri-
teria for the current study of the impact of active assistance
technology on HbA1c, body weight, and blood pressure in
individuals with type 2 diabetes were as follows: known di-
agnosis of type 2 diabetes, elevated HbA1c (>6.5%) or cur-
rently using oral diabetes medication, and age range of 30–70
years. Exclusion criteria were expected poor study compli-
ance (e.g., information technology illiteracy or reluctance to
perform self-monitoring), pregnancy, patients with life ex-
pectancy of less than 1 year, patients with major elective
surgery within the past 6 months or planned for the next 6
months, patients with psychiatric disorders (e.g., depression),
or alcohol or narcotics abuse.
Research design
Stratiﬁed randomization was used to allocate patients to
control and intervention study arms. Patients were stratiﬁed
by sex and dichotomized age (<65 years and ‡65 years).
Using Microsoft (Redmond, WA) Excel-generated random
numbers, patients were then assigned to either the control
(n = 29) or intervention study arms (n= 27). The intervention
group participated in a diabetes lifestyle self-management
promotion program involving remote patient reporting and
automated theory-based health behavior feedback. The con-
trol group received standard medical care, including diabetes
education, annual checkups, and diabetes guidance and ed-
ucation given by a doctor or nurse during patient-initiated
visits to their health center.
Intervention and control arm patients underwent baseline
laboratory tests for HbA1c and blood pressure and related
assessments. If patients had laboratory tests on record that
were no more than 2 months old, these were used. Baseline
visits for intervention patients included appointments with a
physician and a nurse. At the physician visit, a personal care
plan was developed and provided to the patient. In addition,
individual target values concerning blood pressure, weight,
and activity (steps), as well as blood glucose for selected pa-
tients, were established. At the nurse’s visit, all intervention
patients received measurement devices for self-monitoring of
blood pressure, body weight, and physical activity (pedom-
eter). Blood glucose meters were given to six intervention
patients with type 2 diabetes who had particularly high
HbA1c values. A mobile phone with an application (‘‘Mon-
ica’’) was provided to intervention patients for reporting their
health parameters (blood pressure, weight, physical activity,
and, in speciﬁc cases, blood glucose values). The nurse pro-
vided instructions for using the Monica application and
measurement devices. Intervention arm patients were also
given a personal health record account (‘‘Medinet’’) that en-
abled them to view their medical records and remote data
reports that were uploaded using their mobile phone appli-
cation. Intervention subjects were asked to complete an elec-
tronic health questionnaire through the personal health
record at baseline and then again post-intervention. Control
arm patients completed the same questionnaires at baseline
and post-intervention with pen and paper. The personal
health record questionnaire assessed body weight at these
points in time. Following study participation of approxima-
tely 10 months in duration, all patients returned for follow-up
laboratory and clinical assessment. Intervention patients were
asked to complete a questionnaire about the usability, user
experience and usefulness of the Monica and Medinet appli-
cations. The study was approved by the Ethics Committee of
the Hospital District of Helsinki and Uusimaa.
Intervention
The intervention under study consisted of providing pa-
tients with technology (mobile telephone, software applica-
tion, and assessment devices) for monitoring and remote
reporting of diabetes health-related parameters from home.
Intervention patients were provided with automatically
generated, theory-based, health promotion-rich information,
motivation, and behavioral skills feedback messages, linked
to patients’ remote reports of their health parameters and
aimed at strengthening their self-care practices.
The intervention group was instructed to carry out a blood
pressure measurement in the morning and evening of 1 day
each week. They were also instructed to measure their weight
once a week, in the morning. Blood glucose was measured on
3 days each week, for those for whom this was indicated, with
the blood glucose meter provided. Selected intervention pa-
tients were instructed to take paired (pre- and postprandial)
blood glucose measurements—before and 1–2 h after a
meal—on blood glucose testing days. Patients were permitted
to choose if and how they wanted to use the pedometer to
measure activity. Patients were instructed to upload their
health parameter data using the Monica application directly
after making each measurement. For each reported mea-
surement, the patient received a feedback message based on
the reported data and data reported earlier during the trial, on
the basis of a decision support algorithm. Intervention pa-
tients could also access their personal health record (Medinet)
through a browser-based user interface offering the oppor-
tunity for patients to view their personal health information,
including prescriptions, laboratory data, and their personal
care plan.
The information technology architecture used for remote
uploading of patient data to the automated feedback response
system and personal health record is depicted in Figure 1. The
Monica application in the mobile phone supports uploading
of patients’ health parameter measurements. After each up-
load, the application displays graphs reﬂecting the uploaded
data in relation to individual target values and an informa-
tion, motivation, and/or behavioral skills feedback message
to support patient self-care. Study nurses scanned through the
status of all intervention patients each week and contacted
patients if warranted by their remote data reports. All patients
were encouraged to call their healthcare provider if needed.
Automated feedback
Automated feedback messages for patients were generated
by a decision support system directly integrated with
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participants’ personal health records. The objective was to
encourage patients to initiate and maintain lifestyle changes
appropriate to self-care of diabetes and hypertension by
providing personalized, information-, motivation-, and be-
havioral skills-rich feedback, based on patients’ self-measured
remote reported health parameters.
Patients’ personal health record database stored all patient-
reported remote measurements. A rule-based decision sup-
port algorithm scans the data and provides a patient-speciﬁc
feedback message for each measurement value reported by
the patient. For this purpose, we developed 265 separate
feedback messages concerning blood glucose, blood pressure,
weight, and activity (steps). Rules were set deﬁning condi-
tions under which each message was to be delivered to a
patient. These conditions were based on the value of the
monitored parameter (whether it was within or beyond a
target interval) and on the basis of long-term trends of remote
reported measurements. The decision support system is acti-
vated when a new measurement is remotely reported by the
patient. It scans all feedback messages and messages that
fulﬁll the preset conditions that are identiﬁed as eligible for
delivery in the current patient context. An inference engine
then selects the most appropriate feedback message to be
delivered to the patient. The inference engine scores the
messages based on a pre-assigned priority (highest for sus-
pected measurement error and alerts), history of previous
messages, and positive, reinforcing nature of themessage. The
engine also includes a random component introducing natu-
ral variability to avoid unnecessary repetition of the same or
similar messages. Randomness is introduced, however, only
when possible without compromising the delivery of high-
priority alerts. A high-priority message results, for example,
in a situation in which immediate contact with the patient’s
health center is recommended. High-priority messages are
also delivered, via the patient record system, to the attention
of the health personnel who are in charge of patient follow-up.
The medical content of feedback messages that are linked to
patient remote reporting of health parameter data is pro-
vided in accord with evidence-based patient care guidelines
(Duodecim18).
A core concept of the decision support system, as noted, is
to inform patients with easy-to-act-on self-management in-
formation, to motivate them to act on such self-management
information, and to provide behavioral skills coaching to
enhance the patient’s ability to act effectively in self-management
efforts. For this purpose the Information-Motivation-
Behavioral Skills Model was used as a basis for the formula-
tion of feedback message contents. An example of a feedback
message concerning an out-of-range trend for blood glucose
levels follows: ‘‘Your blood sugar levels were above the target
FIG. 1. Architecture of the remote patient monitoring system. DSS, decision support system; PHR, personal health records;
EHR, electronic health record.
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levels of 8mmol/L seven times out of the 12 after-lunch
measurements made during the past 2 months. Please, pay
attention to regular meal times and the contents of your lunch
to avoid excessive variation in your blood sugar levels.’’
Study end points
Primary end points of the study were the change in HbA1c
(% units) and systolic and diastolic blood pressure (mm Hg)
from baseline to post-intervention. A secondary end point
involved reduction in body weight (kg) from baseline to post-
intervention. Patient acceptance and usability and usefulness
of the feedback system were described as the proportion of
patients with a positive experience.
Statistical analysis
Analysis of covariance was used to assess effects of the
intervention onHbA1c, blood pressure, andweight, adjusting
for baseline levels. The 95% conﬁdence intervals and unad-
justed change scores are reported as well. As sex and agewere
used in stratiﬁcation, analyses were repeated adjusting for
these variables. No imputations weremade to replace missing
values, and patients with missing values were excluded from
the corresponding analysis. Signiﬁcance tests were conducted
with a= 0.05.
Results
Recruitment started in December 2010 and ended in April
2011. Invitation letters were sent to 337 patients who were
screened from the electronic health record system at the Sipoo,
Finland, Community Health Centre. In total, 237 patients did
not respond to the invitation letter or declined to participate.
Of the 100 respondents who indicated an interest in the study,
35were excluded as ineligible, and nine patients subsequently
declined to participate. From the 56 randomized patients, 27
were allocated to the intervention group, and 29 were allo-
cated to receive usual care (control). Of 29 control patients,
three did not complete the baseline visit, and consequently 26
control patients were included in the control arm. Six inter-
vention patients were selected for glucose monitoring on the
basis of high HbA1c level, and an equivalent subgroup of ﬁve
patients with highest HbA1c levels was identiﬁed within the
control group. One patient was lost to follow-up in the in-
tervention group, whereas two patients were lost to follow-up
in the control group. Two intervention patients were excluded
from our ﬁnal analysis because they proved not to have type 2
diabetes. The study was thus completed with 24 intervention
patients and 24 control patients.
Baseline characteristics of intervention and control partici-
pants appear in Table 1. The study arms were similar except
for systolic blood pressure (signiﬁcantly higher in the inter-
vention arm) and body mass index (somewhat lower in the
intervention arm). The unadjusted and baseline-adjusted
changes in clinical health end-point variables (HbA1c, blood
pressure, and weight) in the control and intervention groups
are presented in Table 2. Probability values denote the level of
signiﬁcance of the difference between the study groups. As
can be seen in Table 2, the intervention group achieved a sig-
niﬁcantly greater decline in HbA1c and in weight compared
with controls, when values are adjusted for the corresponding
Table 1. Baseline Patient Characteristics
Control group (n = 24) Intervention group (n = 24) P value
Sex (% male) 13 (54%) 13 (54%) 1.0
Age (years) 61.5 (9.1) 62.3 (6.5) 0.745
BMI (kg/m2) 33.5 (8.0) 30.7 (4.5) 0.151
Blood pressure (systolic/diastolic) (mm Hg) 146.5/84.7 (15.3/9.1) 157.0/88.5 (15.6/10.3) 0.029/0.204
Missing 3 0
HbA1c (%) 7.09 (1.51) 6.86 (1.56) 0.609
Education (years) 11.9 (3.9) 11.5 (3.5) 0.718
Exercise 0.730
No regular exercise 6 (25%) 4 (17%)
Regular health-enhancing physical activity 11 (46%) 14 (58%)
Regular ﬁtness-related exercise 6 (25%) 5 (21%)
Practice of competitive sports several times a week 0 0
Missing 1 (4%) 1 (4%)
Stress 0.373
My life situation is almost intolerable 0 1 (4%)
Considerably more than most people 3 (12%) 5 (21%)
To some degree, not more than people usually 11 (46%) 12 (50%)
Not at all 10 (42%) 5 (21%)
Missing 1 (4%)
Alcohol (standard drinks/week) 7.8 (9.4) 9.3 (12.5)
Missing 8 1 0.676
Smoking 1.0
Not at all 18 (75%) 19 (80%)
Occasionally 2 (8%) 1 (4%)
Yes, daily 3 (13%) 2 (8%)
Missing 1 (4%) 2 (8%)
Data are means (SD) or frequency (percentile). The number of missing values is reported where relevant.
BMI, body mass index; HbAlc, glycosylated hemoglobin.
ACTIVE ASSISTANCE TECHNOLOGY IN DIABETES 5
baseline level. HbA1c reduction within the intervention arm
was signiﬁcant (P = 0.025), and weight reduction within the
intervention arm was marginally signiﬁcant (P = 0.058).
HbA1c and weight change were nonsigniﬁcant within the
control group (P = 0.985 and P = 0.941, respectively). We also
observed a signiﬁcant within-group decrease in systolic and
diastolic pressure in both the control (P = 0.018 and P = 0.004,
respectively) and the intervention groups (P< 0.001 and
P < 0.001, respectively) with no difference in magnitude of
change between the study arms. We note that there were no
signiﬁcant differences in medication adjustments among
participants in the two study arms. Adjusting for participant
age, sex, and body mass index did not have any meaningful
effect on results.
Post-intervention reports indicated that 100% of interven-
tion participants (24 of 24 who responded to this question)
regarded Monica, the mobile telephone application, as ‘‘very
easy’’ or ‘‘quite easy’’ to use. More than 90% of respondents
(21 of 23 who responded to this question) reported that
making health parameter measurements and reporting them
was ‘‘very useful’’ or ‘‘quite useful,’’ and approximately 82%
(18 of 22 who responded to this question) of intervention
participants regarded the automatic feedback they received as
‘‘very useful’’ or ‘‘quite useful.’’
Discussion
The current research was structured as an initial random-
ized controlled trial to examine the impact of an active assis-
tance intervention, guided by health behavior theory, on
self-management and health status in individuals with type 2
diabetes. The intervention consisted of mobile telephone-
based remote reporting of blood pressure, weight, and, for
individuals with particularly high HbA1c, blood glucose
levels, linked with synchronous, automatic, theory-based
feedback. Patient feedbackwas enrichedwith self-management
information, motivation, and behavioral skills content. Re-
sults showed that the automated feedback intervention had
signiﬁcant effects on HbA1c and on weight, which declined
reliably in intervention compared with control participants
with type 2 diabetes or type 2 diabetes and hypertension.
Blood pressure trends were more positive for the intervention
group compared with the control group, but this effect was
not signiﬁcant. We note that these effects were present at the
10-month intervention follow-up and indicate sustained in-
tervention impact across a greater interval of time than is the
case in several other studies in this area.21,22
Seen as a proof-of-concept study, current results are sup-
portive of further research with mobile telephone remote re-
porting and automated Information-Motivation-Behavioral
Skills Model-based feedback linked to patient-reported health
parameters. Given the prevalence and consequences of dia-
betes and the fact that healthcare professional management
and self-management of diabetes are time-, effort-, and cost-
intensive, the potential efﬁciency and effectiveness of auto-
mated feedback, articulated to remote patient reports and
guided by health behavior change theory, would seem to be
considerable. In the clinical diabetes reality, ongoing health-
care provider support for diabetes self-management is not
uniformly available. At the same time, however, many, if not
most, individuals with diabetes have mobile communication
devices that provide potential access to information technol-
ogy-based interventions, guided by health behavior models,
from which they may beneﬁt at minimum cost.
Interactive technology support has been shown to improve
glycemic control in individuals with type 2 diabetes,33 but
success in this respect is determined primarily by frequent
contact between intervention patients and healthcare per-
sonnel.34 This increases use of healthcare resources and may
not be an option for all patients. On the other hand, extensive
use of behavioral change techniques via the Internet produces
larger effects than interventions with fewer techniques.35 Our
study applied active assistance technology for automated
processing of health information from patients in an ongoing
interaction with technology. This was achieved with semantic
information processing of patient-reported data and delega-
tion of decision-making to the automated system, which frees
up healthcare personnel resources.
There are several limitations of the current research. It is
notable that our sample size, like many similar published
Table 2. Change in Glycosylated Hemoglobin, Blood Pressure, and Weight as a Function of Study Arm
Control group Intervention group P value
Change in HbA1c (% units)
Adjusted 0.036 (- 0.23 to 0.30) - 0.40 (- 0.67 to - 0.14) 0.022
Unadjusted 0.004 (- 0.35 to 0.36) - 0.37 (- 0.73 to - 0.01) 0.141
Missing 0 1
Change in weight (kg)
Adjusted 0.4 (- 1.1 to 1.9) - 2.1 (- 3.6 to - 0.6) 0.021
Unadjusted - 0.07 (- 1.8 to 1.6) - 1.6 (- 3.3 to 0.1) 0.205
Missing 0 0
Change in systolic blood pressure (mm Hg)
Adjusted - 13.5 (- 21.3 to - 5.8) - 17.1 (- 24.3 to - 9.9) 0.508
Unadjusted - 9.8 (- 18.5 to - 1.0) - 20.5 (- 28.6 to - 12.3) 0.078
Missing 3 0
Change in diastolic blood pressure (mm Hg)
Adjusted - 7.3 (- 10.9 to - 3.8) - 9.5 (- 12.9 to - 6.2) 0.377
Unadjusted - 6.3 (- 10.5 to - 2.1) - 10.5 (- 14.4 to - 6.6) 0.148
Missing 3 0
Data are means (95% conﬁdence intervals).
HbAlc, glycosylated hemoglobin.
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interventions, was modest, but despite modest sample size
and statistical power to detect differences between groups,
signiﬁcant intervention impact was observed in relation to
HbA1c and weight declines across a clinically meaningful
time span. We note that inclusion criteria enabled participa-
tion of patients with type 2 diabetes who had controlled or
uncontrolled HbA1c levels, reducing, to an extent, room
available for signiﬁcant HbA1c reductions. Nonetheless, sig-
niﬁcant HbA1c reductions were observed over a sustained
intervention interval. In addition, we note that our patient
population self-selected to participate in a technology-based
self-management intervention. Although it is not known to
what proportion of patients with diabetes such interventions
would appeal, we found considerable evidence of user ex-
perience satisfaction both with the mobile telephone appli-
cation and with the value of the feedback that was provided.
In publishedWeb-based interventions with adults with type 2
diabetes, participation rates have varied between 32% and
83%.33 Thus, it may be anticipated that active assistance
technology would be an option for roughly half of adults with
diabetes. Sophisticated information technology platforms for
remote patient reporting linked with health behavior change
theory-based automated feedback appear to have potential to
improve patient outcomes in type 2 diabetes andmerit scaled-
up research efforts.
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Abstract
Background: Heart failure (HF) patients suffer from frequent and repeated hospitalizations, causing a substantial economic
burden on society. Hospitalizations can be reduced considerably by better compliance with self-care. Home telemonitoring has
the potential to boost patients’ compliance with self-care, although the results are still contradictory.
Objective: A randomized controlled trial was conducted in order to study whether the multidisciplinary care of heart failure
patients promoted with telemonitoring leads to decreased HF-related hospitalization.
Methods: HF patients were eligible whose left ventricular ejection fraction was lower than 35%, NYHA functional class 
and who needed regular follow-up. Patients in the telemonitoring group (n=47) measured their body ZHLJKWblood SUHVVXUHand
pulse and answered symptom-related questions on a weekly EDVLVreporting their values to the heart failure nurse using a mobile
phone app. The heart failure nurse followed the status of patients weekly and if necessary contacted the patient. The primary
outcome was the number of HF-related hospital days. Control patients (n=47) received multidisciplinary treatment according to
standard practices. Patients’ clinical VWDWXVuse of health care UHVRXUFHVDGKHUHQFHand user experience from the patients’ and
the health care professionals’ perspective were studied.
Results: Adherence, calculated as a proportion of weekly submitted self-measurements, was close to 90%. No difference was
found in the number of HF-related hospital days (incidence rate ratio [IRR]=0.812, P=.351), which was the primary outcome.
The intervention group used more health care resources: they paid an increased number of visits to the nurse (IRR=1.73, P<.001),
spent more time at the nurse reception (mean difference of 48.7 minutes, P<.001), and there was a greater number of telephone
contacts between the nurse and intervention patients (IRR=3.82, P<.001 for nurse-induced contacts and IRR=1.63, P=.049 for
patient-induced contacts). There were no statistically significant differences in patients’ clinical health status or in their self-care
behavior. The technology received excellent feedback from the patient and professional side with a high adherence rate throughout
the study.
Conclusions: Home telemonitoring did not reduce the number of patients’ HF-related hospital days and did not improve the
patients’ clinical condition. Patients in the telemonitoring group contacted the Cardiology Outpatient Clinic more frequently, and
on this way increased the use of health care resources.
Trial Registration: Clinicaltrials.gov NCT01759368; http://clinicaltrials.gov/show/NCT01759368 (Archived by WebCite at
http://www.webcitation.org/6UFxiCk8Z).
(J Med Internet Res 2014;16(12):e282)   doi:10.2196/jmir.3651
KEYWORDS
heart failure; telemonitoring; hospitalization; user experience; clinical outcomes; EHFSBS; health care resources
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Introduction
Heart failure (HF) is a serious and costly disease associated
with poor quality of life [1], a wide range of comorbidities [2],
and a high rate of hospitalization [3]. Nearly 25% of patients
are readmitted within 30 days [4], and by 6 months, the
proportion increases to 50% [5]. Hospitalizations cause a heavy
economic burden since they are responsible for 60-70% of the
total costs of HF care [6]. Moreover, the 1-year mortality of HF
patients is 30% [3], and the 5-year survival rate is poorer than
in most cancers [7].
A multidisciplinary care approach to heart failure is incorporated
with European and American guidelines. The multidisciplinary
care model includes specially trained HF nurses, the education
of patients (and caregivers) regarding precipitating factors and
the need for compliance with medication and diet, follow-up
monitoring by trained staff, and access to specialized HF clinics
[8]. Non-compliance with medication and other lifestyle
recommendations is a major problem among HF patients
resulting in worsening symptoms that can lead to readmission
[9]. Hospitalizations may be preventable by up to 50% mainly
by improving compliance with self-care [10].
Care-delivery models that incorporate telemonitoring as a part
of HF patients’ care have the potential to boost patients’
compliance with self-care while at the same time bringing health
care services closer to them. Meta-analyses from the years
2009-2011 link telemonitoring with improved survival,
decreased hospitalizations, and improved quality of life [11-13].
However, since these meta-analyses were carried out there have
been two large randomized controlled trials that have failed to
show evidence in favor of telemonitoring in terms of reducing
hospitalizations and death [14,15]. Similar findings have been
reported in earlier studies [16,17] and more recently in smaller
studies [18-20], except in the TEN-HMS trial [16], in which
mortality was found to be lower in the telemonitoring group
compared to usual care. Furthermore, results from the recent
Whole Systems Demonstrator (WSD) study, a multisite trial
involving 3230 chronically ill patients shows contradictive
evidence. Telehealth was found to reduce mortality and
emergency admission rates in the secondary care [21] but failed
to improve quality of life or psychological outcomes [22], nor
was it cost-effective [23]. Among patients with social care needs
in WSD study, telecare did not alter the use of health and social
care service or mortality [24]. To summarize, the literature
shows conflicting evidence on the effectiveness of
telemonitoring dependent on the target population and study
environment and the implementation and structure of the
intervention itself.
The current literature does not cover the evaluation of
telemonitoring as a part of multidisciplinary care. The objective
of this study was to investigate whether the multidisciplinary
care of HF patients could be improved with telemonitoring at
the Cardiology Outpatient Clinic of Helsinki University Central
Hospital (HUCH), primarily in terms of reducing HF-related
hospitalizations. We hypothesized that telemonitoring improves
patients’adherence to self-care—something that will be realized
as decreased hospitalizations.
Methods
Study Design
Heart at Home was a two-arm randomized controlled trial
conducted at the Cardiology Outpatient Clinic of HUCH in
2010-2012 (NCT01759368). The study protocol was approved
by the Ethics Committee of the Hospital District of Helsinki
and Uusimaa. All the patients provided a written informed
consent before they were randomized. (See Multimedia
Appendix 1 for the CONSORT EHEALTH checklist [25]).
Matched pair design was used in the randomization. The eligible
patients, who were similar in left ventricular ejection fraction,
NYHA classification, age, and gender, respectively, were
matched in pairs. One was randomized to the control group and
the other to the intervention group.
The study was divided into two parts. The first 30 intervention
patients and 29 control patients started stepwise from November
2010 to February 2011. After the first 59 patients had finished
their follow-up, the second group (17 intervention patients and
18 control patients) started in May to August 2011. The nominal
follow-up time was 6 months. The study was completed in
February 2012.
Participants
Patients suffering from chronic heart failure were recruited to
the study. The inclusion criteria were (1) diagnosis of systolic
heart failure, (2) age of 18-90 years, (3) NYHA class (an
LQWHUYLHZEDVHG FODVVLILFDWLRQ E\ WKH 1HZ YRUN Heart
$VVRFLDWLRQFRQFHUQLQJOLPLWDWLRQVWRSK\VLFDODFWLYLW\left
YHQWULFXODUHMHFWLRQIUDFWLRQDVPHDVXUHGGXULQJhospital
YLVLWVQHHGIRUDUHJXODUFKHFNXSYLVLWDQGWLPHfrom
WKHODVWYLVLWRIOHVVWKDQPRQWKV3DWLHQWVZHUHQRWHOLJLEOHif
WKH\ KDG D SODQQHG PDMRU PHGLFDO RSHUDWLRQ KDG severe
FRPRUELGLW\VXFKDVcancerKDGSDUWLFLSDWHGLQDQRWKHUclinical
WULDO GXULQJ WKH ODVW  PRQWKV RU ZHUH VXVSHFWHG RI poor
FRPSOLDQFH 7KH DVVHVVPHQW RI FRPSOLDQFH ZDV EDVHG on
patient’VWHFKQLFDOVNLOOVVXFKDVDELOLW\WRXVHDPRELOHphone.
The electronic patient database of HUCH was used for the initial
screening of patients with chronic heart failure so as to further
assess their eligibility. Eligible patients were informed about
the study and were asked whether they were willing to
participate (and their formal consent was obtained) when they
came for their normal follow-up visit. For willing patients,
anthropometric and laboratory measurements were taken and
the patients completed the study questionnaires. For each patient,
the medication was checked and optimized. The same procedure
was repeated at the end-point visit.
Usual Care
At the Cardiology Outpatient Clinic of HUCH, there are about
600 HF patients, of whom 150-200 patients have serious heart
failure that requires regular follow-up visits. A multidisciplinary
care approach including patient guidance and support for
self-care has been adopted at the clinic. In the care of these HF
patients, the cardiac team plays a central role in monitoring and
interpreting patient symptoms, optimizing medication, and
providing education. The cardiac team consists of 2 physicians,
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a specialized heart failure nurse, and a physiotherapist who
helps after a hospitalization period. As part of the care process,
patients capable of carrying out self-care were identified and
encouraged to regularly measure their blood pressure, heart rate,
and weight at home. The information exchange between HF
patients and care personnel took place during patients’ visits to
the clinic and by telephone. Systematic collection and
exploitation of the self-measurement data was difficult since it
depended on the patient’s own activity. Often a patient had not
monitored their health parameters as agreed or had forgotten to
bring along the measurement notes. The heart failure nurse
contacted patients by telephone if agreed in the care plan to
motivate and remind them to comply with the self-care plan.
Intervention: A Telemonitoring-Assisted Self-Care
Model
For patients in the intervention arm, a new care process was
introduced in which a patient regularly reported their most
important health parameters to the nurse using a mobile phone
app. At the beginning of the study, the patients were given a
home-care package including a weight scale, a blood pressure
meter, a mobile phone, and self-care instructions. The patients
were advised to carry out and report the measurements together
with the assessment of symptoms once a week.
A pre-installed software app on the mobile phone supported the
uploading of measurements and the self-assessment of
symptoms. In the development of the mobile app, particular
care was paid to the simplicity of the user interface and its ease
of use, since most of the patients were elderly. The
measurements taken at home to be uploaded were diastolic and
systolic blood pressure, pulse, body weight, and an assessment
of symptoms. The symptom assessment concerned the patient’s
feelings of dizziness, dyspnea, palpitation, weakness, and edema.
Patients were also asked to evaluate their overall condition, that
is, whether their condition had deteriorated, improved, or
remained unchanged. In the context of each submission of
information, the patient received automatic machine-based
feedback of whether the reported parameter was within their
personal targets set by the nurse. The overall architecture used
in the self-care process and screenshots of the software app are
depicted in Figures 1 and 2. The system was developed by VTT
Technical Research Centre of Finland.
The measurements were stored on the secured remote patient
monitoring server. The cardiac team was able to access the data
with a browser-based user interface. The nurse followed the
patient’s status and the data once a week or more frequently if
necessary. In the beginning of the study, the nurse contacted
the patient every time the measurement was beyond the target
levels or if the patient reported any of the symptoms. Later, the
contacts were more dependent on the patient’s measurement
history. If the latest measurement markedly differed from
previous measurements, the nurse called the patient. The nurse
could invite the patient for a check-up visit if still necessary
after the phone call. If a patient did not comply with the weekly
reporting plan, the nurse contacted the patient and encouraged
him or her to continue with the monitoring.
Figure 1. Overall architecture for remote patient monitoring.
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Figure 2. Screenshots of the reporting process with the mobile app.
Outcome Measures
Primary Outcome
The primary outcome was the number of HF-related hospital
days during the follow-up. The data were obtained from the
electronic health record system of HUCH.
Secondary Outcomes
Secondary outcomes included clinical outcomes, use of health
care resources, and user experience. The following variables
were analyzed in order to assess clinical effectiveness: death
from any cause, heart transplant operation or listing for
transplant operation, left ventricular ejection fraction (LVEF,
%) measured by echocardiography, plasma concentration of
N-terminal of the prohormone brain natriuretic peptide
(NT-proBNP, ng/l), creatinine (μmol/l), sodium (mmol/l), and
potassium (mmol/l). For the plasma concentrations of sodium,
potassium, and creatinine, there is no unambiguous interpretation
of the direction of change, but the value should be within the
reference range. The reference ranges used at HUCH are sodium
137-145 mmol/l, potassium 3.3-4.9 mmol/l, creatinine among
women 50-90 μmol/l and among men 60-100μmol/l. Sodium,
potassium, and creatinine were dichotomized indicating whether
the observed value was within the reference range.
Self-care behavior was measured using the European Heart
Failure Self-Care Behaviour Scale (EHFSBS). EHFSBS is a
12-item self-administered questionnaire specifically designed
and tested for HF patients including statements on self-care
behavior essential in the care of HF. The statements are scored
from 1-5; the lower the score, the better the performance in
self-care. The summary score was analyzed, and medication
changes were recorded to examine how the telemonitoring
intervention affected activity in medication regimen. The nurse
collected information regarding changes in patients’medication
regimen throughout the study. Changes related to medication
optimization during the baseline visit were excluded. Changes
made to patients’ medication were classified into three
categories: increase of medication (a new drug or increase in
dosage), decrease of medication (termination of a certain drug
or decrease in dosage), and self-imposed medication termination
(patient had stopped taking medicine without physician’s
confirmation). The medications were classified as diuretics,
ACE-I, or beta-blockers.
In terms of the use of health care resources, outpatient visits
were analyzed: the number of (1) unplanned visits to the
Cardiology Outpatient Clinic (nurse or physician), (2) visits to
the emergency department, (3) visits to and time spent with the
nurse, (4) visits to and time spent with the physicians, and (5)
telephone contacts made by the patient and by the nurse. The
baseline visits and the end-point visits were included in the
calculations. The data were retrieved from the electronic health
records and by asking the patient.
Patients’ acceptance and experience towards home
telemonitoring were evaluated using a questionnaire delivered
to patients in the telemonitoring group at the end-point visit.
The questionnaire included statements about their experiences
with the usability of the mobile phone app, as well as their
satisfaction with using the app and the benefits of the
telemonitoring-assisted care model. In addition, an in-depth
interview was conducted with the nurse responsible in order to
assess the user experience from a professional perspective.
Power Calculations
The study was designed to have a power of 90%, an alpha level
of .05, and an effect size of 0.5 determined as the expected
difference of 3 HF-related hospital days between the study
groups (SD 6). A t test was used as a calculation framework.
With these parameters, we calculated that 44 patients per
treatment arm needed to be recruited.
Statistical Analysis
The intention-to-treat principle was applied in statistical
analyses. There was one dropout in the intervention group. The
patient withdrew from the study shortly after the beginning, and
no end-point measurements were available. The patient was
excluded in the end-point analyses. All analyses except zero
inflated Poisson (ZIP) were carried out using SPSS version 19.
ZIP regression models were conducted using R version 2.15.1.
Outcome variables that express counts (eg, HF-related hospital
days, visits to the nurse, visits to the physician, number of phone
calls, unplanned visits to the clinic) were presented using the
mean and a percentage of zero counts. Poisson regression and
ZIP regression models were used in order to analyze the
difference between the study groups. The Vuong test [26] was
used to assess the superiority between Poisson regression and
ZIP for each variable. Finally, ZIP regression was used in the
analysis of the following variables: number of HF-related
hospital days, number of unplanned visits to the clinic, and
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telephone contacts initiated by the patient. In all models, the
patient’s individual study duration (in days) was set as an offset
variable, and the control group was used as a reference group.
The incidence rate ratio (IRR) and its 95% confidence interval
(Cl) were reported.
Repeated contiguous variables were analyzed within and
between the study groups. The paired t test or Wilcoxon
matched-pair signed-rank test in the case of non-normality was
used for the analyses of within-group changes. Non-normality
was confirmed by the Kolmogorov-Smirnov test. Analysis of
covariance was used to investigate differences between the
control and the intervention groups with adjustment for baseline
values. The 95% Cl and P value for the between-group
difference were reported.
Results
Patient Flow
Figure 3 shows the progress of the study. Altogether, 599
patients were screened from the database, of whom 243 were
diagnosed with systolic heart failure. Of these, 123 patients
fulfilled the inclusion criteria. Eligible patients who were similar
in their left ventricular ejection fraction, NYHA classification,
age, and gender were matched; 51 matched pairs were identified.
The 102 patients were invited for a baseline visit where baseline
measurements were taken and information considering the study
was given. Of these, 3 patients declined to participate and
another patient had a changed diagnosis. Respectively, their
matched counterparts were excluded from the study. Finally,
94 patients were randomized. One from each pair was randomly
assigned to receive the usual care, and the other was assigned
to the telemonitoring group. There was one dropout in the
telemonitoring group. The patient withdrew from the study after
23 days. The patient felt that monitoring his condition made
him anxious as it reminded him constantly of the disease.
Baseline Characteristics
Table 1 displays the baseline characteristics of the study subjects
in both the control group and the telemonitoring group.
Figure 3. Screening, randomization, and follow-up of patients.
Vuorinen et alJOURNAL OF MEDICAL INTERNET RESEARCH
Table 1. Baseline characteristics of the patients: mean (standard deviation) or frequency (percentile).
Telemonitoring group (n=47)Control group (n=47)
39 (83)39 (83)Sex (male), n (%)
58.3 (11.6)57.9 (11.9)Age in years, mean (SD)
28.4 (6.0)27.9 (4.7)BMI (kg/m2), mean (SD)
112 (13)116 (16)Systolic blood pressure (mmHg), mean (SD)
71 (10)72 (10)Diastolic blood pressure (mmHg), mean (SD)
69 (11)70 (12)Heart rate (bpm), mean (SD)
27.3 (4.9)28.6 (5.0)Left ventricular ejection fraction (% units), mean (SD)
NYHA, frequency (%)
19 (40)17 (36)Slight limitations in physical activity (Class II)
27 (58)28 (60)Marked limitation in physical activity (Class III)
1 (2)2 (4)Severe limitations in physical activity (Class IV)
Comorbidities, frequency (%)a
2 (4)2 (4)Diabetes
8 (17)6 (13)Hypertension
14 (30)6 (13)Atrial fibrillation
2 (4)5 (11)Asthma/COPD
0 (2)4 (9)Renal insufficiency
12 (26)9 (19)No comorbidities
35 (76)42 (89)Smoking (number of non-smokers), n (%) a
aData missing from one patient in the telemonitoring group.
Primary Outcome
On average there were 1.4 (SD 3.5) HF-related hospital days
in the control group and 0.7 (SD 2.4) HF-related hospital days
in the telemonitoring group. Of the control patients, 72%
(34/47), and of the telemonitoring patients, 83% (38/46) had
no hospital days during the 6-month follow-up. The difference
between the study groups was not statistically significant
(IRR=0.812, 95% Cl 0.525-1.256, P=.351).
Secondary Outcomes
Contrary to expectations, none of the subjects died, underwent
a heart transplant operation, or were listed for a transplant
operation. In both study groups, two patients had an emergency
episode.
Table 2 shows clinical outcomes at baseline and post
intervention. There were no statistically significant differences
between the study groups in either of the clinical variables.
However, in both study groups, there were significant
within-group changes: an increase in LVEF (4.2%, P=.001 for
control group and 5.0%, P=.003 for telemonitoring group) and
in EHFSBS (-3.8 points, P<.001 in the control group and -5.0,
P<.001 in the telemonitoring group) and a decrease in
NT-proBNP levels in the telemonitoring group (-198ng/l,
P=.01).
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Table 2. Clinical outcomes at the beginning and the end of the study and the within-group change with the corresponding confidence intervals (P value
refers to the significance level for the between-group difference).
Telemonitoring group (n=47)Control group (n=46)
P valueEffect size (95%
Cl)
Change
(95% Cl)
EndBeginChange
(95% Cl)
EndBegin
.256
Median difference
-148
-198
(-1921 to
170)
1014
(609-2631)
2347
(998-3568)
-50
(-831 to 260)
731
(368-2408)
1338
(474-2974)
NT-proBNP (ng/l), me-
dian (interquartile
range)a
.982ȕ 
(-3.658 to 3.743)
5.0
(1.8-8.1)
32.4 (9.8)27.3 (4.9)4.2
(1.8-6.5)
32.8 (8.2)28.6 (5.0)LVEF (%), mean (SD)
.298ȕ 
(-3.842 to 1.184)
-5.0
(-7.1 to -3.0)
22.6 (6.9)27.6 (6.8)-3.8
(-5.4 to -2.1)
24.1 (8.3)27.9 (6.5)EHFSBS score, mean
(SD)
.435
Median difference
0.9
3.5
(-1.0 to 9.0)
95.0
(83.5-112.3;
0.57)
92.5
(83.8-105.3;
0.67)
2.4
(-2.5 to 6.5)
92.0
(84.0-115.0;
0.57)
88.0
(78.0-121.0;
0.60)
Serum creatinine
(μmol/L), median (in-
terquartile range; pro-
portionb)a
.918
ȕ 
(-0.141 to 0.156)
-0.1
(-0.3 to 0.01)4.2 (0.4; 1.0)
4.3 (0.4;
0.94)
-0.06
(-0.18 to
0.05)
4.2 (0.4;
0.98)
4.2 (0.3;
0.98)
Serum potassium
(mmol/L), mean (SD;
proportionb)
.318
ȕ 
(-1.592 to 0.523)
1.0
(0.2-1.8)
140.7 (2.5;
0.96)
139.6 (3.0;
0.89)
0.2
(-0.7 to 1.1)
140.4 (3.4;
0.85)
140.2 (3.0;
0.96)
Serum sodium
(mmol/L), mean (SD;
proportionb)
aNon-parametric test.
bProportion of patients whose values were within reference interval.
Changes in medication regimen are presented in Table 3.
Significantly more medication changes were done to the patients
in the telemonitoring group (P=.042 for medication increase
and P=.026 for medication decrease). All decreases in
medication were done to telemonitoring patients, and the
decreases were applied to diuretics. The increases in medication
in the telemonitoring group involved the following types of
medication: five increases in angiotensin converting enzyme
inhibitor (ACE-I) therapy, three increases in beta-blockers, and
two increases in diuretics. In the control group, the two increases
were applied to diuretics.
Table 3. Categorized medication adjustments and the number of patients to whom the adjustments were applied.
P valueTelemonitoring group (n=46)Control group (n=47)Adjustments
.0428 (17)2 (4)Increase in medication, n (%)
.0265 (11)0 (0)Decrease in medication, n (%)
1.02 (4)3 (6)Self-imposed medication termination, n (%)
Table 4 shows the use of health care resources. The use of the
nurse’s resources was significantly greater in the telemonitoring
group (mean time at the reception was 48.7 minutes longer, and
the number of nurse visits was 1.73 times greater, P<.001 and
P<.001 respectively). There were more telephone contacts
between the nurse and the telemonitoring patients (IRR=5.6 for
nurse initiated contacts and IRR=1.63 for patient initiated
contacts, P<.001 and P=.049 respectively). Typically the patients
called the nurse for information to interpret the monitoring
results (eg, the safe range for blood pressure) or because they
wanted to make changes to their diuretic medication. The most
frequent reason for nurse-induced calls was patients’
non-adherence to self-monitoring: the nurse called patients to
remind them to carry out and report the measurements. The
number of unplanned visits to the Cardiology Outpatient Clinic
was significantly bigger in the telemonitoring group (IRR=3.31,
P<.001). The control group had on average one unplanned visit
to the clinic while telemonitoring patients had 3-4 unplanned
visits. The most common reason for unplanned visits was
patients’ concern about their worsening condition and the need
to discuss it with the nurse. In some cases, patients visited
physician reception if they needed immediate help. The reasons
for phone calls and unplanned visits were based on nurse’s
notes. There was no difference in the use of physician resources:
the number of visits and the time used at reception were similar
between the study groups.
Depending on the patient’s skills, 10-20 minutes was spent at
the baseline visit for educating the patient to use the mobile
phone app and blood pressure meter. During the follow-up
period, only six telephone calls concerning purely technical
problems took place. In three cases, the nurse called the patient
during the first days to help them get started with the mobile
app. The other three calls were initiated by the patient and were
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caused due to failed Internet connections. All other contacts took place for medical reasons.
Table 4. The use of health care resources per patient during the study.
P valueaEffect size (95% CI)Telemonitoring group (n=46)Control group (n=47)
<.001Mean difference 48.7
(32.5-64.8)
136 (43)87 (35)Nurse time (minutes), mean (SD)
<.001IRR=1.73
(1.38-2.15)
4.5 (2.2)2.7 (1.0)Number of visits to the nurse, mean (SD)
.340Mean difference 6.7
(6.0-18.6)
76 (34)69 (23)Physician time (minutes), mean (SD)
.738IRR=0.95
(0.71-1.28)
1.9 (0.9)2.0 (0.8)Number of visits to the physician, mean (SD)
<.001IRR=5.6
(3.41-7.63)
3.0 (2.4)/(15.2%)0.6 (0.9)/(57.4%)Number of telephone contacts initiated by
nurse, mean (SD)/[% patients with zero-count]
<.049IRR=1.63
(0.999-2.66)
2.3 (2.1)/(30.4%)0.6 (1.5)/(72.3%)Number of telephone contacts initiated by pa-
tient, mean (SD)/[% patients with zero-count]
<.001IRR=3.31
(2.15-5.09)
3.7 (2.6)/(13%)1.0 (1.5)/(46.8%)Number of unplanned visits to the Cardiology
Outpatient Clinic, mean (SD)/[% patients with
zero-count]
aDifference between groups.
Professional Experience
The HF nurse who was involved experienced telemonitoring
as a valuable support to the current practice. She reported that
the patients of the telemonitoring group took self-measurements
more regularly and had internalized the importance of regular
self-monitoring. Reception visits were more efficient, since no
time was wasted on irrelevant issues. The nurse found that
patients had taken their drugs more precisely, although no
numerical evidence was collected. The nurse reported that both
study groups were more curious about the ongoing study and
that patients contacted her more frequently than prior to the
study. The benefit that the nurse prioritized was the up-to-date
data she received from the patients. The data also provided
important support for physicians in their decisions about the
patient’s treatment, for example, in terms of adjustments to
medication. A potential disadvantage that the nurse brought up
was that the measurement data were input by the users; there
was a possibility that some users sometimes sent false data by
mistake or even intentionally. During the study, however, there
were no signs of such problems. Automatic data transfer from
monitoring devices would reduce the risk of erroneous data.
The nurse responsible for the patients did not see any obstacles
in adding telemonitoring as a part of their multidisciplinary care
model.
Patient Experience
Of 46 patients, 44 (96%) responded to the user experience
questionnaire. Almost all patients (95%, 42/44) found that
making and reporting measurements with the mobile phone app
was “very useful” or “quite useful”. The automatic feedback
they received after sending the measurements was found to be
useful; in fact, 91% (40/44) of patients felt it was “very useful”
or “quite useful”. However, 9% (4/44) patients responded that
they did not derive any benefit from the feedback. Two thirds
(66%, 29/44) responded that the feedback helped them pay more
attention to issues essential in the treatment of their disease. In
fact, 91% (40/44) of patients responded that the feedback
motivated them to take measurements and report them regularly.
Just over a quarter of patients (27%, 12/44) reported that the
feedback also gave them motivation to change their lifestyle.
Most of the patients accepted the home telemonitoring as part
of their care routine. The adherence, calculated as a proportion
of weekly submitted self-measurements, was 86% in weight
reporting and 89% in blood pressure, heart rate, and symptom
reporting. The median number of weight reports was 28
(interquartile range 23-33). The median number of blood
pressure and symptom reports was 32 (interquartile range
27-43).
Post-Hoc Power Calculations
The post-hoc power was calculated using the Poisson model
framework. Using the following definitions: exp(beta)=.8, base
rate=0.03, total sample=97, mean exposure time=200 days,
alpha=.05, R2=0 (since the study group was the only predictor),
distribution of group allocation= binomial with pi=0.5, the
post-hoc power of 0.81 was obtained.
Discussion
Principal Results
This study evaluated whether a multidisciplinary care model
would benefit from telemonitoring as an additional element in
the care of heart failure patients, primarily in terms of reducing
HF-related hospital days. We found that the
telemonitoring-assisted care approach led to increased use of
health care resources while showing no quantified improvement
in the patients’condition. There was no difference in the number
of HF-related hospital days, which was the primary outcome.
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However, patients and health care providers reacted positively
to telemonitoring. Patients’ adherence to the weekly reporting
plan was close to 90%, which is high in a population with a
severe chronic condition.
The increased use of health care resources was primarily seen
in the nurse’s workload. The telemonitoring group had an
increased number of visits to the nurse reception, a longer time
spent at the reception, and more frequent telephone contacts
with the nurse. Similarly, in the studies by Cleland et al [16]
and Wade et al [19], home telemonitoring was associated with
frequent patient contacts including home and office visits,
telephone contacts, and emergency visits. However, in our study
there was neither increased need for physician consultation nor
increased number of visits to the emergency department. Despite
the increased workload, the nurse found the increased number
of contacts with patients to be a positive change. In her
experience, telemonitoring invoked the patients’ interest in their
condition and raised questions that resulted in contacts. The
nurse also felt that the control group patients were more active
after their enrollment in the study. Patients’ increased curiosity
was not reflected in a lower number of HF-related
hospitalizations, but we can speculate whether low death rates
were associated with this. During the 6-month follow-up, we
found no deaths in either of the study groups, which is
unexpected since the mortality rate at 30 days after hospital
admission is 11% [27], rising to 30% during the first year [3].
When implementing telemonitoring in the care process, the
increased workload of care professionals needs to be accounted
for. Patients’ increased awareness of their disease is likely to
increase contacts. Patients need help in interpreting the
monitoring results, and they seek individual advice in order to
manage their disease and maintain their enthusiasm. This kind
of activity may lead to positive health outcomes during a longer
follow-up period than was the case in the present study. It should
be carefully considered whether the current resources are able
to handle the increased demand, or whether additional personnel
should be hired. As Chaundry et al [14] concluded, a
telemonitoring strategy would be more effective if embedded
in cardiology practices with a greater organizational capacity
to implement it. To lessen the increased workload of health care
professionals, the potential of active assistance technology is
worthy of consideration. Such technologies include highly
sophisticated automatic messaging systems providing
personalized guidance to patients with minimum involvement
of health care personnel. Promising results with active assistance
technology have been reported in the care of diabetes patients
[28].
In this study, telemonitoring was linked to more individualized
care in terms of the pharmacological therapy of HF patients.
This shows an important aspect, since optimal pharmacological
management reduces morbidity and mortality, but it is complex
and objective guidelines are lacking [29]. Significantly more
changes in medication regimen were made in the telemonitoring
group—medication was increased for 17% of these patients
whereas in the control group the corresponding percentage was
4%. In addition, all reductions in medication were done for
telemonitoring patients. Reductions were applied to Furosemide,
which is a diuretic, indicating successful management of fluid
retention. Whether medication changes were the result of
self-measurement data that telemonitoring patients provided or
through their increased self-care or both cannot be confirmed
with these data. The frequency of which the measurements were
done may alone not be sufficient to constitute the medication
changes, but at least the intervention opened patients’ eyes and
raised discussion concerning their medication.
Our negative finding regarding the hospitalization rate is in line
with findings in studies [14-20]. However, several studies do
show evidence in favor of telemonitoring in the care of HF
patients. This brings up the challenge in providing telehealth
for the right patients in the right context. In the TIM-HF study,
a subgroup analysis revealed that patients with lower depression
scores had significantly lower hospitalization and mortality
[30]. Comorbidities such as chronic obstructive pulmonary
disease, chronic kidney disease, and anemia may have a negative
effect by blurring the signal from the monitored variables and
thus lowering their predictive value [31]. Furthermore, in their
review of telemonitoring for chronic diseases, Pare et al [32]
concluded that the beneficial effects of telemonitoring are more
consistent in pulmonary and cardiac studies than in diabetes
and hypertension. In the tele-HF study [14], the authors
concluded that none of the participant characteristics including
age, sex, race, LVEF, and NYHA class identified a group in
which telemonitoring was more effective. A similar conclusion
was drawn in [30] in terms of LVEF, gender, age, or NYHA.
We outline four factors that may be associated with unchanged
HF-related hospitalizations rates. First, as multidisciplinary care
was part of the care practice at the Cardiology Outpatient Clinic
of HUCH, all the patients including the control group received
high standard interactive care, and some were already used to
home self-monitoring. Second, the study was carried out in the
Helsinki area where patients live a short distance from health
services. Patients were able to visit the clinic easily without
great effort. We found that the most common reason for
unplanned visits was that the patient wanted to discuss with the
nurse face-to-face the signs of deterioration and worsening
condition. Home telemonitoring may be more beneficial when
applied in rural areas where patients do not have direct access
to health care. Third, our study population was relatively young,
and medication for all patients was optimized during the baseline
visit. Ejection fraction was on average 28%, which is higher
than in the TEN-HMS study [16] of high-risk HF-patients.
Telemonitoring may be more efficient among patients with poor
prognosis. In the TEN-HMS study, which found home
telemonitoring associated with improved survival, patients were
older, had severe cardiac dysfunction, were recently
hospitalized, and had high mortality rates. Finally, the follow-up
time was possibly too short. Improved self-care may be realized
as a lower number of hospitalizations after a time interval longer
than 6 months.
Limitations
Post-hoc calculations were conducted based on the Poisson
model framework resulting in a power of 0.81, which was less
than was determined in initial power calculations. Considering
the fact that the 95% confidence interval for the IRR ranged
from 0.525 to 1.256, we do not expect that there was a true
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difference in the number of HF-related hospital days between
the study groups, although we did not reach the level of 0.1 for
the type II error. However, the predicted difference of 3 days
was overestimated since the number of hospital days was 1.4
in the control group. In addition, we note that we conducted
multiple hypothesis testing, which increases the probability of
falsely rejecting the null hypothesis. However, the statistically
significant findings that were seen in the use of health care
resources were consistent in several variables supporting each
other.
The usage of the nurse’s time was somewhat biased. The time
consumed at the baseline visit for the delivery of telemonitoring
technology to the patients was counted as time spent by the
nurse. Also, when technical problems emerged, patients
contacted the nurse. The time used at baseline visit was 10-20
minutes per patient. During the monitoring period, only six
contacts were made with the nurse due to technical problems.
Therefore, it can be concluded that the time spent on technical
issues was marginal and that the increased use of nurse’s
resources by telemonitoring patients took place due to medical
reasons. Technical issues did not increase the required time to
an extent that would lead to significant overestimation. An
additional source of bias is the fact that monitoring took place
under control of only one research nurse and the professional
experience was based only on her interview. Consequently, it
is not possible to draw general conclusions on the attitudes of
health care professionals on monitoring.
Conclusions
In the Heart at Home study, we found that home telemonitoring
was not efficient to support the multidisciplinary care approach
in terms of reducing the number of HF-related hospital days or
outpatient visits or improving patients’ clinical condition. The
telemonitoring increased significantly the nurse’s workload by
increasing the number of reception visits and the number of
telephone contacts. The increased workload should be carefully
considered when implementing telemonitoring in the care of
HF patients. Extra work is required on top of the
multidisciplinary care approach. To lessen the increased
workload of health care professionals, the potential of active
assistance technology is worthy of further consideration to
respond to patients’ queries and to keep them motivated.
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Abstract
Background: There is a strong will and need to find alternative models of health care delivery driven by the ever-increasing
burden of chronic diseases.
Objective: The purpose of this 1-year trial was to study whether a structured mobile phone-based health coaching program,
which was supported by a remote monitoring system, could be used to improve the health-related quality of life (HRQL) and/or
the clinical measures of type 2 diabetes and heart disease patients.
Methods: A randomized controlled trial was conducted among type 2 diabetes patients and heart disease patients of the South
Karelia Social and Health Care District. Patients were recruited by sending invitations to randomly selected patients using the
electronic health records system. Health coaches called patients every 4 to 6 weeks and patients were encouraged to self-monitor
their weight, blood pressure, blood glucose (diabetics), and steps (heart disease patients) once per week. The primary outcome
was HRQL measured by the Short Form (36) Health Survey (SF-36) and glycosylated hemoglobin (HbA1c) among diabetic
patients. The clinical measures assessed were blood pressure, weight, waist circumference, and lipid levels.
Results: A total of 267 heart patients and 250 diabetes patients started in the trial, of which 246 and 225 patients concluded the
end-point assessments, respectively. Withdrawal from the study was associated with the patients’ unfamiliarity with mobile
phones—of the 41 dropouts, 85% (11/13) of the heart disease patients and 88% (14/16) of the diabetes patients were familiar
with mobile phones, whereas the corresponding percentages were 97.1% (231/238) and 98.6% (208/211), respectively, among
the rest of the patients (P=.02 and P=.004). Withdrawal was also associated with heart disease patients’ comorbidities—40%
(8/20) of the dropouts had at least one comorbidity, whereas the corresponding percentage was 18.9% (47/249) among the rest
of the patients (P=.02). The intervention showed no statistically significant benefits over the current practice with regard to
health-related quality of life—heart disease patients: beta=0.730 (P=.36) for the physical component score and beta=-0.608
(P=.62) for the mental component score; diabetes patients: beta=0.875 (P=.85) for the physical component score and beta=-0.770
(P=.52) for the mental component score. There was a significant difference in waist circumference in the type 2 diabetes group
(beta=-1.711, P=.01). There were no differences in any other outcome variables.
Conclusions: A health coaching program supported with telemonitoring did not improve heart disease patients' or diabetes
patients' quality of life or their clinical condition. There were indications that the intervention had a differential effect on heart
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patients and diabetes patients. Diabetes patients may be more prone to benefit from this kind of intervention. This should not be
neglected when developing new ways for self-management of chronic diseases.
Trial Registration: ClinicalTrials.gov NCT01310491; http://clinicaltrials.gov/ct2/show/NCT01310491 (Archived by WebCite
at http://www.webcitation.org/6Z8l5FwAM).
(J Med Internet Res 2015;17(6):e153)   doi:10.2196/jmir.4059
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health coaching; telemonitoring; type 2 diabetes; heart disease; personal health record; health-related quality of life
Introduction
There is a strong will and need to find alternative models of
health care delivery [1], driven by the ever-increasing burden
of chronic diseases. To ensure adequate resources for the
delivery of health care and to further improve the level of care,
care-delivery models need to be changed in a way that patients
themselves become more involved in their own care.
Home telemonitoring of chronic diseases seems to be a
promising disease management approach with the potential to
boost patients’ compliance with self-care, while bringing health
care services closer to patients and, thus, resulting in improved
quality of life. However, the evidence of the effectiveness of
telemonitoring is contradictive and is dependent on the nature
of the disease [2]. In a systematic review by Pare et al [2], it
was found that telemonitoring improved glycemic control of
diabetics, decreased blood pressure levels of hypertensive
patients, and improved peak expiratory flows of patients with
asthma and symptoms associated with the illness. However, the
beneficial effect of telemonitoring was not associated with heart
failure and the evidence is still contradictive. Meta-analyses
conducted among heart failure patients from 2009 and 2011
conclude that there are beneficial effects of telemonitoring with
linkage to improved survival and decreased hospitalizations
[3,4]. However, since these meta-analyses, there have been two
large-scale randomized controlled trials [5,6] failing to show
the effectiveness of telemonitoring as concluded by Pare et al
[2]. Correspondingly, the evidence of telemonitoring on
improved glycemic control is contradictive. Typically, the
observed reduction in hemoglobin A1c (HbA1c) has been 0.5%
[7,8], raising a question of its clinical significance. Moreover,
there have been studies that show nonsignificant changes in
glycemic control among diabetics [9].
In chronic diseases the condition of a patient is highly dependent
on their engagement of self-care and their ability to adhere to
the management recommendations long term. For successful
disease management, the education of a patient is important.
However, the education-based interventions are by themselves
insufficient [10]. Health coaching helps the patient to clarify
his motivation to initiate and maintain change, offering a variety
of perspectives and recognizing that numerous factors contribute
to achieving goals [11]. Promising results have been obtained
among type 2 diabetes patients in health coaching conducted
by telephone [11]. However, the 1-year long health coaching
by telephony to support self-care in chronic diseases (TERVA)
trial, in which a health coaching approach was applied, failed
to achieve most of the expected improvements in clinical
measures [12]. Similar findings were found by Ruggiero et al
[13]. In addition to the importance of self-management, patients
and health care professionals need to share complementary
knowledge in health care processes, which brings challenges
and responsibility from both sides [14]. Telemonitoring provides
a possibility for improved interaction. The combination of
telemonitoring and remote monitoring has shown promising
results among hypertensive patients [15].
The purpose of this study was to assess the benefits of a
structured mobile phone-based health coaching program,
supported by a remote monitoring system among chronically
ill patients. We expected the intervention to improve patients’
engagement in self-management and to enrich the interaction
between patients and health care professionals that would
eventually result in improved quality of life and/or the clinical
condition. Primarily, we hypothesized that we would see
improved quality of life among patients suffering from heart
disease or diabetes.
Methods
Study Design
The study was conducted as a two-armed randomized controlled
trial (RCT) between February 2011 and December 2012 in the
South Karelia Social and Health Care District (Eksote) in
Finland. The trial was registered at ClinicalTrials.gov
(NCT01310491). Eksote is responsible for arranging all primary
and secondary health care for the inhabitants of eight
municipalities, approximately 100,000 inhabitants. Patients with
type 2 diabetes and patients suffering from heart disease were
recruited to the study and assigned to either the control group
or the intervention group. The study was approved by the Ethics
Committee of the Social and Health Care District of South
Karelia.
Intervention
Overview
The intervention consisted of health coaching over mobile
phones and self-monitoring of health parameters with the help
of a remote patient monitoring (RPM) system.
Health Coaching
Each patient in the intervention group was assigned a personal
health coach who called them at regular intervals—every 4 to
6 weeks. A comprehensive evaluation of the patient’s clinical,
mental, and social condition was made during the first coaching
call and small, achievable health behavior changes were agreed
upon with the patient. A self-management plan was created
based on the targeted changes. During the mobile phone calls
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that were planned to last for approximately 30 minutes, the
health coach provided information, assistance, and support to
the patients. The health coaching approach was provided by
Pfizer Oy. The approach followed Wagner’s Chronic Care
Model [16]—one of the key foundational constructs for the
approach of chronic care management—and has been developed
and tested earlier. The detailed structure of the health coaching
program and the behavior change techniques involved are
reported elsewhere [12].
Health Coach Recruitment
Health coaches and a health coach supervisor were recruited
among the personnel of Eksote. Six coaches were recruited out
of 13 applicants. Four of the recruits were working in outpatient
care and two in a hospital. The selected coaches continued in
their regular positions and worked as health coaches 1 day a
week. The health coaches were trained to obtain the needed
knowledge about Pfizer’s health coaching model, behavioral
management skills, remote monitoring system, and trial
procedures. The health coaching model was a solution-oriented
working model where all patients received coaching based on
their individual needs. For quality control and educational
purposes, each health coach recorded some of the coaching
calls, which were evaluated together with a behavioral science
professional once in every 3 months. The equal quality of all
health coaches was assured by continuous education and regular
meetings, which all the health coaches and the trainer attended.
Remote Patient Monitoring
Each patient in the intervention group received a remote
monitoring toolbox to be used in the trial. The toolbox consisted
of a mobile phone with specific software, a mobile personal
health record (PHR) app, and a set of measurement devices
connected to the patient’s PHR account. The mobile PHR app
was needed for manual and/or automatic reporting. All patients
received a blood pressure meter, which was connectable to the
mobile phone via Bluetooth. When the patients measured their
blood pressure, the value was automatically transferred to the
PHR using a binary short message service (SMS) text message.
Other health parameters to be followed were body weight, blood
glucose level for diabetics, and step count for heart disease
patients. The patients were instructed to measure and send these
values manually via the mobile phone to the PHR once a week.
The health coaches and patients were able to see the patients’
measurements in the PHR and were advised to utilize them
during health coaching phone calls. A self-management guide
was given to the patients with the intention to increase their
knowledge of their chronic disease.
Remote Patient Monitoring System
The intervention was supported by the RPM system, eClinic,
provided by Medixine Ltd (Espoo, Finland) (see Figure 1). The
self-management server is the central component of its
architecture, providing services for the storing and accessing
of information content (ie, RPM data) related to the
self-management process. The RPM data included various types
of information: health parameters registered by the
corresponding measurement devices, personal care plan entered
by the health coach in agreement with the patient, and data
obtained from the electronic health record (EHR). The HTTPS
protocol was used for sending all data from the mobile app to
the server. The system underwent no major changes or updates
during the trial.
Figure 1. Technical architecture of the health coaching system supported with remote patient monitoring.
Standard Care
Patients assigned to the control group received the care they
would have received in the absence of the study. As part of
standard care, patients suffering from type 2 diabetes or heart
disease receive a disease management information booklet at
the time of diagnosis. Standard care includes laboratory tests
taken once a year and 1 appointment or phone call by a nurse
or doctor. Patients can contact health care services any time
they feel they need to.
Participants and Baseline Assessment
The patients’ eligibility was assessed primarily based on their
diagnosis. The diabetic patients were recruited based on a
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diagnosis of type 2 diabetes mellitus and their glycosylated
hemoglobin (HbA1c) level, which needed to be above 6.5%
within 1 year prior to the screening. It was required that the
patients had been diagnosed with diabetes at least 3 months
earlier. The heart disease group consisted of patients with a
diagnosis of ischemic heart disease, heart failure, or both. Other
inclusion criteria for all patients were as follows: 18 years of
age or older, ability to fill in questionnaires in Finnish, ability
to use the RPM system and the devices provided, having
adequate cognitive capacities to participate, and being able to
walk.
Potential participants were screened using the electronic health
record system of Eksote. EHRs cover information about citizens
living in the health care district of South Karelia who have
contacted health care services at least once. Invitation letters
including information about the study were sent to eligible
patients. Patients willing to participate signed an informed
consent form before randomization. After that, the supervisor
contacted each of the patients to schedule an appointment for
a baseline visit. Randomization was done after the appointment
was settled.
All patients who came in for the baseline visit were asked to
fill in a demographic questionnaire and the Short Form (36)
Health Survey (SF-36), version 2 [17], which measures
health-related quality of life. At the baseline visit, a health coach
measured the patient’s blood pressure, height (to the nearest 0.1
cm), weight (to the nearest 0.1 kg), and waist circumference (to
the nearest 0.1 cm), and calculated their body mass index (BMI).
Each patient’s medical history was reviewed based on the data
in the EHR system. If laboratory tests were older than 2 months,
new laboratory tests (ie, HbA1c, cholesterol, triglycerides) were
done. At the end of the visit, the health coach checked that the
required questionnaires were returned. If not, the patient was
asked to fill out the questionnaire at home and send it to a nurse
on the following day.
After 1 year following the baseline visit, all patients were invited
to an end-point visit. The same procedures were conducted as
they were during the baseline visit.
Randomization
A stratified randomization design was used to assign patients
to the control and intervention groups. Heart disease and
diabetes patients were randomized into separate groups. Patients
were further stratified into four subgroups according to their
sex and dichotomized age—18 to 65 years versus older than 65
years. Within these subgroups, Excel-generated random numbers
were produced. The allocation sequence was concealed from
the research nurse by means of an opaque and sealed envelope
until the baseline visit. During the baseline visit the envelope
was opened and, according to its content, each patient was
assigned to either group. The randomization was conducted by
the Technical Research Centre of Finland (VTT).
Outcome Variables
Short Form (36) Health Survey
The primary outcome for both disease groups was self-evaluated,
health-related quality of life (HRQL) assessed based on the
SF-36 health survey. Eight domains of HRQL and two summary
component measures of physical and mental health were
analyzed. Additionally, HbA1c level was another primary
outcome for the diabetes patients.
Clinical Outcomes
Secondary outcomes were as follows: blood pressure (mmHg),
weight (kg), waist circumference (cm), triglycerides (mmol/l),
total cholesterol (mmol/l), low-density lipoprotein (LDL)
(mmol/l), and high-density lipoprotein (HDL) (mmol/l). The
selection of outcome variables was based on the use of a model
for assessment of telemedicine applications [18]. However, this
paper examines the first three out of the seven domains
concentrating on the medical perspectives. Other domains, such
as organizational and economic outcomes, will be reported in
other articles in the future.
Adherence
Adherence to the health coaching was measured as the number
and duration of health coaching calls. The duration of a call
consisted of three parts—the time a nurse needed to prepare for
a call (eg, familiarize herself with the self-measurement data of
a patient), the duration of the actual coaching call, and the time
a nurse needed to finalize the call (eg, notes, information
delivery). Another perspective of the adherence measure was
based on the frequency of home telemonitoring, measured as
the total number of measurements made during the study and
calculation of the number of weight, blood pressure, blood sugar,
and step count reports. Both pre- and postprandial measurements
were included in blood glucose reports.
Statistical Analysis
We assumed we would see a difference of three points in the
SF-36 scores between the intervention and control groups with
a standard deviation of eight. The allocation ratio was
unbalanced—approximately 2:1. The number of intervention
patients was higher because we wanted to maximize the
exposure to, and gain experience about, this new intervention.
Defining a power of 80% and a Type I error rate of 5%, 163
intervention patients and 61 control patients were required.
Predicting a dropout rate of up to 20%, at least 200 intervention
patients and 75 control patients had to be randomized. The
numbers were applied to both the heart disease group and
diabetes group, resulting in 550 patients to be randomized in
total. We used the t test as a basis for the power calculations,
which is a conservative approach considering that repeated
measures were available in the data, and thus more powerful
tests could have been used.
The characteristics of dropout patients in terms of their baseline
measures were explored using Student’s t tests and chi-square
tests. All analyses were conducted separately for the diabetes
and heart disease groups. The analysis of covariance
(ANCOVA) was used to study whether the intervention and the
control groups differed in terms of their outcome variables. The
analyses were done by adjusting for the corresponding baseline
level by adding the baseline measure as a covariate in the
regression model. The 95% CIs and the corresponding P values
were reported. Additionally, within-group changes from baseline
to postintervention were analyzed using paired t tests.
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Analyses were conducted following the intention-to-treat
principle, meaning that all patients were analyzed in their
original allocation group regardless of the extent to which they
followed the intervention. No imputations were made to missing
values, but missing values were excluded from the analyses.
All reported P values were two sided. Analyses were conducted
using IBM SPSS Statistics version 19.
Results
Patient Flow
Figure 2 describes the progress of the trial. The electronic health
records were utilized to screen patients with either heart disease
or diabetes mellitus type 2. The diagnosis was either type 2
diabetes mellitus with HbA1c >6.5% or one of the following
two heart diseases: ischemic heart disease or heart failure. The
number of patients fulfilling the criteria was 1649 with heart
disease diagnoses, and 1987 patients with diabetes diagnoses.
Of these patients, 499 heart disease patients and 500 diabetes
patients were randomly selected and received invitation letters
in October 2010. The number of patients who refused to
participate, changed their mind before the trial began, or did
not show up at the baseline visit, was higher than expected.
Therefore, the invitation procedure was repeated in November
2010 and August 2011 to achieve the predefined power for the
pilot. In total, invitation letters were sent to 2084 patients, of
which 28.02% (584) agreed to participate. Eventually, 595
patients were randomized and, of these, 519 patients (87.2%)
attended the baseline visit. All participants filled out the baseline
questionnaires before they were told into which group they were
randomized.
There were 48 patients out of 519 (9.2%) lost to follow-up: 3
heart patients and 4 diabetes patients died, and 20 and 21
patients, respectively, withdrew from the trial without
participating in the concluding visit. The baseline characteristics
of the withdrawn patients were analyzed against patients who
concluded the trial. Quitting was associated with the patients’
unfamiliarity with mobile phones—of the dropouts in the heart
disease group, 85% (11/13) were familiar with mobile phones,
whereas the corresponding percentage was 97.1% (231/238)
among the rest of the patients (P=.02). Of the dropouts in the
diabetes group, 88% (14/16) were familiar with mobile phones,
whereas the corresponding percentage was 98.6% (208/211)
among the patients who concluded the trial (P=.004). Among
heart patients, withdrawal was also often associated with
comorbidities—40% (8/20) of the dropouts had at least one
comorbidity, whereas the corresponding percentage was 18.9%
(47/249) among the rest of the patients (P=.04). There was no
difference in the dropout rate between intervention and control
groups. Eventually, 246 heart disease patients and 225 diabetes
patients concluded the trial.
Figure 2. The patient flow within the trial. H: patients with a diagnosis of ischemic heart disease or heart failure, D: patients with a diagnosis of diabetes
mellitus type 2 and HbA1c > 6.5%.
Baseline Characteristics
Table 1 displays the baseline characteristic of patients separated
according to their primary disease. Overall, patients were similar
in the intervention group and in the control group in both disease
groups. The mean age among heart patients was 69.1 (SD 9.1)
years, and diabetes patients were slightly younger with a mean
age of 66.2 (SD 8.6) years. The majority of patients were men
in the heart disease group (178/269, 66.2%) and in the diabetes
group (129/250, 51.6%). BMI was higher in the diabetes group
than in the heart disease group, but BMI distribution was similar
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between the treatment arms. Over two-thirds of the patients
(361/519, 69.6%) were retired. Approximately 8.1% (42/519)
were smokers. The rate of missing values was clearly higher
regarding smoking and alcohol questions compared to the other
baseline questions. The high proportion of missing values
regarding the alcohol question was explained by the fact that
patients did not find a suitable option among the provided
choices for answers. They told this to the nurse at the baseline
visit, or it was written in the questionnaire that no proper choice
was given because they did not use alcohol at all. The majority
of the patients were familiar with mobile phones, and
approximately half of the patients were familiar with computers.
The most common comorbidities were diagnosed connective
tissue disease, rheumatic disease, or chronic pulmonary disease.
There were only a few patients with dementia or cerebrovascular
disease.
Short Form (36) Health Survey
Tables 2 and 3 show the baseline, postintervention, and change
scores of HRQL—the eight dimensions of the HRQL assessment
and the two summary scores. There were no significant
differences between the control and intervention arms in either
of the disease groups for any of the variables.
A total of 45 patients completed the baseline questionnaire at
home and later sent it to the nurse. On average, these patients
posted their questionnaires 5.3 (range 1 to 7) months after they
started in the trial. To exclude the bias that the late responses
may have caused, the analyses of HRQL were repeated without
the late responses. The level of significance of the difference
between the control and intervention groups remained above .1
in all variables. Thus, no change in the interpretation was
observed.
The number of respondents varied from question to question.
In the diabetes group, the number of respondents varied from
146 to 159 in the intervention group and 55 to 60 in the control
group, depending on the questions, which is slightly less than
was assumed in the pre hoc power calculations. The lower
sample size leads to a post hoc power of .76 when using the t
test framework. However, the magnitude of .80 was reached
when using the ANCOVA framework. The predefined power
was reached in the heart disease group.
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Table 1. Baseline characteristics of the patients in the two disease groups.
Diabetes patients
(n=250), mean (SD) or n (%)
Heart disease patients
(n=269), mean (SD) or n (%)
Baseline characteristic
Intervention
(n=180)
Control
(n=70)
Intervention
(n=190)
Control
(n=79)
81 (45.0)30 (43)66 (34.7)25 (32)Sex (female), n (%)
66.6 (8.2)65.5 (9.6)69.6 (9.1)68.1 (9.4)Age (years), mean (SD)
31.1 (5.4)30.9 (5.7)28.6 (4.7)28.1 (4.3)BMIa(kg/m2), mean (SD)
Education, n (%)
75 (41.7)30 (43)98 (51.6)29 (37)Primary school or less
65 (36.1)24 (34)59 (31.1)31 (39)Secondary or high school
27 (15.0)12 (17)24 (12.6)9 (11)College/university or higher
13 (7.2)4 (6)9 (4.7)10 (13)Missing
Marital status, n (%)
10 (5.6)4 (6)8 (4.2)1 (1)Never married
120 (66.7)53 (76)133 (70)69 (87)Married/cohabitating
25 (13.9)4 (6)24 (12.6)3 (4)Separated
22 (12.2)9 (13)23 (12.1)5 (6)Widowed
3 (1.7)0 (0)2 (1.1)1 (1)Missing
Work status, n (%)
34 (18.9)11 (16)34 (17.9)12 (15)Working
11 (6.1)3 (4)6 (3.2)4 (5)Unemployed (able to work)
5 (2.8)0 (0)5 (2.6)0 (0)Unemployed (unable to work)
118 (65.6)52 (74)138 (72.6)53 (67)Retired
1 (0.6)0 (0)0 (0)0 (0)Student
11 (6.1)4 (6)7 (3.7)10 (13)Missing
Smoking, n (%)
16 (8.6)6 (9)14 (7.4)6 (8)Smoker
23 (12.8)14 (20)27 (14.2)17 (22)Missing
Alcohol, n (%)
5 (2.8)2 (3)6 (3.2)2 (3)5-7 days a week
34 (18.9)13 (19)40 (21.1)21 (27)1-4 days a week
37 (20.6)11 (16)47 (24.7)14 (18)Monthly
65 (36.1)23 (33)52 (27.4)18 (23)Less than monthly
39 (21.7)21 (30)45 (23.7)24 (30)Missing
Familiar with PC b use, n (%)
102 (56.7)41 (59)102 (53.7)41 (52)Familiar
14 (7.8)8 (11)14 (7.4)10 (13)Missing
Familiar with mobile phone use, n (%)
161 (89.4)61 (87)173 (91.1)69 (87)Familiar
14 (7.8)9 (13)10 (5.3)8 (10)Missing
Comorbidities, n (%)
47 (26.1)15 (21)190 (100)79 (100)Heart diseases
9 (5.0)3 (4)4 (2.1)0 (0)Cerebrovascular disease
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Diabetes patients
(n=250), mean (SD) or n (%)
Heart disease patients
(n=269), mean (SD) or n (%)
Baseline characteristic
Intervention
(n=180)
Control
(n=70)
Intervention
(n=190)
Control
(n=79)
19 (10.6)12 (17)22 (11.6)8 (10)Chronic pulmonary disease, including COPDc
36 (20.0)9 (13)30 (15.8)8 (10)Connective tissue disease or rheumatic disease
180 (100)70 (100)46 (24.2)18 (23)Diabetes
12 (6.7)4 (6)17 (8.9)7 (9)Cancer
135 (75.0)52 (74)111 (58.4)49 (62)Otherd
23 (6.2)14 (9)39 (20.5)16 (20)No comorbidities
aBMI: body mass index
bPC: personal computer
cCOPD: chronic obstructive pulmonary disease
dHypertension is the most common “other” comorbidity.
Table 2. The baseline, postintervention, and change scores in the eight dimensions of the health-related quality-of-life assessments and in the two
summary scores for heart disease patients.
P aBetween-group dif-
ference,
beta (95% CI)
Intervention scoresControl scoresAssessment
Change
(95% CI)
PostBase-
line
nChange
(95% CI)
PostbBase-
line
n
.360.730
(-3.00, 1.78)
1.25
(0.29, 2.22)
40.839.51620.39
(-0.72, 1.49)
40.740.368Physical component
score
.62-0.608
(-6.19, 6.26)
-0.05
(-1.47, 1.37)
50.350.41620.55
(-1.53, 2.58)
51.050.568Mental component
score
.990.02
(-3.89, 3.93)
1.42
(-0.82, 3.67)
64.162.71701.16
(-1.77, 4.09)
66.164.968Physical functioning
(PF)
.95-1.72
(-6.09, 5.75)
3.16
(-0.58, 6.90)
62.158.91682.79
(-1.84, 7.42)
63.560.768Role-physical (RP)
.302.59
(-2.34, 7.51)
3.51
(0.58, 6.44)
59.956.41710.70
(-3.27, 4.66)
57.957.268Bodily pain (BP)
.361.77
(-2.06, 5.61)
2.60
(0.36, 4.84)
50.347.71710.56
(-2.93, 4.05)
49.248.768General health (GH)
.820.52
(-4.03, 5.06)
0.48
(-2.03, 3.00)
56.856.3165-0.25
(-4.71, 4.22)
56.957.168Vitality (VT)
.820.585
(-4.44, 5.61)
0.88
(-2.15, 3.90)
79.878.9171-0.18
(-4.93, 4.56)
80.080.168Social functioning
(SF)
.611.54
(-7.42, 4.34)
1.74
(-1.74, 5.22)
73.071.21682.86
(-2.63, 8.35)
75.472.567Role-emotional (RE)
.70-0.80
(-5.00, 3.36)
-0.23
(-1.47, 1.37)
77.277.41640.64
(-2.92, 4.21)
77.977.368Mental health (MH)
aP values show the level of statistical significance between the treatment arms.
bPostintervention score.
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Table 3. The baseline, postintervention, and change scores in the eight dimensions of the health-related quality-of-life assessments and in the two
summary scores for diabetes patients.
P aBetween-group dif-
ference,
beta (95% CI)
Intervention scoresControl scoresAssessment
Change
(95% CI)
PostBase-
line
nChange
(95% CI)
PostbBase-
line
n
.850.875
(0.80 9, 0.95)
0.53
(-0.40, 1.47)
43.242.61460.51
(-1.19, 2.21)
42.041.555Physical component
score
.52-0.77
(-3.15, 1.61)
1.06
(-0.42, 2.53)
51.250.21481.84
(0.02, 3.71)
52.050.156Mental component
score
.73-0.715
(-4.74, 3.13)
0.17
(-1.83, 2.17)
68.268.11571.09
(-2.87, 5.06)
66.064.958Physical functioning
(PF)
.99-0.036
(-6.19, 6.26)
3.11
(-0.45, 6.68)
68.865.71563.23
(-2.81, 9.27)
68.465.258Role-physical (RP)
.44-2.02
(-7.20, 3.13)
-0.18
(-3.05, 2.68)
62.262.41593.52
(-0.94, 7.98)
58.855.358Bodily pain (BP)
.262.34
(-1.72, 6.41)
3.47
(1.04, 5.89)
53.650.11591.34
(-1.48, 4.17)
50.649.260General health (GH)
.22-2.98
(-7.78, 1.83)
0.98
(-1.88, 3.83)
58.657.61495.21
(1.29, 9.19)
58.152.958Vitality (VT)
.33-2.54
(-7.70, 2.61)
1.19
(-2.05, 4.44)
81.180.01573.96
(-0.18, 8.10)
83.379.460Social functioning
(SF)
.920.30
(-5.50, 6.10)
3.93
(0.26, 7.60)
78.774.71573.81
(-1.72, 9.35)
78.174.359Role-emotional (RE)
.61-1.12
(-5.43, 3.19)
0.87
(-1.75, 3.50)
77.576.71492.07
(-1.80, 5.93)
78.576.558Mental health (MH)
aP values show the level of statistical significance between the treatment arms.
bPostintervention score.
Clinical Outcomes
Tables 4 and 5 display the baseline, postintervention, and change
scores in the anthropometric and laboratory measures, and the
comparison between the treatment arms in both disease groups.
In the heart disease group, there was no difference between the
treatment arms in any of the variables. However, there was a
significant within-group decrease in waist circumference
(P=.02), systolic blood pressure (P<.001), and LDL-cholesterol
(P<.001) in the intervention group. Also, in the control group,
LDL-cholesterol decreased significantly (P<.001), as did systolic
blood pressure (P<.001).
Among diabetics, there was a significant difference between
the treatment arms in waist circumference (P=.01). In the
intervention group, there was a significant decrease in weight
(P=.02), waist circumference (P<.001), systolic blood pressure
(P<.001), diastolic blood pressure (P=.007), and
LDL-cholesterol (P<.001). In the control group, systolic blood
pressure and LDL-cholesterol decreased significantly (P=.02
and P<.001, respectively).
Adherence
Out of 190 heart disease and 180 diabetes patients, 186 (97.9%)
and 177 (98.3%) patients, respectively, received at least one
health coach call. The average number of calls per patient was
8.7 (SD 1.6) in the heart disease patient group and 8.5 (SD 1.9)
in the diabetes group. The difference between the disease groups
was not significant (P=.40). The mean duration of a coaching
call was 20.1 (SD 8.0) minutes in the heart disease group and
19.2 (SD 8.1) minutes in the diabetes group, with a significant
between-group difference (P=.004). The mean time consumed
by the nurse for the preparation of calls was 3.5 (SD 2.5)
minutes in the heart disease group and 4.2 (SD 3.2) minutes in
the diabetes group, and the between-group difference was
significant (P<.001). The time consumed by the nurse after the
coaching calls among heart disease and diabetes patients was
3.8 (SD 3.0) and 4.5 (SD 3.6) minutes, respectively, with a
significant between-group difference (P<.001).
The median number of all self-measurements reported through
mobile phones was 209 (interquartile range [IQR] 124-324)
among heart patients and 217 (IQR 104-346) among diabetes
patients. The median number for heart disease group-specific
monitoring parameters per patient were the following: 18 (IQR
2-40) weight reports, 18 (IQR 4-43) step counts, 57 (IQR 36-89)
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blood pressure reports, and 42 (IQR 12-67) blood glucose
reports—6 patients made blood glucose monitoring reports. The
median number for diabetes group-specific monitoring
parameters per patient were the following: 15 (IQR 3-39) weight
reports, 15 (IQR 5-31) step counts, 56 (IQR 28-80) blood
pressure reports, and 47 (IQR 20-89) blood glucose reports,
including pre- and postprandial sugar. In the heart disease group
and in the diabetes group, 174 out of 190 (91.6%) and 171 out
of 180 (95.0%) patients, respectively, adhered to the
self-monitoring intervention to the extent that they sent at least
one report of any kind during the follow-up. Among 190 heart
disease patients, 136 (71.6%) sent at least one weight
measurement, 173 (91.1%) sent at least one blood pressure
measurement, 6 (3.2%) sent at least one blood glucose
measurement, and 118 (62.1%) sent at least one step count
report. Out of 180 diabetes patients, the corresponding numbers
were 119 (66.1%) for weight, 170 (94.4%) for blood pressure,
126 (70.0%) for blood glucose, and 13 (7.2%) for step count.
Table 4. Baseline, postintervention, and change scores in clinical outcomes for the heart disease group.
P a
Between-group dif-
ference,
beta (95% CI)Intervention scoresControl scoresClinical outcome
Change
(95% CI)PostBaselinen
Change
(95% CI)Postb
Base-
linen
.150.934
(-0.34, 2.21)
0.04
(-0.67, 0.76)
81.581.4170-0.84
(-1.85, 0.16)
79.179.970Weight
.15-1.518
(-3.57, 0.53)
-0.88
(-1.61, -0.16)
100.6101.51601.10
(-1.65, 3.85)
98.797.665Waist
.451.587
(-2.51, 5.68)
-5.43
(-8.12, -2.75)
140.1145.5161-6.36
(-10.7, -2.01)
138.0144.468Systolic
.730.468
(-2.24, 3.18)
-0.27
(-1.95, 1.41)
82.182.3161-0.18
(-2.81, 2.45)
80.981.167Diastolic
.920.009
(-0.168, 0.185)
-0.05
(-0.17, 0.06)
4.014.06168-0.08
(-0.25, 0.09)
4.054.1368Total cholesterol
.87
-0.018
(-0.086, 0.05)
0.02
(-0.01, 0.06)1.311.29168
0.03
(-0.02, 0.08)1.261.2368HDLc
.91
-0.008
(-0.15, 0.13)
-0.34
(-0.43, -0.24)2.162.50168
-0.36
(-0.51, -0.21)2.212.5668LDLd
.360.071
(-0.08, 0.22)
-0.01
(-0.13, 0.08)
1.351.37168-0.12
(-0.27, 0.03)
1.321.4368Triglycerides
aP values show the level of statistical significance between the treatment arms.
bPostintervention score
cHDL: high-density lipoprotein
dLDL: low-density lipoprotein
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Table 5. Baseline, postintervention, and change scores in clinical outcomes for the diabetes group.
P a
Between-group dif-
ference,
beta (95% CI)Intervention scoresControl scoresClinical outcome
Change
(95% CI)PostBaselinen
Change
(95% CI)Postb
Base-
linen
.34
-0.106
(-0.33, 0.11)
0.04
(-0.09, 0.17)7.297.25156
0.18
(-0.02, 0.35)7.367.2061HbA1cc
.39-0.566
(-1.86, 0.73)
-0.90
(-1.71, -0.22)
88.789.6153-0.30
(-1.21, 0.60)
88.688.960Weight
.01-1.711
(-3.042, -0.38)
-2.03
(-2.76, -1.29)
105.8107.8143-0.29
(-1.47, 0.90)
107.1107.457Waist
.93-0.196
(-4.57, 4.18)
-6.10
(-9.10, -3.09)
149.3155.4148-4.12
(-7.43, -0.81)
147.8151.960Systolic
.650.668
(-2.18, 3.52)
-2.61
(-4.50, -0.72)
86.689.2148-2.08
(-4.50, 0.34)
84.686.760Diastolic
.540.065
(-0.15, 0.28)
-0.1
(-0.23, 0.04)
4.254.35153-0.16
(-0.35, 0.03)
4.194.3660Total cholesterol
.61
0.005
(-0.054, 0.064)
0.02
(-0.01, 0.05)1.261.24156
0.03
(-0.05, 0.12)1.291.2660HDLd
.66
0.037
(-0.19, 0.20)
-0.40
(-0.51, -0.28)2.352.74156
-0.39
(-0.55, -0.23)2.272.6660LDLe
.25-1.22
(-0.32, 0.09)
0.01
(-0.10, 0.10)
1.711.701540.11
(-0.14, 0.36)
1.891.7859Triglycerides
aP values show the level of statistical significance between the treatment arms.
bPostintervention score
cHbA1c: hemoglobin A1c
dHDL: high-density lipoprotein
eLDL: low-density lipoprotein
Discussion
Principal Findings
This study evaluated whether health coaching, supported with
home telemonitoring, improved health-related quality of life
and/or the clinical condition of type 2 diabetes patients and heart
disease patients after 12 months. The intervention failed to
improve patients’ quality of life or their clinical condition.
Patients received regular health coaching calls throughout the
study and the majority of the patients adhered to the home
telemonitoring plan and frequently monitored at least one of
the required health parameters.
The intervention showed a statistically significant difference
only in waist circumference among type 2 diabetics. However,
due to the lack of consistency in other variables, this finding is
likely a result of multiple tests conducted in this study rather
than true a difference between the study groups. Multiple testing
increases the likelihood of false positive discoveries and this
should be acknowledged when interpreting the findings. In
addition, blood pressure and cholesterol levels showed beneficial
trends for all patients. Overall, the improvements in clinical
variables were more apparent in the type 2 diabetes group than
in the heart disease patient group.
There were 48 out of 519 patients (9.2%) that were lost to
follow-up. We found that unfamiliarity with mobile phones and
poor health status measured as a result of the presence of
comorbidities were associated with withdrawal. These findings
highlight the importance of offering and targeting interventions
to an audience with the appropriate skills. eHealth literacy is a
prerequisite for the success of eHealth interventions and should
be appropriately accounted for. Electronic health tools provide
little value if the intended users lack the skills to effectively
engage with them [19]. As suggested by Cruz et al [20], the
patient skills and acceptance of the technology should be
measured prior to its implementation. Appropriate skills are
also required on the professional side. A recent study evaluating
the use of email in the communication between the primary
health care system and general practitioners showed that the
easier the general practitioners thought the email system to be,
the more they used it [21]. In our study, six nurses were
specifically trained for health coaching and to actively utilize
the RPM system as part of the care.
The positive changes in patients’ clinical conditions in both
study groups emphasize the well-known fact that control patients
improve their lifestyles as a consequence of being involved in
a trial, even if they are not subjected to the actual intervention.
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Some of the control group patients were disappointed for not
being randomized into the intervention group and they decided
to take better care of themselves. Regarding disease-specific
effects, we found that diabetes patients who received the
intervention improved their health status among several health
parameters. The findings were not verified by testing statistical
interaction of group and disease variables, but the results in
Table 5 showed significant within-group reductions in patients’
weight, waist circumference, blood pressure, and LDL. We can
speculate whether diabetes patients are more prone to benefit
from this kind of intervention. Similarly, Pare et al reported that
telemonitoring was associated with a decline in hemoglobin
and better blood glucose control, but clinical effects on the
condition of patients suffering from cardiac problems were not
as evident [2]. Signals reflecting the state of diabetes are not
apparent. Even the symptoms of the worsening condition of a
patient may stay unrecognized. Therefore, the importance of
self-management as a part of diabetes care should be
emphasized. The utilization of self-management in health care
is a good direction to take, as it was shown by Rose et al [22]
that there is a risk of general practitioners, who are sensitive to
patients’ low self-efficacy in blood glucose monitoring, taking
over the monitoring role, and inadvertently reducing
self-management. Furthermore, a recent study showed that the
significant improvements in HbA1c achieved during a 6-month
trial of home telemonitoring, combined with active medication
management, were sustained for at least that same 6 months
[23].
Patients adhered to home telemonitoring in terms of measuring
their blood pressure. Assuming the duration of the trial was
approximately 12 months, 52 parameters were expected to be
reported. Heart disease and diabetes patients respectively
produced 55 and 57 blood pressure measurements on average.
Across other health parameters, the monitoring frequency varied
from 15 to 42. Patient groups seemed not to differ from each
other in terms of monitoring frequency. Some patients had a
lack of skills in using remote monitoring devices or they had
technical problems, which reduced the number of remote
monitoring measurements. Health coaching was realized as
planned. The expected number of health coaching calls was
between 9 and 12, with 4 to 6 weeks calling frequency. The
number of health coaching calls was 8.7 and 8.6 in the heart
disease and diabetes group, respectively. Our health coaching
model was solution oriented. All coaching calls were tailored
to the individual needs that affected variation to the call
durations. Few patients had lengthy hospital stays, which
affected the number of health coaching calls. The number and
duration of health coaching calls were significantly different
between the disease groups. The low level of significance was
likely due to a small standard deviation in the call duration. A
1-minute difference, as seen in the call duration, has no practical
relevance.
The low inclusion criteria in terms HbA1c for diabetic patients
posed a limitation on this study. For inclusion, a diabetic patient
was required to have an HbA1c higher than 6.5%. On average,
the HbA1c levels were 7.2%, showing that there was little room
for improvement.
A lack of social support was a potential factor that may have
influenced the negative findings of this study. Receiving
real-time social support may help people to stay engaged and
feel supported, which is important in order to initiate and
maintain improvements in health-related behaviors [24]. Another
appealing approach to keep patients motivated, specifically
those involved with self-monitoring of their health parameters,
is the utilization of active assistance technology. Active
assistance technology involves automatic processing of health
or behavior data and delivers automatic tailored messages to
users [25]. Results in this field have been promising, including
work by Quinn et al [26], Charpentier et al [27], and Orsama et
al [28]. As Bock et al [29] have recently shown, in order to
produce successful mHealth apps with lasting effects, it is
important to obtain user input throughout development. In our
study, the patients were contacted every 4 to 6 weeks. An
automatic feedback system, based on their self-monitored health
parameters, could have kept patients motivated and informed
by the delivery of individualized feedback with a coaching
perspective.
Conclusions
In conclusion, this study failed to show a beneficial effect of
health coaching supported by telemonitoring on patients’quality
of life or their clinical status. However, we do not yet know the
long-lasting benefits of the intervention. There were indications
that the intervention had a differential effect on heart disease
patients and diabetes patients. Diabetes patients may be more
prone to benefit from this kind of intervention. This should not
be neglected when developing new ways for self-management
of chronic diseases.
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Abstract.  
Background eHealth studies typically suffer from high attrition rates. Objec-
tive To investigate type 2 diabetes and heart disease patients’ adherence to a 
self-management intervention that combined health coaching and telemonitor-
ing. Methods Renewing Health Finland was a 12-month randomized controlled 
trial to improve quality of life (QoL) and/or HbA1c of 595 patients with chronic 
conditions. The intervention consisted of 1) weekly measurement of health pa-
rameters 2) health coaching every 4-6 weeks. Adherence to telemonitoring was 
defined as the percentage of weeks with at least one reported health measure-
ment. Adherence to coaching was defined as the number of received calls. Re-
sults The median percentage of monitored weeks was 65% without time-
dependent attrition. 66% of participants received 7-11 calls that corresponds to 
the predefined coaching schedule. Adherence did not correlate with QoL or 
HbA1c. Discussion Our results indicate that the intervention in the Renewing 
Health Finland trial was delivered almost with planned intensity. 
Keywords: adherence, telemonitoring, health coaching, QoL, HbA1c, type 2 
diabetes, heart disease 
1 Introduction 
Increasing burden of chronic diseases combined with aging population and reductions 
in health care resources create a need to identify care models that respond to the 
growing demand while maintaining and/or improving the quality of the care. 
Chronic care models that incorporate remote patient monitoring have shown prom-
ise in the past decades. Specifically telemonitoring interventions that involve measur-
ing and reporting disease-specific information remotely and transferring the data to 
health care providers have been widely studied with positive outcomes among a varie-
ty of chronic conditions including diabetes, hypertension, chronic obstructive pulmo-
nary disease and heart failure [1], [2]. Such interventions may improve patient’s en-
gagement with self-management while sharing the self-monitoring data with health 
care professionals provides continuous up-to-date information for care professionals 
to support their clinical decision making.  However, there is a growing bulk of litera-
ture including large-scale rigorous randomized controlled trials that have failed to 
validate the hypothesized benefits of telemonitoring interventions [3]–[7]. 
Attrition is a common feature for eHealth studies; interventions that are not critical 
but are based on patients’ voluntariness and that are easy to discontinue typically 
suffer from high nonusage rates [8], [9]. While it has been argued that high drop-out 
rates might be natural feature for eHealth trials, attrition is underreported and poorly 
understood and might even cause publication bias as it is often associated with failure 
of the intervention [8]. Study reports show aggregated statistics on usage, however, 
they often lack longitudinal aspects. Detailed analyses of uptake and possible discon-
tinuation of the intervention are needed and required [10] to understand and further 
improve the effectiveness of eHealth interventions. 
Between 2010-2013, we conducted a randomized controlled trial that assessed the 
effect of telemonitoring assisted self-management intervention on the quality of life 
and glycemic control of patients with chronic conditions [11]. Renewing Health Fin-
land was a part of the European research project Renewing Health where nine collab-
orating countries assessed the effect of telehealth interventions with RCT settings. In 
conjunction with the majority of the other trials [5], Renewing Health Finland did not 
find significant effect on primary health outcomes. In this paper we seek to find po-
tential factors that may have contributed to the nonsignificant findings by analysing 
patients’ engagement with the intervention in the Renewing Health Finland trial and 
investigating the effect of adherence on the health outcomes. 
2 Methods 
2.1 Renewing Health Finland 
Renewing Health Finland (RHF) was a 12-month randomized controlled trial aiming 
to improve health-related quality of life of type 2 diabetes and heart disease patients 
and glycemic control of type 2 diabetes patients with an intervention that combined 
telemonitoring and health coaching. The study population consisted of 308 heart dis-
ease patients (ischemic heart disease or heart failure) and 287 type 2 diabetes patients 
that were recruited from the health care district of South Karelia and further random-
ized either to the telemonitoring group or to standard care (2:1). Of the 595 partici-
pants, 361 (61%) were men, mean age was 67±9 years and mean BMI was 29.7±5.2 
kg/m2. 
The telemonitoring intervention consisted of weekly measurement of weight, blood 
pressure, blood glucose (for diabetics) and steps (heart disease patients) and reporting 
the measurements to the back-end systems using a mobile phone. Patients were given 
a self-monitoring toolbox that consisted of a mobile phone and measurement devices 
(incl. blood pressure meter, blood glucose meters, scale and a pedometers). In addi-
tion, each patient was assigned a personal health coach. During the first study visit the 
patient and the health coach created a self-management plan that included small 
achievable health behaviour changes agreed by the patient. The coach called the pa-
tients at a 4-6 week interval. During the calls the coach reviewed the goals and pro-
vided the patients with information, assistance and support to achieve them. Before 
each call, health coaches reviewed patient’s self-monitoring data. If the data showed 
abnormalities, the coach advised patient to contact primary care. If self-measurement 
data were missing and the patient had received the self-monitoring devices, the coach 
reminded the patient of the importance of self-monitoring and asked to conduct self-
measurements and report them to the system on a regular basis. Detailed description 
of the intervention and study results is described by Karhula et al. [11].  The telemoni-
toring system of Renewing Health Finland is depicted in Figure 1. 
Fig. 1. Technical architecture of telemonitoring system used in Renewing Health Finland 
 
 
2.2 Measures 
The telemonitoring system stored time-stamped self-monitoring data originating from 
the patients’ measurement devices. The log-data from coaching calls included starting 
time and ending time and status of the call (failed or answered). The logfiles allow 
detailed analysis of patients’ engagement with the telemonitoring intervention in the 
course of time and the responsiveness to the health coaching. 
Adherence 
Adherence to telemonitoring was defined as the percentage of weeks that included 
at least one measurement (blood glucose,body weight, blood pressure, steps) reported 
to the system.  Each week was analysed separately and was relative to the individual 
starting time. In addition, adherence to glucose monitoring was analysed separately as 
HbA1c was the primary outcome. Adherence to glucose monitoring was similarly 
defined as the percentage of weeks including at least one glucose measurement. 
Adherence to health coaching was defined as the total number of answered health 
coaching calls and the mean duration of the answered calls. As coaching calls were 
planned to be done with a 4-6 week interval, each patient was supposed to receive 7-
11 calls when the baseline and concluding calls were excluded. The first and last calls 
were excluded because the control group received the corresponding calls. However, 
the content of the calls was not similar but control patients received only study-related 
information. 
Quality of life 
The primary outcomes of the Renewing Health Finland trial were the health-related 
quality of life (QoL) measured using SF-36 and HbA1c. SF-36 was collected at base-
line and at the end of the study after 12 months. Physical component score (PCS) and 
mental component score (MCS) of SF-36 were used in the analyses. 
 
HbA1c 
Among type 2 diabetes patients the other primary outcome was HbA1c. Laboratory 
tests were done at baseline and at the end of the trial. 
2.3 Analysis 
Firstly, we calculated descriptive statistics for adherence to the overall telemonitoring, 
glucose telemonitoring and health coaching and illustrated the adherence trajectories 
over time. Secondly, the association between adherence and following sociodemo-
graphic variables were analysed: : sex, age, body mass index (BMI), comorbidities, 
education, familiarity with mobile phone, familiarity with computer, QoL (PCS and 
MCS) at baseline, and HbA1c at baseline. The analyses were done separately for 
telemonitoring and health coaching components by employing a t-test and analysis of 
variance (ANOVA). Thirdly, the correlations between adherence to the intervention 
and primary outcomes (SF-36 and Hb1Ac) were analysed using ANCOVA which 
allowed controlling for potential confounders. QoL models were controlled for sex, 
age, baseline level of QoL and comorbidities. HbA1c models were controlled for sex, 
age, and baseline level of HbA1c. For HbA1c and glucose monitoring analyses only 
the type 2 diabetes group was included. 
3 Results 
3.1 Adherence to telemonitoring 
The majority of participants adhered to weekly telemonitoring (Figure 2). The median 
percentage of adherent weeks was 65%; the 25th and 75th percentiles were 27% and 
85%, respectively. When only intervention completers were included, the median 
adherence increased slightly to 67%. Of the 370 patients, 43% and 29% were 70% 
and 80% adherent with weekly telemonitoring. No major attrition was observed in the 
course of the 12-month follow-up. The retention with telemonitoring was fairly good 
with the percentage of adherent participants varying from 51% (week 37) to 68% 
(week 6). However, there was a statistically signifiFDQWOLQHDUGHFUHDVHRYHUWLPHȕ -
0.002 [-0.003to-0.001]).  Adherence did not differ between the disease groups and the 
median number of monitored weeks was 30 in both groups. 
 
Fig. 2.   Adherence to weekly telemonitoring - the percentage of participants who made at least 
one measurement on a given week 1 
 
 
 
Adherence to glucose monitoring among diabetes patients was investigated sepa-
rately as HbA1c was the second primary outcome for the diabetes group (Figure 3). 
Of the 180 diabetes patients, 39 (22%) did not report any glucose measurements via 
the mobile application. The median number of glucose monitoring weeks was 17 
(33%). Twenty-six and eighteen percent of the patients were 70% and 80% compliant, 
respectively. Among those who started glucose monitoring, the median number of 
monitored weeks was 52. Similarly to the overall adherence to telemonitoring, adher-
ence to the glucose monitoring remained on a constant level throughout the study; the 
highest (42%) and lowest (36%) adherence rates were observed at weeks 4 and 14, 
respectively. 
 
Fig. 3. Adherence to weekly telemonitoring of blood glucose; the percentage of participants 
who made at least one glucose report on a given week2 
                                                          
1  The figure is limited to the week 47 because trial’s end-point visits were scheduled to start from week 48 
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3.2 Adherence to the health coaching 
The mean number of calls was 7.5 when starting and end-point calls were exclud-
ed. Sixty-six percent of participants received 7-11 calls which corresponds to the pre-
defined coaching schedule. Eighty-nine percent received at least 6 calls. The mean 
duration of calls was 26.7 minutes. There were no differences between the disease 
groups (md=.19, p=.305 for number of calls and md=.007, p=.993 for the mean dura-
tion). 
 
3.3 Predictors of Adherence 
Of baseline characteristics, male gender (adherence for males and females: 60% vs. 
50%, p=.004), younger age (correlation coefficient r=-0.181, p<.001) and familiarity 
with mobile phones (adherence for familiar and nonfamiliar participants: 58% vs. 
33%, p=.009) and computers (adherence for familiar and nonfamiliar participants: 
YV SޒZHUH DVVRFLDWHGZLWK KLJKHU DGKHUHQFH ,Q WRWDO RQO\SD
tients reported they were not familiar with mobile phones. Education level, BMI, 
baseline level of QoL and number of comorbidities were not associated with adher-
                                                                                                                                          
2  The figure is limited to the week 47 because WULDO¶Vend-point visits were scheduled to start from week 48 
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ence to telemonitoring. Adherence to glucose telemonitoring was associated with age 
(correlation coefficient r=-0.144, p=.054) and familiarity with computer (adherence 
for familiar and nonfamiliar participants: 47% vs. 28%). There were only 5 diabetes 
patients who were not familiar with mobile phone; among those the adherence was 
7%. The baseline level of HbA1c did not affect adherence. 
 
Adherence to health coaching was associated with familiarity with computer meas-
ured as a higher number (7.8 vs. 7.4, p=.027) and longer duration (27 vs. 26 minutes, 
p=.04) of coaching calls. 
 
3.4 The Impact of Adherence and QoL and HbA1c 
Fig 4 illustrates the relationship between adherence to telemonitoring and change 
in quality of life and HbA1c. Adherence to the telemonitoring was not associated with 
3&6ȕ S RU0&6ȕ S :KHQDGMXVWHGIRUEDVHOLQHFKDUDF
teristics there was a statistically significant positive association between adherence 
and MCS: ȕadj= ..033, p=.042. However, the clinical significance is limited as 10% unit 
increase in adherence increases MCS by only 0.3 points. The association with PCS 
UHPDLQHGQRQVLJQLILFDQWȕadj=.011, p=.295 after the adjustments. The effects of adher-
ence to glucose telemonitoring or adherence to overall telemonitoring on Hba1c were 
negative and statistically QRQVLJQLILFDQW ȕ - S  DQG ȕ -0.0002 (p=.891), 
respectively.  
+HDOWK FRDFKLQJ PHDVXUHG DV WKH QXPEHU RI DQVZHUHG FRDFKLQJ FDOOV ȕ 
S  IRU 3&6 ȕ -.132, p=.808 IRU 0&6 DQG PHDQ GXUDWLRQ RI FDOOV ȕ -.049, 
S IRU3&6DQGȕ S IRU0&6GLGQRWFRUUHODWHZLWK3&6RU0&6 
 
Fig. 4. The relationship between adherence to telemonitoring and change in quality of life 
 
 
4 Discussion 
In this paper we investigated type 2 diabetes DQGKHDUWGLVHDVHSDWLHQWV¶DGKHUHQFHWRD
self-management intervention that combined health coaching and telemonitoring, and 
further assessed the impact of adherence on QoL and Hba1c. 
The health coaching component in the Renewing Health Finland (RHF) trial was 
realized closely as planned. Sixty-six percent (66%) of patients received 7-11 coach-
ing calls which corresponds to the predetermined 4-6week interval for health coach-
ing, and 89% of participants received six or more calls indicating the majority of par-
ticipants missed one call at maximum. 
Participants’ adherence to the telemonitoring component was moderate: in the 
course of 12 months the participants conducted telemonitoring on 65% of the weeks 
on average. Unlike in many eHealth interventions [8], [12] there was no major attri-
tion towards the end of the trial but the percentage of adherent patients remained 51- 
68% over time. In telemonitoring studies adherence rates have been shown to vary 
from 52% to 75% [2], [7], [13], [14]. However, in these studies likewise in a number 
of other telemonitoring trials, health parameters were monitored on a daily basis that 
makes the numbers incomparable. Moreover, adherence numbers are typically based 
on aggregated averages failing to take into account the time effect that was presented 
in our study.  
Glucose telemonitoring was realized with lower adherence rates.  Type 2 diabetes 
patients conducted glucose measurements on 33% of the weeks on average and only 
18% of the participants were 80% adherent. The results indicate lower engagement 
than found in other studies. For example in the DiaTel trial [14], 75% of non-insulin 
type 2 diabetes patients engaged in daily glucose monitoring. Low adherence might 
be related to the unchanged HbA1c levels found in RHF study. 
Interestingly, telemonitoring activity did not correlate with QoL or HbA1c but the 
changes in those health parameters were similar regardless whether a patient was high 
or low adherent to the telemonitoring component. Our results are contradictory to the 
earlier studies showing improved quality of life in telemonitoring trials [1], [15], and 
improved HbA1c as a result of self-monitoring of blood glucose [16], though the 
benefits among type 2 diabetics not using insulin are inconclusive [17].The analysis 
of predictors of adherence did not shed light on what could explain the lack of this 
relationship. Participants’ baseline BMI and HbA1c levels and QoL were not associ-
ated with adherence to telemonitoring. Adherence was neither affected by the number 
of comorbidities. Of baseline characteristics, sex, age and familiarity with a mobile 
phone and a computer predicted higher adherence. The results imply that technology-
assisted interventions might have potential to appeal younger men who are typically 
underrepresented and nonadherent to lifestyle interventions. However, the clinical 
effectiveness of telemonitoring in this context remains questionable. 
While self-monitoring is the cornerstone of effective self-management in chronic 
diseases, it is only as effective as actions taken in response to the measurements [18]. 
In RHF health coaching was designed to respond to individual needs and empower 
patients and educate patients for better self-management. Health coaches reviewed 
patients’ self-monitoring data before each call, however, the medication changes that 
critically affect patient’s condition, were not specifically addressed. We do not have 
data about whether coaching calls resulted in further actions to intensify pharmaco-
logical treatment. 
5 Conclusions 
Our results on adherence indicate that the intervention in Renewing Health Finland 
was realized with at least moderate intensity. The vast majority of participants re-
ceived almost a complete health coaching intervention and the adherence to telemoni-
toring of health parameters was moderate with 34 monitored weeks on average. How-
ever, despite their engagement in the intervention, patients did not show improvement 
in QoL or glycemic control. In fact, the level of adherence to telemonitoring did not 
correlate with QoL or HbA1c at all. The results suggest that the self-management 
intervention components (telemonitoring and health coaching) were not effective in 
improving the quality of life and glycemic control of patients with chronic conditions 
even when successfully delivered and adhered to. Further research is needed to identi-
fy effective approaches to improve the care of chronic conditions. 
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